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Abbreviations 
Ab   antibody 
ACHA   anti-cholesterol antibody 
APC   antigen-presenting cell 
BCR    B cell receptor 
BLNK    B cell linker protein 
CD    cluster of differentiation 
CRAC  cholesterol recognition/interaction amino acid 
consensus
CTX-B   cholera toxin-B 
DAP-12   DNAX-activating protein of 12 kDa 
DRM    detergent resistant membrane 
ER    endoplasmic reticulum 
Fab    Fragment antigen binding 
Fas    TNF superfamily receptor 6 
FCS    fluoresence correlation spectroscopy 
FRET    föster/fluorescnence resonance energy transfer 
Gal    galactose 
Glc    glucose 
GlcNAc   N-acetylglucosamine 
GPI    glycosylphosphatidylinositol 
HCV    hepatitis C virus 
HEV    high endothelial venule 
HIV-1    human immunodeficiency virus type I 
HSA    heat stabile antigen 
IL    interleukine 
ITAM    immunoreceptor tyrosine-based activation motif 
ITIM    immunoreceptor tyrosine-based inhibitory motif 
LAT    linker for activation of T cells 
Lck    leukocyte-specific protein tyrosine kinase 
Lyn    an src family tyrosine-protein kinase 
MHC     major histocompatibility gene complex 
PBMC    peripheral blood mononuclear cell
PI(4,5)P2   phosphatidylinositol 4,5-bisphosphate
PKC protein kinase c theta 
Sia    sialic acid 
Siglecs    sialic acid binding immunoglobulin-like lectins 
SNA    Sambucus nigra agglutinin 
SLP-76   SH2-domain-containing leukocyte protein of 76 kDa 
Syk    spleen tyrosine kinase 
TCR    T cell receptor 
Th    T helper 
Tc    T cytotoxic 
TNF    tumor necrosis factor 
YIYF    tyrosine-isoleucine-tyrosine-phenylalanine





The immune system is a remarkably adaptive defense apparatus that has 
evolved in vertebrates to protect them from invading pathogenic microorganisms and 
cancer, preserving this way the consistency of the genetic code. This unique apparatus 
is able to generate an enormous variety and numbers of cells and molecules capable of 
recognizing and eliminating foreign invaders. Either the innate immunity, providing 
immediate and non-specific response, or the adaptive immunity which is capable of 
specific recognition and selective elimination of pathogenic agents upon activation by 
the innate response, consist of both soluble and cellular components. The cell 
membrane physically separates the intracellular components from the extracellular 
environment, keeping thereby the integrity of cells and serving also as a 
communication platform. Therefore, intact plasma membrane is required for cell 
viability and normal cell functions. Plasma membrane of immune cells consists of 
proteins, lipids and carbohydrates attached to the previous ones. Distribution and 
glycosylation of membrane molecules is highly inhomogeneous. 
Simons and Ikonen formulated the ‘lipid raft hypothesis’, according to which 
the lateral assembly of glycosphingolipids, sphingomyelin and cholesterol creates 
ordered microdomains floating in a glycerophospholipid-rich fluid environment and 
able to recruit a specific set of proteins while excluding others. (Simons and Ikonen, 
1997). Many studies explored various roles of lipid rafts in immunocyte signalling, 
membrane trafficking and in entry of various pathogens into target cells, 
demonstrating their importance in the function of immune cells (Horejsi, 2003; Matko 
and Szollosi, 2002). 
Glycosylation of raft-associated or non-raft membrane components is another 
critical factor that controls cell functions. Sialic acid and its derivatives are ligands of 
Sia-binding proteins, many of them expressed by cells of hematopoietic origin. These 
receptors, involving siglecs and selectins, play role in cell-cell interactions, cell 
signalling or endocytosis. In this way, they regulate the homing and activation of 
lymphoid and myeloid cells. 
Since the details of lipid raft- and glycosylation-dependent immune functions 
remained in many cases (e.g. infection by pathogens, cellular activation, motility, 
homing, maturation etc.) controversial or unclear, studying the role of cholesterol and 
sialic acid in the membrane of immune cells can certainly broaden our knowledge 
about these processes.
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1.1. Lipid rafts and the immune system 
1.1.1. Composition and heterogeneity of lipid rafts 
Lipid rafts of mammalian cells have unique lipid and protein composition. 
Sphingomyelin and glycosphingolipids with saturated acyl chains associate with each 
other and are more tightly packed than the surrounding bilayer (Simons and Ikonen, 
1997). Cholesterol, the major structural component of these domains, fills gaps 
between saturated fatty acids and is required in establishing proper membrane fluidity 
over the range of physiological temperatures (Brown and London, 2000). Raftophilic 
lipids, due to their biophysical properties, are in a liquid-ordered (Lo) type of 
organization in the membrane, while other parts of the plasma membrane are in 
liquid-disordered phase (Ld) (Mukherjee and Maxfield, 2004). The interaction of 
cholesterol with lipids is dictated to a large extent by fitting of its planar steroid ring 
to the fully saturated acyl chains of neighbouring lipids, supporting van der Waals 
attractive forces. Moreover, hydrogen bonding between the hydroxyl group of 
cholesterol and the amide group of sphingomyelin could further stabilize the 
interaction between these raft-resident lipids (Veiga et al., 2001). In model membrane 
vesicles it has been demonstrated that small modifications of cholesterol structure 
have moderately deleterious effects on the ability to support raft formation (Wang et 
al., 2004). For example, the free 3- -hydroxyl group is important, but not absolutely 
necessary, for the promotion of ordered domain formation by steroids. Ceramide can 
accumulate in detergent-resistant membrane domains upon sphingomyelinase action 
(Megha et al., 2006), leading to formation of large platforms in certain types of 
apoptosis and bacterial infections. Cholesterol is displaced in these ceramide-rich 
domains and that is likely to have consequences for raft functions based on altered 
association of cholesterol-bound proteins with rafts (Megha and London, 2004). 
Different types of protein-lipidations can direct proteins to raft microdomains. 
GPI-linkage targets proteins exclusively to lipid rafts, because phosphoinositide 
anchors usually have saturated acyl chains (Schroeder et al., 1998). On leukocytes, 
many GPI-anchored proteins have been revealed to be detergent resistant, e.g. CD14, 
HSA (CD24), CD48, CD55, CD59, Thy-1 (CD90) (Horejsi et al., 1999). These 
glycoproteins are members of adhesion molecules, pathogen receptors, ectoenzymes, 
complement-regulatory proteins etc. In the cytomplasmic leaflet, palmitoylated and 
myristoylated proteins partition into ordered domains. Most prominent members are 
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src-family protein tyrosine kinases, containing palmitic and/or myristic acid moieties, 
that are implicated in relaying signals downstream of a wide variety of cell-surface
receptors to evoke and regulate diverse cellular responses including proliferation,
differentiation and cell survival (Lowell, 2004). In contrast, the uneven surface of a 
prenyl group commonly excludes proteins from raft domains (Melkonian et al., 1999). 
The nature and length of the transmembrane helical segment might also be factors 
critically determining sorting of integral membrane proteins into raft or non-raft 
regions (McIntosh et al., 2003). Dozen’s of proteins, including TCR and BCR, can be 
recruited to lipid rafts upon multimerization or conformational changes. In addition, 
CRAC motif and YIYF amino acid sequence in the juxtamembrane segment are 
thought to play role in recognizing cholesterol, thereby keeping proteins in raft 
regions (Kuwabara and Labouesse, 2002; Li et al., 2001).
Caveolae is a special group of rafts that are small, flask-shaped invaginations 
(25-150 nm) stabilized by caveolin, a cholesterol-binding protein (Thorn et al., 2003). 
Caveolin-1 contains three sites of palmitoylation at cysteine residues. When 
palmitoylation sites were mutated, the resulting protein still translocated to caveolae 
(Dietzen et al., 1995). CRAC motif occurs in caveolin-1 that can partition the mutated 
protein into rafts (Williams and Lisanti, 2004). The HIV-1 gp41 protein has been also 
shown to contain a segment with a CRAC motif adjacent to its transmembrane helix 
that promotes membrane fusion (Salzwedel et al., 1999). CCR7, which is an important 
chemokine receptor of lymphocyte homing to peripheral lymph nodes and spleen, 
have both CRAC and YIYF motifs (Epand, 2006). In spite of this, raft-association of 
CCR7 is still elusive (Molon et al., 2005), suggesting that other parts of the protein 
might interfere with localization to detergent resistant membranes (DRMs).
The rafts in cells appear to be heterogeneous both in terms of their protein and 
lipid content, and can be localized to different regions of the cell. They are 10-200 nm 
sized dynamic membrane structures that can extend up to 1 m sized stabile 
microdomains upon cross-linking or different stimuli. Therefore, the activation and 
differentiation state of a given cell type determines the raft size and composition. 
Different methods provide evidence for raft heterogeneity. These are the differential 
detergent-sensitivity, separation of raft proteins by immunoaffinity chromatography 
and direct visualization of raft proteins and lipids in spatially distinct regions of the 
cell (Pike, 2004). For example, the GPI-anchored CD24 was found in detergent 
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resistant membrane fractions by Triton X-100 solubilization, but only 42% of this 
protein was in the rafts fractions if murine T-lymphoma cells were extracted with 
60mM octylglucoside (Ilangumaran et al., 1999). Thy-1 did not show this difference. 
Immunopurification of Thy-1 or CD3  by monoclonal antibodies in another cell line, 
also suggest that CD3  is present only a small subset of lipid rafts, whereas the bulk 
of the Thy-1 is distributed into other detergent-resistant domains (Drevot et al., 2002). 
Gomez-Mouton et al. demonstrated that ganglioside GM3 and the GPI-anchored 
protein, urokinase plasminogen activator receptor, were localized exclusively at the 
leading edge of the polarized T cells. Conversely, ganglioside GM1 and the raft-
localized transmembrane domain protein, CD44, were localized at the trailing edge of 
the cells. All four of these components were present in the low-density detergent-
insoluble fraction of Jurkat T cells (Gomez-Mouton et al., 2001). Thus, in intact cells 
the investigated raft markers were physically distinct and spatially segregated from 
each other. Analysis of early events of T cell activation also provided evidence for raft 
heterogeneity. Colocalization of Lck kinase and LAT adaptor protein to distinct raft 
domains was shown by electron microscopy (Schade and Levine, 2002). 
Consequently, not only lipid-lipid, but lipid-protein and protein-protein 
interactions can also essentially influence formation and composition of lipid rafts. In 
Figure 1 the structure of cholesterol and a schematic representation of lipid raft 
organization can be seen. 
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Figure 1. (A) Structure of cholesterol. The body of cholesterol consists of a series of fused 
rings, which make that part of the molecule quite rigid. At one end of this planar ring system 
is a hydroxyl group and at the other end is a hydrocarbon tail, so cholesterol, like other 
membrane lipids, has both hydrophilic and hydrophobic poles that determine its positioning 
within the lipid bilayer. (B) Schematic representation of lipid raft organization in the cell 
membrane. The outer leaflet of the membrane rafts (liquid-ordered phase; Lo) is enriched in 
glycosphingolipids and sphingomyelin and the corresponding inner leaflet is illustrated as 
containing glycerolipids with predominantly saturated fatty acyls. Cholesterol partitions 
preferentially into the Lo phase. GPI-anchored proteins are attached to the exoplasmic leaflet, 
















1.1.2. What is the function of lipid rafts in the membrane of immune cells? 
Functions of lipid rafts have been widely studied in the last 15 years. 
Caveolin+ and caveolin- lipid rafts play an important role in many cellular processes, 
including signal transduction, membrane sorting and trafficking, cell polarization, 
immunological synapse formation, cell movement or pathogen entry (Figure 2). Next, 
I will mention several examples without the claim of completeness. 
The spatial organization of immune receptors and components of their 
signalling cascades plays a central role in the initiation and regulation of signal 
transduction. The abundance of signalling molecules in lipid rafts suggests that these 
domains are key organizing elements of signal transduction (Brown and London, 
1998). Many antigen receptors of the immune system belong to the family of 
multichain immune recognition receptors (MIRRs). Binding of ligand (antigen) to 
MIRR results in receptor phosphorylation, triggering downstream signalling pathways 
and cellular activation (Sigalov, 2005). TCR on T lymphocytes, BCR on B cells or 
Fc RI expressed by mast cells belong to this family. It has been shown by detergent 
resistance measurements or confocal microscopic colocalization studies that rafts are 
critical in signalling of these receptors. In resting lymphocytes TCR is excluded from 
rafts, while other signalling components, such as Lck, LAT or CD4/CD8 co-receptors 
are concentrated to them (Dykstra et al., 2003). Upon engagement, TCR becomes raft-
associated and other members of the ‘signalosome’ including the kinase ZAP-70, the 
adaptor protein SLP-76 and PKC , are also recruited to lipid rafts following TCR 
activation (Dykstra et al., 2003). Indeed, more than seventy raft-associated proteins 
have been identified in resting and activated Jurkat T cells by proteomic analysis (von 
Haller et al., 2001). Similar events take place during B cell activation, just in this case, 
the BCR, kinases Lyn and Syk or BLNK adaptor protein are the key signal elements 
(Cheng et al., 1999). The raft proteome of B cells involves cytoskeletal proteins, 
transmembrane receptors, cell surface glycoproteins, Src-family kinases, small G 
proteins, heterotrimeric G proteins, motor proteins and trafficking proteins as 
analyzed by mass spectrometry of isolated DRMs (Gupta et al., 2006). 
The role of lipid rafts in spatial organization and compartmentalization of 
receptors other than MIRRs and downstream signalling elements has also been 
proven. For instance, cross-linking of MHC class II molecules on APCs with specific 
antibody was followed by its colocalization with GM1 gangliosides and partition into 
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insoluble membranes (Huby et al., 1999). Other studies demonstrated a constitutive 
raft-association of class II molecules (Anderson et al., 2000; Gombos et al., 2004). 
Furthermore, coengagement of CD28, co-receptor known to lower the threshold for 
TCR activation, resulted in both an increase of raft-localization and its redistribution 
to the immunological synapse (Martin et al., 2001; Viola et al., 1999). Thus, 
formation of clustered rafts in T cells and APCs is needed to the formation of the 
immunological synapse (Gombos et al., 2004). 
Lipid rafts play role, beside cell activation, in other signalling events, such as 
apoptosis, cell growth or differentiation. Recruitment of TNF receptor 1 or Fas 
receptor to these microdomains was revealed by different groups (Legler et al., 2003; 
Scheel-Toellner et al., 2002). In addition, the disruption of lipid rafts has led to the 
inhibition of ligand-induced apoptosis. Differences in raft composition and abundance 
have been implicated in regulating responses in the T cell subsets (Th1, Th2, Tc) and 
in naïve or effector T cells (Balamuth et al., 2001; de Mello Coelho et al., 2004; 
Tuosto et al., 2001). The response of B lymphocytes to BCR stimuli depends on their 
differentiation state as well. In pre-B cells, the pre-BCR constantly resides in lipid 
rafts and signals for survival. BCR is excluded from rafts in immature and mature 
resting B cells. However, upon cross-linking, BCR became stably raft-associated only 
in mature cells, but not in immature or tolerant ones (Chung et al., 2001; Weintraub et 
al., 2000).
Not just immune synapse formation, but chemotaxis also requires asymmetric 
redistribution of membrane receptors, signalling molecules and the actin cytoskeleton. 
(Manes and Viola, 2006). The spatial segregation of different raft-associated 
molecules in polarized T lymphocytes is described in the previous section. Another 
example is the morphologic polarization of human hematopoietic stem cells, where 
redistribution of several lipid raft markers, including cholesterol-binding protein
prominin-1 (CD133), during migration has been observed (Giebel et al., 2004). 
The endocytic role of caveolae and lipid rafts has been substantially 
investigated by Fivaz et al. (Fivaz et al., 2002). They concluded that trafficking of 
GPI-anchored proteins (GPI-APs) is controlled by their residence time in rafts, and 
hence that raft partitioning regulates GPI-APs sorting in the endocytic pathway. 
However, caveolae/raft ligands can also be internalized by other endocytic pathway. 
For instance, cholera and shiga toxins bind to cell surface raft domains and yet are 
internalized via clathrin-dependent pathways (Sandvig et al., 1989; Shogomori and 
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Futerman, 2001). Various bacteria, viruses and even parasites use lipid rafts/caveolae 
as portals of entry into target cells. For example, the FimH (mannose-binding fimbrial 
adhesin) expressing form of Escherichia coli is taken up by mast cells and 
macrophages via an endocytic route that does not include fusion with lysosomes and 
thus, the intracellular bacteria remain in viable state. The receptor for it was identified 
as CD48, a GPI-anchored protein (Shin and Abraham, 2001). Another interesting 
finding is that the parasitophorous vacuole of Plasmodium falciparum and 
Toxoplasma gondii is enriched in GPI-anchored proteins and raftophilic lipids (Lauer 
et al., 2000; Mordue et al., 1999). In the following section, I will focus on a specific 
case, the role of lipid microdomains in the infection by HIV-1, a member of the 
retrovirus family. 
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Figure 2. Role of lipid rafts in immune cell functions. Cholesterol- and sphingolipid-rich 
lipid rafts are capable to spatio-temporally organize membrane proteins and thereby regulate 
various functions of immunocytes including signal transduction, membrane trafficking and 
pathogen uptake. 
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1.1.3. Lipid rafts and the pathogenesis of HIV-1  
Role of lipid rafts in the pathogenesis of HIV-1 is an important area of 
nowadays’ biology. Many papers have reported on cholesterol- and lipid raft-
requirement for the entry of the virus into the target cells. This is compatible with the 
finding that CD4, the primary receptor of HIV-1, is a palmitoylated protein, and thus 
it is constitutively present in raft microdomains (Fragoso et al., 2003). The CCR5 and 
CXCR4 chemokine receptors, known as co-receptors of the virus, are at least raft-
partitioned and can dynamically associate to DRMs upon various stimuli (Baker et al., 
2007; Nguyen and Taub, 2002; Xiao et al., 2000). HIV-1 entry into the host cell is a 
multistep process that comprises viral attachment, co-receptor interactions and fusion 
(Figure 3). Initial interactions between gp120 (an abundant glycoprotein in the virus 
shell) and CD4 are followed by conformational changes in Env viral protein, 
permitting the interaction of the gp120-CD4 complex with the co-receptor leading to a 
further barrage of conformational changes that eventually lead to gp41 six-helix 
bundle formation and fusion (Gallo et al., 2003). Cholesterol is indeed required to this 
process. Depletion of the host membrane cholesterol strongly decreased HIV-1 
infectivity by diminished binding of the virus (Guyader et al., 2002; Liao et al., 2001). 
Another group has also confirmed this observation by using cholesterol oxidase to 
sequester cholesterol from lipid rafts (Nguyen and Taub, 2003), instead of -
cyclodextrin, known to form soluble inclusion complexes with cholesterol, thereby 
removing it from the membrane. Furthermore, cross-linking HIV-1 particles by 
antibodies has led to the coaggregation of various raft-associated proteins, like CD59 
and CD90 (Nisole et al., 2002). The presence of gp120 glycoprotein in membrane 
microdomains has also been reported. Recombinant gp120 highly colocalized with the 
raft component GM1 ganglioside and could be detected in DRM fractions (Popik et al., 
2002). The proximity of gp120 and GM1 was shown by fluorescence resonance energy 
transfer (FRET) imaging as well (Yi et al., 2006). 
On the other hand, cholesterol-rich membrane microdomains proved to be also 
critical in HIV-1 assembly/budding (Figure 4). Gag is a structural component of the 
viral particle driving virion assembly. The protein is myristoylated on the N-terminal, 
therefore it favours tightly packed part of the plasma membrane where it is directed 
post-synthesis (Kawada et al., 2008). Gag also interacts with PI(4,5)P2 and annexin2, 
two  raft-localized  molecules  (Harrist et al., 2009; Lindwasser and Resh, 2001).  The 
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annexin2-Gag protein interaction is PI(4,5)P2-dependent, since depletion of PI(4,5)P2
caused failure of Gag trafficking to the plasma membrane (Harrist et al., 2009). Two 
other viral proteins, Env and Nef, were described to be palmitoylated and 
myristoylated, respectively (Bhattacharya et al., 2004; Wang et al., 2000). The 
cytoplasmic domain of gp41, an Env protein, contains cysteine residues (C764 and 
C837) which are targets for palmitoylation and when these cysteine residues were 
mutated, gp41 was not able to associate with lipid rafts (Bhattacharya et al., 2004). 
Furthermore, Gag regulates the raft-association of Env, since in the absence of Gag, 
Env proteins failed to associate with DRMs (Bhattacharya et al., 2006). It has been 
shown by confocal microscopy that HIV-1 incorporated GPI-linked host cell proteins, 
CD59 and CD90, and GM1 ganglioside in its membrane (Nguyen and Hildreth, 2000). 
Analysis of the HIV-1 ‘lipidome’ showed that cholesterol and sphingomyelin is 
accumulated in the viral membrane, and inhibition of sphingomyelin synthesis 
reduced virus infectivity (Brugger et al., 2006). HIV-1 can also spread by direct 
contact of infected cells with non-infected ones. High colocalization of Gag and Env 
proteins with GM1 in the virological synapse has been reported by Jolly et al. (Jolly 
and Sattentau, 2005). All these investigations can contribute to our understanding how 
HIV-1 infection and spread take place, and could be the basis of finding new targets 













Figure 3. HIV-1 entry into the 
target cell. Env glycoprotein, 
gp120, on the surface of HIV-1 
virion binds to CD4 receptor in 
the lipid raft region of HIV-1 
permissive cells. This binding 
induces conformational changes 
in the glycoprotein leading to 
interaction with CCR5/CXCR4 
co-receptor. The glycoprotein 
gp41-mediated membrane fusion 
between viral and plasma 
membrane results in viral entry 
and uncoating (Waheed and 
Freed, 2009).
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Figure 4. HIV-1 assembly and release from infected cells. Pr55Gag viral protein is directed to 
the plasma membrane where it associates with lipid raft microdomains. Viral Env 
glycoproteins are incorporated into multimerized Gag complexes. After assembly of viral 
















Env incorporation Env 
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1.2. Sialic acid and Sia binding proteins 
1.2.1. Introduction to sialic acid biology 
Amongst the major classes of conjugated macromolecules in biology, the 
glycoconjugates are the most complex ones. Their complexity is comprised of a large 
variety of monosaccharides, linkages and branching structures, as well as a 
remarkable degree of intra- and interspecies diversity (Bishop and Gagneux, 2007). 
Glycosylation is an enzymatic process producing a diverse repertoire of glycans 
linked to proteins, lipids or other saccharides. An increasing number of studies show 
the importance of  glycans in different biological functions such as protein maturation 
and turnover, cell adhesion and trafficking, receptor binding and activation, and also 
pathogen recognition (Marth and Grewal, 2008; van Kooyk and Rabinovich, 2008). 
Sialic acid (Sia) is a general term for a diverse family of nine-carbon sugar 
containing -2 acid group that are all derived from neuraminic acid (Neu) or keto-
deoxynonulosonic acid (KDN) (Taylor and Drickamer, 2003). They are typically 
found on the exposed termini of mammalian oligosaccharide chains attached to cell 
surface proteins or lipids. Sialic acids are transferred using 2-3, 2-6 or 2-8
linkages to subterminal sugars by a family of about twenty sialyltransferases (STs). 
These sialyltransferases are grouped into four families according to the carbohydrate 
linkages they synthesize: -galactoside 2-3 STs (ST3Gal I-VI), -galactoside 2-6
STs (ST6Gal I, II), N-acetylgalactosamine 2-6 STs (ST6GalNAc I-VI) and 2-8 STs 
(ST8Sia I-VI) (Harduin-Lepers et al., 2001; Takashima, 2008). More than fifty 
different sialic acid structures have been found in nature including Neu, KDN, and 
their acetylated, methylated, lactylated, sulfated, and phosphorylated derivatives 
(Angata and Varki, 2002). One prominent Sia detected in many mammals is N-
glycolylneuraminic acid (Neu5Gc) which differs from the other common Sia, N-
acetylneuraminic acid (Neu5Ac), in one additional oxygen atom in the acyl group at 
the C5 position (Varki, 2001) (Figure 5A). Schauer and co-workers discovered and 
studied in details CMP-Neu5Ac-hydroxylase (CMAH) (Figure 5B), the enzyme 
converting CMP-Neu5Ac to CMP-Neu5Gc (Schoop et al., 1969). Due to a mutation 
occurred in the Cmah gene during evolution (Chou et al., 2002; Chou et al., 1998; 
Hayakawa et al., 2001) human have only Neu5Ac. The loss of Neu5Gc resulted in 
relaxation  of the specificity of Sia-binding proteins (e.g. Siglec-7, Siglec-9) described 
to prefer Neu5Gc in chimpanzees and gorillas (Sonnenburg et al., 2004). This means 
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adjustments in the binding pockets of these Siglecs, allowing the binding of Neu5Ac, 
without loss of NeuGc binding. Additional human-specific changes have been also 
found, affecting at least ten genes known to be involved in the biology of sialic acids 
(Altheide et al., 2006). Most of these changes affected members of the Siglec protein 
family and include gene inactivation, amino acid changes altering function, and 
expression differences (Varki, 2009).
Figure 5. (A) Structural differences between two major molecular species of sialic acid 
(Sia). The metabolic precursor N-acetylneuraminic acid (Neu5Ac) and its modified form N-
glycolylneuraminic acid (Neu5Gc) differing only by an oxygen atom at the C5 position. (B) 
Biosynthesis of sialylated glycoproteins in mouse. Cytidine monophosphate (CMP)-Neu5Ac 
synthetase (CMAS) catalyzes the activation of Sia to CMP-Sia. The enzyme CMP-Neu5AC 
hydroxylase (CMAH) is responsible for the conversion of CMP-Neu5Ac to CMP-Neu5Gc. 
CMP-Sia is imported into the Golgi apparatus and used by sialyltransferases (STs). These 
enzymes attach CMP-Sia to oligoglycosaccharides (OGS) found on glycoproteins and 




1.2.2. Sia-binding proteins: essential membrane receptors in the immune system 
Leukocyte extravasation is an important process in inflammation and in 
lymphocyte homing (Fabbri et al., 1999; Hogan and Foster, 1996). Selectins belong to 
the C-type lectin family of adhesion molecules (Figure 6A) that are involved in 
leukocyte-endothelial cell adhesion. Three types of selectins have been discovered so 
far. L-selectins are expressed by leukocytes, the expression of E- and P-selectins is 
inducible on vascular endothelium upon cytokine stimuli, and P-selectins were also 
found on platelets (Kansas, 1996; Keelan et al., 1994). Their ligands was described as 
sialic acid-containing tetrasaccharides, called sialyl-Lewisx and sialyl-Lewisa
(Galustian et al., 1999; Welply et al., 1994). The main ligand for P-selectin is P-
selectin glycoprotein ligand-1 (PSGL-1). This receptor is primarily expressed in 
hematopoietic cells such as granulocytes, monocytes, and certain subsets of T cells, 
and is also expressed by activated endothelial cells. PSGL-1 can be recognized, but 
with lower affinity, by the other two selectins as well.  E-selectin has been described 
to bind to several glycoconjugates on various hematopoietic and cancer cells in 
affinity or binding assay. These ligands may include L-selectin, E-selectin ligand-1, 
CD43, CD44, 2 integrins and glycolipids (Barthel et al., 2007). All these ligands can 
promote tethering and rolling of activated leukocytes or tumour cells on the 
endothelium. Glycosylation-dependent cell adhesion molecule-1, CD34, and mucosal 
addressin cell-adhesion molecule-1 have been discovered as ligands for L-selectin 
(Rosen, 2004). They are sialomucins, belonging to vascular addressins expressed on 
HEVs, which can present O-linked sugar chains to the lectin domain of L-selectin. 
The other important group of Sia-binding proteins is the Siglec family 
belonging to type I membrane proteins. Siglecs are sialic acid binding 
immunoglobulin-like lectins (Figure 6B) that are known to influence various 
functions of mammalian immune cells, such as regulation of cellular signalling, cell-
cell interactions and endocytosis (Crocker et al., 2007). Most of them contain ITIM- 
and/or ITIM-like motifs that can negatively regulate signal transduction. Some non-
ITIM containing Siglecs have been shown to interact with DAP-12, an ITAM-
containing adaptor that triggers both activating and inhibitory signalling (Crocker and 
Redelinghuys, 2008). Siglec-1 (Sialoadhesin), Siglec-2 (CD22), Siglec-3 (CD33) and 
Siglec-4 were the original members of the family. Many new members were identified 
in the last ten years and are called CD33-related Siglecs based on their high homology 
with CD33. Until now, 14 different siglecs have been described in human. Siglec 
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expression has been found mainly in the hematopoietic and immune system (Crocker 
et al., 2007). Sialoadhesin is a macrophage-specific adhesion molecule and CD22 is a 
well studied protein known to play role in regulation of B cell signalling (O'Keefe et 
al., 1996) and homing of B cells to the bone marrow (Floyd et al., 2000; Nitschke et 
al., 1997). In contrast, the CD33-related Siglecs show more complex expression 
patterns on innate immune cells. Most cell types in the human and mouse express at 
least one Siglec, while others express several. Siglecs can bind to either cis or trans
ligands. Cis interactions with sialic acids in the same plasma membrane could 
potentially regulate their function by ’masking’ them from ligands presented on the 
surface of other cells or pathogens. The ’unmasking’ of the Siglecs could be mediated 
by a variety of possible mechanisms, including a cell surface sialidase, via altered 
glycosilation or by reorganization of plasma membrane domains (Crocker et al., 2007; 
Crocker and Varki, 2001). Determination of the sialic acid-bearing molecules that 
could be feasible ligands of Siglecs is a developing area of biological research. 
Binding of Siglec-4 to gangliosides was already shown by Schnaar et al (Schnaar et 
al., 1998). The CD22-Ig Fc fusion protein has been reported to bind to CD45, serum 
IgM and many other B cell (and T cell) glycoproteins in vitro (Law et al., 1995; 
Stamenkovic et al., 1991). However, defining the precise function of Siglecs upon 
binding to biologically relevant ligands raise an important challenge. 
Figure 6. Structure of mammalian Sia-binding proteins.  (A) Selectins are type 1 membrane 
proteins with different functional domains. They have role in leukocyte extravasation through 
endothelial wall. (B) Siglecs are sialic acid binding immunoglobulin-like lectin 





1.2.3. Brief history of the sialic acid-containing GL7 epitope 
GL7, a rat monoclonal IgM antibody (developed previously in the NIH) was 
produced against in vitro stimulated mouse B lymphoblasts and proposed to bind to a 
35 kDa late activation antigen expressed by mouse B and T lymphocytes (Laszlo et 
al., 1993). GL7 antibody bound to only 0-9% of freshly separated splenic B cells and 
0-1% of splenic T lymphocytes. The GL7 epitope density increased to approximately 
70% on activated lymphocytes. All the tested DNA, RNA and protein synthesis 
inhibitors strongly prevented the expression of the GL7 epitope. The GL7 Ab staining 
pattern was found very similar to that of peanut agglutinin (PNA) in mouse lymph 
node and spleen, namely the epitope is strongly expressed by IgD- B cells in the 
germinal center (Cervenak et al., 2001). The epitope also had been found on a small 
subpopulation (~9-22%) of ‘TCR-bright’ thymocytes (Hathcock et al., 1995). In the 
mouse bone marrow the GL7 epitope is detectable as early as on the pro-B/early pre-
B cell stages and its expression becomes very high on large pre-B cells but it is 
completely down regulated on mature naive resting B cells, so it may define the 
cycling stage of B cell maturation (Murasawa et al., 2002). In a study that analysed 
functional capacities of activated and sorted lymph node B lymphocytes, only GL7+
cells had high antigen presenting capacity and produced antibodies (Cervenak et al., 
2001). Comparative study of thymocyte subpopulations showed, that GL7+ cells 
proliferated vigorously and produced more cytokines (IL-2, IL-4) compared to the 
GL7-/low fraction. Later the antibody was shown to recognize the Neu5Ac 2-6Gal 1-
4GlcNAc 1-3Gal 1-4Glc carbohydrate epitope that is also expressed by different 
human B cell lines (Naito et al., 2007). Furthermore, two enzymes was shown to 
regulate the expression of GL7 (Naito et al., 2007). CMP-Neu5Ac hydroxylase 
enzyme (CMAH) was found to be down-regulated in activated mouse B cells in 
negative correlation with GL7 expression. Another enzyme, ST6Gal I 
sialyltransferase was revealed to positively regulate the expression of the epitope, 
since its gene expression and GL7 Ab reactivity positively and strongly correlated in 
different human B cell lines. All these results indicate that the GL7 epitope may have 
role in lymphocyte functions. 
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Cholesterol is a key, stabilizing molecule of membrane microdomains. 
Therefore, studying its role in lipid raft-mediated immune processes may help better 
understanding how lipid rafts function. Furthermore, based on these properties, 
membrane cholesterol and other raft components became potential new targets for 
immunotherapies. In spite of the considerable knowledge on lipid rafts, there are still 
only a few reliable and properly selective markers for these microdomains.  No in situ 
modulators of rafts are available so far either, which could affect biological role of 
rafts in immune processes without depleting/deprivating cholesterol from the 
membrane.  Having in hand two novel IgG type anti-cholesterol monoclonal 
antibodies (ACHAs), developed in our laboratory, we set the following goals and 
questions:
1. Characterization of the novel cholesterol-specific monoclonal antibodies 
(ACHAs) in terms of their specificity, affinity and plasma membrane or 
intracellular binding sites. 
Monoclonal IgG3-type cholesterol-specific antibodies (AC1, AC8) have recently 
been developed in our laboratory by immunizing mice with cholesterol-rich 
liposomes. Our aim was to characterize in details their binding to membrane 
cholesterol in liposomes and various immune cells. We investigated the potential 
of monoclonal IgG ACHAs as selective markers of lipid rafts/caveolae, as well.
2. What is the molecular background behind the capacity of monoclonal ACHAs 
to inhibit in vitro HIV infection/production? 
Our collaboration partners (Z. Beck and co-workers: University of Debrecen, 
Hungary/Walter Reed Army Institute of Research, Rockville, MD, USA) found 
that treatment of HIV-1 target cells, but not of the virus, with AC1 or AC8 
antibodies prior to in vitro infection significantly diminished the virus production. 
Our goal was to study the background mechanism of this inhibitory potential of 
ACHAs, with special attention to their effects on distribution/interaction pattern, 
accessibility, mobility or raft association of the primary (CD4) and co-receptors 
(CXCR4) of HIV-1. 
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Another important membrane component is sialic acid, a carbohydrate, 
attached to glycoconjugates (glycoproteins and glycolipids), serving as ligands to Sia-
binding proteins that are known to regulate cell signalling and cell-cell interactions. 
GL7 antibody has been shown to bind to the surface of mouse lymphocytes and 
human B cell lines. It has been also revealed that the antibody’s epitope have a Sia 
moiety. The cell specific expression and membrane localization of the GL7 epitope on 
immune cells as well as the functional role of the molecule(s) bearing the epitope still 
remained unresolved. Therefore, here we set the following goal: 
3. Characterization of the GL7 epitope: its expression and localization in human 
immunocytes.
The expression of GL7 epitope by human immune cells has not yet been 
sufficiently characterized. Therefore, we propose to characterize the expression of 
the epitope by various human lymphoid and myeloid cells and the localization of 
the epitope-bearing cells in lymphoid organs. Furthermore, we analysed the 
membrane localization and the nature of the GL7 epitope. These investigations 
may contribute to identify GL7 epitope-bearing molecule(s) and, in this way, 
assign a function to the epitope. 
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Chapter 3
Summary of new scientific results 
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1. Characterization of the novel cholesterol-specific monoclonal antibodies 
(ACHAs) in terms of their specificity, affinity and plasma membrane or 
intracellular binding sites. (Chapters 4, 5, 7 and reviewed in Chapter 6)
Binding properties of the generated monoclonal ACHAs to cells were determined 
by flow cytometry and confocal microscopy. AC1 and AC8 antibodies bound to 
different murine and human intact lymphocyte and monocyte-macrophage cell 
lines, which was enhanced substantially by a limited papain digestion of the cell 
surface that removes most of the largely protruding extracellular protein domains. 
The AC8 antibody strongly colocalized with markers of caveolin+ and caveolin-
cholesterol-rich lipid rafts at the cell surface and intracellularly with markers of 
ER and Golgi apparatus, suggesting that monoclonal ACHAs recognize clustered 
cholesterol in live cells. 
Specificity was further confirmed by cholesterol modulating agents, cholesterol 
oxidase or filipin III antibiotics, by which treatments the binding of our antibodies 
could be decreased either to cells or to isolated DRMs. 
Using surface plasmon resonance (SPR) technique, a medium affinity (Kd = 7.8 x 
10-10 M) binding of AC8 monoclonal ACHA to cholesterol-rich liposomes was 
found.
3. What is the molecular background behind the capacity of monoclonal ACHAs 
to inhibit in vitro HIV infection/production? (Chapter 7) 
Upon binding to human T cells or monocytes, AC8 induced lateral lipid raft 
clustering, assessed by confocal microscopy. This clustering was characterized 
with an increased average raft-size (from 200-300 to 500-1000 nm) and elevated 
number (by five-fold) of highly ‘patchy’ cells. 
AC8 monoclonal ACHA promoted the association of CXCR4 with both CD4 and 
lipid rafts, as shown by the increased (by approximately two-fold) colocalization 
or FRET efficiency between CXCR4 and CD4 or CTX, calculated from confocal 
images. Consistent with this, the lateral mobility of CXCR4, measured by FCS 
microscopy, also significantly decreased. Fab fragments of ACHAs and antibodies 
against non-raft membrane proteins did not show these effects. 
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3. Characterization of the GL7 epitope: its expression and localization in human 
immunocytes. (Chapter 8)
Our results clearly demonstrate that the sialic acid-containing GL7 epitope is 
exclusively expressed by lymphocytes among human blood cells, similarly to 
mouse and rat. However, an important difference is that while in rodents the GL7 
epitope appears only after 48h activation of T and B cells, in human the epitope is 
constitutively expressed. 
Fluorescence immunohistochemical staining of human tonsil showed that GL7 
epitope is maximally highly expressed in the B cell follicles by CD19+ IgD+
IgMlow naïve B lymphocytes. Other B cell subpopulations and T cells have lower 
expression level of the epitope. 
The GL7 epitope strongly colocalized with the lipid raft marker GM1 ganglioside 
in human primary lymphocytes and B or T cell lines, whereas the non-raft protein 
CD71 showed only a moderate colocalization with GL7. Flow cytometric 
detergent resistance measurements (FCDR) further confirmed this raft-association. 
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Novel anti-cholesterol monoclonal immunoglobulin G
antibodies as probes and potential modulators of
membrane raft-dependent immune functions
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Abstract Natural autoantibodies against cholesterol are
present in the sera of all healthy individuals; their function,
production, and regulation, however, are still unclear. Here,
we managed to produce two monoclonal anti-cholesterol
antibodies (ACHAs) by immunizing mice with cholesterol-
rich liposomes. The new ACHAs were specific to cholesterol
and to some structurally closely related 3b-hydroxyl ste-
rols, and they reacted with human lipoproteins VLDL, LDL,
and HDL. They bound, usually with low avidity, to live
human or murine lymphocyte and monocyte-macrophage
cell lines, which was enhanced substantially by a moderate
papain digestion of the cell surface, removing some pro-
truding extracellular protein domains. Cell-bound ACHAs
strongly colocalized with markers of cholesterol-rich lipid
rafts and caveolae at the cell surface and intracellularly with
markers of the endoplasmic reticulum and Golgi com-
plex. These data suggest that these IgG ACHAs may serve
as probes of clustered cholesterol (e.g., different lipid rafts)
in live cells and thus may also have immunomodulatory
potential.—Bı́ró, A., L. Cervenak, A. Balogh, A. Lórincz, K.
Uray, A. Horváth, L. Romics, J. Matkó, G. Füst, and G.
László. Novel anti-cholesterol monoclonal immunoglobulin
G antibodies as probes and potential modulators of
membrane raft-dependent immune functions. J. Lipid Res.
2007. 48: 19–29.
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Because of its widespread distribution and important
biological roles, cholesterol has long been assumed to be
a nonimmunogenic or poorly immunogenic molecule.
However, several laboratories reported the activation of the
classical and alternative pathways of the complement sys-
tem by cholesterol (1–4). Natural autoantibodies of both
IgM and IgG isotypes against cholesterol were shown to be
present ubiquitously in the sera of healthy individuals
(2, 3). Because cholesterol is an evolutionally conserved,
abundant structural lipid in the plasma membrane of
mammalian cells, it was tempting to speculate whether
naturally occurring antibodies against cholesterol could
bind to the surface of cells. Under physiological condi-
tions, antibodies against lipids, such as phospholipids
or cholesterol, are not expected to bind with high affin-
ity to intact cell membranes, because of the small size of
the antigen epitope and the steric hindrance by surround-
ing glycolipids or large, protruding glycoproteins (3).
However, when either the affinity of anti-lipid antibodies
or the molecular pattern/morphology of the cell surface
is altered, such interaction between antibodies and lipids
may take place (e.g., under pathological conditions).
Monoclonal anti-cholesterol antibodies (ACHAs) were
first reported in 1988 by Swartz et al. (1) after immu-
nizing mice with cholesterol-containing liposomes, to-
gether with lipid A as adjuvant. They found cholesterol
to be a surprisingly excellent immunogen, and murine
monoclonal IgM-type complement-fixing antibodies to
cholesterol were easily obtained (1). Perl-Treves et al. (4)
developed and examined monoclonal IgM antibodies
against cholesterol monohydrate crystals by implantation
of cholesterol crystals in the spleen of mice. This choice
was motivated by the fact that cholesterol, in the living
organism, may aggregate or precipitate in pathological
situations as microcrystals (gallstones, atherosclerotic
plaques). These IgM antibodies did not seem to recog-
nize the cholesterol molecule itself but rather a de-
Manuscript received 5 April 2006 and in revised form 11 August 2006 and
in re-revised form 3 October 2006.
Published, JLR Papers in Press, October 5, 2006.
DOI 10.1194/jlr.M600158-JLR200
1 A. Bı́ró, L. Cervenak, and A. Balogh contributed equally to this work.
2 To whom correspondence should be addressed.
e-mail: glorial@elte.hu
Copyright D 2007 by the American Society for Biochemistry and Molecular Biology, Inc.
This article is available online at http://www.jlr.org Journal of Lipid Research Volume 48, 2007 19










fined, extended pattern of molecular motifs exposed on
the cholesterol crystal surfaces. Kruth et al. (5) directly
visualized plasma membrane cholesterol clusters with
a monoclonal antibody that specifically detects ordered
cholesterol arrays, but only when the cells were pre-
viously enriched with cholesterol. This antibody de-
tected a specific plasma membrane pool of cholesterol,
responsive to agents that modulate cholesterol traffick-
ing. The cholesterol-rich domains they detected in the
plasma membrane did not seem equivalent to the so-
called lipid rafts (6), because they were highly sensitive
to ice-cold Triton X-100 extraction, whereas lipid rafts
are not.
The presence of ACHAs in normal serum raised another
important question: do these antibodies against choles-
terol play a role in the regulation of cholesterol levels, and
by extension, in atherosclerosis, in vivo? A putative role of
ACHAs in atherosclerosis, induced by a cholesterol-rich
diet, can be postulated from results of experiments with
rabbit models (7).
Altered serum levels of ACHA were reported in pa-
tients with atherosclerosis (8, 9) and with chronic viral
infections (8, 10). Although IgG isotype ACHAs can be
detected in the sera of both healthy individuals and
patients with several diseases, only IgM isotype ACHA
has been produced and characterized to date. Thus, the
question emerged whether it is possible to produce IgG
isotype monoclonal antibody against cholesterol by im-
munization. From a practical point of view, an IgG isotype
antibody would be much more convenient in most im-
munological techniques, such as immunohistochemistry,
flow cytometry, and ELISA.
Furthermore, generation and in vitro characteriza-
tion of the biological activity of IgG-type ACHAs seem
critically important steps toward understanding their
physiological roles. On the other hand, various choles-
terol- and sphingolipid-rich membrane microdomains
(e.g., the caveolar and noncaveolar lipid rafts) were
implicated in controlling/regulating numerous cellular
functions (6, 11–15), including activatory and inhibi-
tory signal transduction events and the cellular uptake
of various pathogens (viruses, bacteria, protozoa) and
toxins (16, 17). Thus, IgG-type ACHAs might have sig-
nificance in probing or functional modulation of such
membrane microdomains.
Therefore, the aim of this study was to produce IgG
isotype monoclonal ACHAs by immunizing mice with
cholesterol-enriched liposomes. We managed to produce
two IgG isotype monoclonal antibodies against cholesterol
(AC1 and AC8) and found that they specifically detect
cholesterol and several structurally closely related sterols
in cell-free assays, as well as specifically bind to human
lipoprotein fractions. The IgG-type ACHAs also bound to
various cellular compartments, both extracellularly and
intracellularly, identified as clustered plasma membrane
cholesterol, lipid rafts, caveolae or intracellular lipid ves-
icle membranes, endoplasmic reticulum, and Golgi com-
partments. The basic properties, selectivity, and cellular
and subcellular localization of the novel IgG3 ACHAs,




Jurkat [American Type Culture Collection (ATCC)] and MT-4
(HTLV-11; a generous gift from Z. Beck, University of Debrecen,
Hungary) human T-cell lymphomas and MonoMac6 (a kind gift
of Z. Bajtay, Eötvös University, Budapest) and U937 (ATCC)
human monocyte-macrophage cell lines were cultured in RPMI
1640 supplemented with 10% fetal calf serum. Murine P388D1
and J774A.1 monocyte-macrophage cell lines, A20 (ATCC) B lym-
phoma cells, and the Keyhole Limpet Haemocyanin-specific
murine TH hybridoma (2/13), produced as described previously
(18), were all cultured in RPMI 1640 supplemented with 10%
fetal calf serum and 2-mercaptoethanol.
Cholesterol liposomes
Cholesterol-rich multilamellar vesicles (71 mol% cholesterol)
used for the induction of antibody production to cholesterol
were composed as described by Dijkstra et al. (19). Briefly, they
were made of 1,2-dimyristoyl-sn-glycero-3-phosphocholine
(DMPC), 1,2-dimyristoyl-sn-glycero-3-phosphoglycerol, and choles-
terol in a molar ratio of 9:1:25, and for immunization they were
completed with adjuvant monophosphoryl lipid A at 25 mg/mmol
phospholipid. Reagents were purchased from Sigma-Aldrich (St.
Louis, MO). The lipids were divided into aliquots from stock solu-
tions in chloroform in a pyrogen-free, round-bottom flask, and the
solvent was removed by rotary evaporation. Sterile deionized water
was added to the dry lipid film, achieving 50 mM total phos-
pholipid, and vortexed until all of the lipids were resuspended.
The material was subsequently incubated for 2 h at room tem-
perature. Aliquots of the liposomal preparations were lyophilized
in vaccine vials, stored at 2708C, and reconstructed before use in
PBS to 10 mM final concentration of total phospholipids.
Immunization with cholesterol-rich liposomes
For the induction of antibodies to cholesterol, four male
inbred mice (BALB/c) were immunized with 100 ml of the
cholesterol-rich multilamellar vesicles (2.5 mmol of cholesterol)
intraperitoneally and subcutaneously. After 4 weeks, the mice
were given a boost injection of 2.5 mmol of cholesterol. Two
weeks later, the mice were bled from the tail vein to collect im-
mune sera. Preimmune sera were collected just before the pri-
mary inoculation; a 1:50 dilution was used to measure reactivity.
ELISA for cholesterol was used to determine serum titer change
in mice, and one of them was selected to be used for cell fusion.
The animal studies were reviewed and approved by the ap-
propriate institutional review committee.
Production of monoclonal antibodies against cholesterol
Monoclonal antibodies were generated by hybridizing Sp2/0-
Ag14 myeloma cells with the splenocytes of immunized mice. Hy-
bridomas were selected by growth in hypoxanthine-aminopterin
thymidine medium. Initial screening was performed by ELISA
on cholesterol. Two IgG and eight IgM clones were selected for
expansion and initial characterization. Isotyping was carried out by
anti-mouse IgG1, IgG2a, IgG2b, IgG3, IgM, n, and l horseradish
peroxidase-conjugated antibodies (SouthernBiotech, Birming-
ham, AL).
The two IgG3 subclones, AC1 and AC8, were further charac-
terized in detail. The IgGs were purified on Protein-G Sepharose
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4 Fast Flow (Amersham Pharmacia Biotech AB, Uppsala,
Sweden) columns by affinity chromatography from the superna-
tant of the hybridoma cells. The purity of antibodies was analyzed
by SDS-PAGE.
Enzyme-linked immunoassay of antibody binding to
cholesterol and other lipids
Polystyreneplates (Greiner, Frickhausen,Germany)werecoated
with cholesterol (0.01–10 mg/well), ergosterol, coprostane, 7-
ketocholesterol, cholesteryl oleate, 25-hydroxy-cholesterol, cholic
acid, DMPC, DL-alpha-dipalmitoyl-phosphatidylcholine (DPPC),
orL-alpha-dipalmitoyl-phosphatidylethanolamine(DPPE)(10mg/
well for all lipids) (Sigma) dissolved in 100 ml of absolute ethanol
and incubated at 48C for 24 h. After washing with PBS and block-
ing with 0.1% casein (Reanal, Budapest, Hungary) in PBS, wells
were incubatedwith100ml of serumsamplesorpurifiedIgGdiluted
in PBS containing 0.1% casein. Binding of ACHAs was detected
by anti-mouse horseradish peroxidase-conjugated g-chain-specific
goat antibodies (DAKO, Glostrup, Denmark), with o-phenylene-
diamine (Sigma) and H2O2 as substrates. The optical density was
measured at 490 nm (reference at 600 nm). Concentrations of
monoclonal antibodies at which an optical density of 0.2 (490–
600 nm) was reached are demonstrated by the following symbols
in Table 1: 2, no reaction (at 100 mg/ml); 1, low reaction (10–
100 mg/ml); 11, medium reaction (1–10 mg/ml); 111, strong
reaction (,1 mg/ml).
Competitive ELISA with human lipoproteins
Purified monoclonal IgG was mixed with different concentra-
tions of human lipoproteins VLDL, LDL, andHDL (Calbiochem,
San Diego, CA), or with 0.1% casein as a control, and incubated
at 378C for 60 min. The preincubated mixtures were applied to
cholesterol-coated plates, and IgG binding was detected as de-
scribed previously. Lipoprotein concentrations were normalized
to the same surface area using the following data. For particle
mass: VLDL, 40,000 kDa/mol; LDL, 2,300 kDa/mol; HDL,
200 kDa/mol. For particle diameter: VLDL, 50 nm; LDL, 20 nm;
HDL, 10 nm. Initial concentrations used for the serial dilutions
were determined based on normalization for the surface area
corresponding to 20 mg of HDL.
Measurement of fluorescence resonance energy transfer
2-(4,4,-Difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-
pentanoyl)-1-hexadecanoyl-sn-glycero-3-phospho-choline (BOD-
IPY-FL C5-HPC) was purchased from Molecular Probes-Invitrogen
(Eugene, OR). Fluorescence resonance energy transfer (FRET)
from BODIPY-FL C5-HPC (donor) bound to HDL and LDL to
Alexa555-conjugated AC8 antibody (acceptor) was measured by
recording the emission spectra of BODIPY-FL C5-HPC-labeled
lipoproteins in the absence or presence of fluorescent AC8 on
an Edinburgh Instruments F900 fluorescence spectrometer (Liv-
ingston, UK), using 460 nm excitation wavelength. Anti-human
CD11a/LFA-1a antibody (MEM-25; a kind gift fromVaclavHorejsi,
Prague, Czech Republic) was used as a negative control. The ef-
ficiency of FRET was estimated from both the quenching of donor
fluorescence and the sensitization of acceptor fluorescence (20).
Detection of cell-bound ACHA by flow cytometry and
confocal microscopy
The lymphoid and human monocyte-macrophage cell lines
were incubated with 1–10 mg/ml monoclonal ACHA for 30 min
on ice, washed and incubated with Alexa488-conjugated goat
anti-mouse IgG secondary antibody (Molecular Probes-Invitro-
gen), and assayed by flow cytometry. Alternatively, directly
labeled Alexa488-ACHA was also used to label cells for flow
cytometry or confocal laser scanning microscopy, using Ka40
tobacco mosaic virus-specific mouse monoclonal antibody
(produced in our laboratory) as an isotype control. For intra-
cellular staining, cells were incubated with Alexa488-AC8 after
fixation by 2% formaldehyde and permeabilization by 0.1%
saponin plus 0.1% BSA. Cells (53 105 cells/sample) were labeled
for all experiments. In flow cytometric experiments, 10,000 cells
were collected and analyzed in a Becton-Dickinson FACSCalibur
flow cytometer using CellQuest Pro software. In confocal laser
scanning microscopy imaging experiments, the labeled cells were
placed onto 0.15 mm thin coverslips in a chamber and assayed
with an Olympus (Hamburg, Germany) Fluoview500 confocal
microscope equipped with four optical channels using a 603,
high-numerical aperture oil-immersion objective.
Papain treatment of cells
Cells were exposed to a limited digestion by 5 or 10 U/ml
papain (Sigma) with 10 U/mg specific activity for 5 and 10 min at
378C in HBSS (Gibco). Cells were then washed extensively with
ice-cold FACS buffer (Becton-Dickinson) supplemented with
0.1% BSA and labeled with antibodies as described previously.
Modification of membrane cholesterol level/distribution
Membrane cholesterol level was modulated by depletion with
methyl-b-cyclodextrin (RAMEB, CycloLab), treating the cells with
2–10 mM methyl-b-cyclodextrin for 15 min at 378C, as described
previously (21), or with cholesterol oxidase (Sigma) (22). Briefly,
cells were incubated with 0.5 or 1 U/ml cholesterol oxidase
(from Pseudomonas fluorescens) for 2 h at 378C and washed exten-
sively. For complexing and segregating membrane cholesterol,
1–10 mg/ml concentrations of filipin III antibiotics (Sigma) were
applied for a 45 min incubation at 378C (23).
Isolation of detergent-insoluble buoyant membrane from
TH cells and immunodot blot analysis
Detergent-resistant and -soluble membrane fractions were
isolated from TH cells by a cold Triton X-100 lysis and subsequent
TABLE 1. Cross-reactivity of monoclonal anti-cholesterol IgG3
antibodies AC1 and AC8 with other lipids
Lipid Type Name AC1 AC8
Sterols containing Cholesterol 11 111
free 3b-hydroxyl Ergosterol 1 111
7-Ketocholesterol 11 111
25-Hydroxy-cholesterol 2 2
Sterols lacking free Cholesteryl oleate 2 2
3b-hydroxyl Coprostane 2 2









DPPC, DL-alpha-dipalmitoyl-phosphatidylcholine; DPPE, L-alpha-
dipalmitoyl-phosphatidylethanolamine. ELISA plates were coated with
cholesterol, ergosterol, 7-ketocholesterol, 25-hydroxy-cholesterol, choles-
teryl oleate, coprostane, cholic acid, 1,2-dimyristoyl-sn-glycero-3-phospho-
choline, 1,2-dimyristoyl-sn-glycero-3-phosphoglycerol, DPPC, or DPPE.
AC1 and AC8 antibodies were serially diluted and added to the plates.
Concentrations of monoclonal antibodies at which an optical density of
0.2 (490–600nm)was reachedaredemonstratedby the following symbols:
2, no reaction (at 100 mg/ml); 1, low reaction (10–100 mg/ml); 11,
medium reaction (1–10 mg/ml);111, strong reaction (,1 mg/ml).
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separation using sucrose density gradient (5–40%) ultracentri-
fugation, as described previously (24). Immunodot blots were
developed on nitrocellulose membranes (Bio-Rad Laboratories,
Hercules, CA). Cholesterol was diluted from stock solution in
absolute ethanol to 50 mg/ml using PBS, and detergent-resistant
(low buoyant density: 5% sucrose) and detergent-soluble (high
buoyant density: 36–40% sucrose) membrane fractions were
dropped onto the membrane in small amounts (2 ml) either
directly or at 23 dilution and dried. Pretreatment of the samples
with cholesterol oxidase was performed as described above. After
blocking with 0.1% casein in PBS for 1 h, AC8 was added (1.5 mg/
ml) for 1 h and then washed three times with PBS. The dot blots
were finally developed by incubating with horseradish peroxi-
dase-conjugated GAM IgG3 (SouthernBiotech) for 1 h, followed
by washing six times with PBS, and evaluated using enhanced
chemiluminescence reagent (Pierce Chemicals, Rockford, IL)
and X-ray film (Agfa, Mortsel, Belgium).
Confocal microscopic colocalization assay
Cells were stained for lipid raft markers (GM1 gangliosides)
with Alexa488- or Alexa647-cholera toxin B (Molecular Probes-
Invitrogen), according to the manufacturer’s instructions;
FITC-anti-caveolin-1 antibody (rabbit IgG; Santa Cruz Biotech-
nology, Inc., Santa Cruz, CA) was used to label caveolae after
a mild permeabilization of the plasma membrane (25). The
long-chain diIC18 (3) (Molecular Probes-Invitrogen) lipid
probe partitioning into liquid-ordered/gel-phase membrane
regions was used according to the manufacturer’s instructions.
Human CD71-specific Cy3-MEM-75 (mouse IgG1 antibody) was
a kind gift from Vaclav Horejsi, and FITC-conjugated rat anti-
mouse antibody G7.4 (IgG2c; from ATCC) was used to label
Thy1. CD2 on T-cells were labeled with FITC-conjugated anti-
human CD2 monoclonal antibody (Sigma). ACHAs were
applied either as Alexa488-conjugated AC8 or biotinylated
AC8 plus Alexa647-conjugated neutravidin. For all antibodies,
appropriate isotype control antibodies or cell lines were used
as negative controls. BODIPY-brefeldin A558 (fixed/permeabil-
ized cells, 100 nM, 30 min, 378C) and BODIPY FL C5-ceramide
(live cells, 5 mM, 30 min, 48C; Molecular Probes-Invitrogen)
were used as markers of the endoplasmic reticulum/Golgi com-
plex, whereas LysoTracker 568 (live cells, 75 nM, 30 min, 378C;
Molecular Probes-Invitrogen) served as a marker of lyso-
somes. Cell nuclei and mitochondria were stained with Draq5
(live cells, 2.5 mM, 10 min, room temperature; Biostatus, Ltd.,
Leicestershire, UK) and MitoTracker (live cells, 50 nM, 30 min,
378C; Molecular Probes-Invitrogen), respectively. All of these
markers were applied for cell labeling as described in the
manufacturer’s protocol. For plasma membrane cholesterol
staining, live cells were used; to identify the subcellular localiza-
tion of cholesterol, however, cells were fixed/permeabilized, as
described above. Colocalization indices were determined with
ImageJ software using appropriate plug-ins (Image Correlator
Plus), from .100 regions of interest per sample, selected from
at least 20 cells.
Statistical analysis and image processing
GraphPad Prism 4 for Windows (version 4.02) software
(GraphPad Software, San Diego, CA) was used for the statisti-
cal analyses. Inhibitory effects of lipoproteins were compared by
two-way ANOVA. Confocal microscopic images were further
processed and analyzed with ImageJ software (Wayne Rasband,
National Institutes of Health, Bethesda, MD), available at the




Preimmune sera reacted with cholesterol very weakly,
similar to healthy mouse control sera (Sigma). After im-
munizing with liposomes containing 71% cholesterol,
both IgG and IgM ACHA titers were largely increased
(data not shown). Monoclonal antibodies were generated
by hybridizing Sp2/0-Ag14 myeloma cells with spleen cells
from immunized mice of the highest antibody titer. After
subcloning, three IgG- and eight IgM-secreting hybrid-
omas were selected based on their capacity to produce
antibodies reacting with cholesterol. All of the IgG anti-
bodies were of the IgG3 isotype, and all of the IgG and IgM
antibodies had n light chains. Several IgMs specific to
cholesterol had already been generated and characterized
(1, 4, 19); therefore, we focused our investigations on the
IgGs. Two selected clones (AC1 and AC8) were further
analyzed in terms of their specificity and binding to intact
cells (plasma membrane/subcellular localization).
Reactivity of monoclonal IgG ACHAs to cholesterol and
other lipids
When applied in solid phase to ELISA plates, choles-
terol has been reported to show a concentration-depen-
dent aggregation (4). At 1 mg of cholesterol per well,
cholesterol dominantly exists in noncrystalline form,
except for a few microscopic crystals, whereas a significant
amount of microcrystals exists at 10 mg of cholesterol per
well. To determine whether the clustering or crystal
structure of cholesterol has an effect on the binding of
our monoclonal antibodies, plates were coated with 0.01–
10 mg/well cholesterol, and ACHA binding was tested in
an ELISA system. Both AC1 and AC8 monoclonal anti-
bodies bound in a dose-dependent manner to cholesterol
adsorbed on polystyrene plates. The binding of both
monoclonal antibodies was fairly independent of choles-
terol concentration between 0.1 and 10 mg/well choles-
terol. Their binding capacity, however, declined sharply
to ,0.1 mg/well (Fig. 1). The isotype control antibody
(Ka40) did not bind to the coat (Fig. 1B).
The binding of ACHAs to various structurally related
sterols and to other lipids was also tested by ELISA. The 3b-
hydroxyl group was proposed previously as a critical struc-
tural motif in the binding of anti-cholesterol IgMs (9). To
investigate the fine specificities of AC1 and AC8, six struc-
turally related sterols (ergosterol, coprostane, cholesteryl
oleate, 25-hydroxy-cholesterol, 7-ketocholesterol, and cho-
lic acid) and three other nonsterol lipids (DMPC, DPPC,
andDPPE)were tested as coated antigens. Like cholesterol,
ergosterol, 7-ketocholesterol, and 25-hydroxy-cholesterol
contain a free 3b-hydroxyl group, whereas cholic acid,
coprostane, and cholesteryl oleate do not. ELISA results
showed a more efficient binding of AC8 to cholesterol,
ergosterol, and 7-ketocholesterol than to the other ste-
rols. AC1 consistently showed a lower affinity to all sterols
than did AC8, and the sterols to which they bound with
the highest affinity were different (cholesterol for AC1 and
7-ketocholesterol for AC8). This indicates that the molec-
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ular determinants may be slightly different for AC8 and
AC1. In spite of the presence of a 3b-hydroxyl group of 25-
hydroxy-cholesterol, the ACHAs did not bind to it. On the
other hand, there was no detectable binding to other
sterols lacking the 3b-hydroxyl group (Table 1). These
results together suggest that the epitope recognized by
ACHAs comprises the 3b-hydroxyl group in sterols,
although other parts of the structure (not present in 25-
hydroxy-cholesterol) cannot be excluded. As a control, no
significant binding of IgG3 ACHAs to three other selected
phospholipids was observed (Table 1).
The IgG3 ACHAs specifically bind to lipoproteins
Lipoproteins contain a significant amount of choles-
terol in both the free and esterified forms. To assess the
ability of ACHAs to interact with the human lipoproteins
VLDL, LDL, and HDL, purified ACHAs were premixed
with different concentrations of lipoproteins. After incu-
bation at 378C for 60 min, the mixture was applied to
cholesterol-coated plates. All of the human lipoproteins
(VLDL, LDL, and HDL) inhibited the binding of ACHAs
to cholesterol in a dose-dependent manner (Fig. 2A). The
lipoproteins did not bind to the cholesterol coat under the
same conditions (data not shown). When the results were
normalized to the surface areas (corresponding to the
available binding sites for antibody) of the various lipo-
proteins, binding of ACHA to HDL was found to be only
Fig. 2. Binding of anti-cholesterol IgG3 antibodies (ACHAs) to
lipoproteins. A: Inhibition of the ACHA-cholesterol interaction by
human lipoproteins. Serially diluted liposomes or human VLDL
(closed circles), LDL (open circles), and HDL (closed inverted
triangles) were mixed with anti-cholesterol IgG, AC8 (10 mg/ml).
The surface of 20 mg is equal to 1.8 3 1022 m2. All the concen-
trations of lipoproteins (HDL, LDL, VLDL) were adjusted to this
surface. The mixture was incubated at 378C for 60 min, then
dropped onto cholesterol-coated ELISA plates. Bound IgG was de-
tected by goat anti-mouse IgG labeled with horseradish peroxidase.
Means of three independent experiments 6 SEM are shown. No
significant differences were found between the inhibitory effects of
the three lipoproteins using two-wayANOVA.OD, optical density. B:
In fluorescence resonance energy transfer (FRET) measurements,
LDL (500 mg total lipid/ml) with or without 2-(4,4,-difluoro-5,7-
dimethyl-4-bora-3a,4a-diaza-s-indacene-3-pentanoyl)-1-hexadecanoyl-
sn-glycero-3-phospho-choline (BODIPY-FL C5-HPC; 110 nM) was
titrated with increasing concentrations (X axis) of Alexa555-AC8 or
Alexa555-anti-CD11a (as a negative control). FRET efficiencies (see
inset) with AC8 (solid line) or anti-CD11a (dotted line) acceptors
were calculated from either the decrease of corrected donor emis-
sion intensities at 519 nm or the acceptor sensitization at 570 nm,
upon excitation at 460 nm. mAb, monoclonal antibody.
Fig. 1. Binding of monoclonal antibodies to cholesterol. Choles-
terol was adsorbed to polystyrene plates at concentrations of 0.01
(open triangles), 0.1 (closed inverted triangles), 1.0 (open circles),
and 10 (closed circles) mg/well. ELISA was carried out with serially
diluted purified monoclonal IgG [initial concentrations: AC1 IgG,
100 mg/ml (A); AC8 IgG, 25 mg/ml (B)], then goat anti-mouse IgG
labeled with horseradish peroxidase was applied. In B, binding of
the isotype control Ka40 antibody (closed squares) is also displayed.
Representative results from three independent experiments are
shown. OD, optical density.
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slightly weaker than to VLDL or LDL, in contrast to earlier
findings with IgM ACHAs. Binding of AC8 to lipoproteins
(LDL and HDL) was further confirmed by direct FRET
measurements betweenBODIPYFLC5-HPC lipid probe and
Alexa555-AC8. A highly efficient (Emax z 0.4) and concen-
tration-dependent FRET was observed in LDL (Fig. 2B).
Similar, but less efficient (Emax z 0.3), FRET was obtained
with HDL (data not shown). No FRET was detected when
Alexa555-anti-CD11a antibody was used as the acceptor.
IgG3 ACHAs bind to various intact cells both
extracellularly and intracellularly
Several cell types of different origin, expressing lipid rafts
or caveola microdomains enriched in cholesterol, were
selected to investigate the binding of monoclonal ACHAs
to the cell surface or to intracellular compartments: mouse
helper T-cell hybridoma (2/13), human T-lymphoma cell
lines (Jurkat, MT-4), human monocyte-macrophage cell
lines (MonoMac6, U937), and murine B- and macrophage
cell lines (A20 and P388D1, respectively). A low-avidity
spontaneous binding of both IgG3 ACHAs was observed
in all cell lines, which was cell type-dependent (Fig. 3A–D).
The expression pattern of long, protruding glycoproteins
or glycolipids, which may shield the presumably small anti-
gen determinant(s) of ACHAs, may vary among cell types.
Therefore, we tested whether a limited papain digestion of
the cell surface, expected to remove some long external
proteindomains, affects thebindingofourACHAs. Indeed,
an optimized papain treatment significantly decreased the
magnitude of immunofluorescence arising from several
long cell surface glycoproteins, such as CD45R/B220 on
B-cells and CD44 on T-lymphocytes (Fig. 3E, F). Binding
of AC8 antibody substantially increased in all cell types
upon papain digestion, proportionally with the papain
dose (Fig. 3A–D), and thedifferences in theextentofACHA
binding among cell types also became more pronounced.
This suggests that a limited digestion of the cells by papain
(10 U/ml, 10 min, 378C) may serve as an “epitope exposi-
tion tool” for ACHAs on either fixed or unfixed cells of
different origin, allowing “snapshot imaging” of clustered
cholesterol at the surface of cells under various physiolog-
ical or pathological conditions (Fig. 4).
Confocal microscopy showed that AC8 IgG intensely
stained the plasma membrane of murine TH cells after
papain digestion (Fig. 4B, C), whereas no or very weak
staining was observed with the fluorescent isotype control
antibody Ka40 (Fig. 4A) or in the absence of epitope ex-
position by papain (data not shown), respectively, in ac-
cordance with the flow cytometric data (Fig. 3A–D). The
plasma membranes of various cells were labeled by AC8
uniformly, in a strongly patchy manner, with an approxi-
mate average patch size of 200–400 nm (Fig. 4C).
Membrane ganglioside (raft) expression, assessed by
flow cytometric analysis of fluorescent cholera toxin B
binding, showed a fairly good correlation with the mag-
nitude of ACHA binding on various murine and human
cell types (Fig. 3G). Notably, monocyte-macrophage cells
were represented mostly in the high double expression
region (Fig. 3G, right side), possibly because of their ca-
veolar raft expression. In contrast, an IgM isotype ACHA,
displaying cholesterol selectivity in cell-free assays, did not
show detectable binding to any of the tested cell types,
even after papain digestion (data not shown).
AC8 antibody also bound intracellularly in mouse or
humanTH cells, after their formaldehyde fixation/saponin
permeabilization. The intracellular staining may be attrib-
uted largely to cholesterol-containing membranes of lipid
vesicles of varying size (Fig. 4D). Colocalization of ACHA
with different intracellular organelle markers was also
analyzed and quantified in mouse and human T-cells and
macrophages. Intracellularly bound ACHA colocalized
with fluorescent brefeldin A [colocalization coefficient
(cc), 0.30] (Fig. 4E), a marker of the endoplasmic retic-
ulum and Golgi complex, with the Golgi complex-specific
BODIPY-ceramide5 (cc, 0.32), and more weakly with a
marker of lysosomes, LysoTracker (cc, 0.25), but not with
markers ofmitochondria or cell nuclei (cc,, 0.1) (Fig. 4J).
Cell surface-bound ACHA and the cholesterol-rich lipid
raft microdomains
Because cholesterol is known to be enriched in various
caveolar or noncaveolar lipid rafts, we intended to investi-
gate how the surface-bound IgG3 ACHAs relate to these
membrane microdomains, using snapshot imaging after
epitope exposition by papain, as described above. ACHA
AC8 strongly colocalized in T-cell membranes with cholera
toxin B bound to GM1 gangliosides (cc, 0.69) (Fig. 4F) and
with a proteinmarker of lipid rafts, Thy1 (cc, 0.55) (Fig. 4G),
and, although slightly weaker (cc, 0.39), with transferrin
receptors (CD71) marking preferentially the chlathrin-
coated pit membrane structures (Fig. 4H). In addition,
AC8 antibody colocalized substantially with the diIC18 (3)
lipid probe (cc, 0.48) as well, reported to preferentially par-
tition into liquid-ordered or gel-phase membrane regions
(26) (data not shown), indicating that ACHAs may bind to
various cholesterol-rich, ordered microdomains/compart-
ments of the cellular plasma membranes. This is further
confirmed by the strong colocalization (cc, 0.63) between
AC8 and caveolin-1 inmacrophages (Fig. 4I). In contrast, in
T-cells,ACHAdidnot colocalizewithCD2(Fig. 4J), reported
as a nonraft protein in unstimulated T-lymphocytes (27).
In addition, AC8 bound to the detergent-resistant mem-
brane fractions isolated from TH cells and did not bind or
bound very weakly to soluble membrane fractions of the
same cells, as demonstrated by immunodot blot technique
(Fig. 5C). Furthermore, treatment with cholesterol oxi-
dase (COase) resulted in decreased binding of AC8 to
both cholesterol and the detergent-resistant fraction on
the dot blots. In contrast, no binding was observed to the
cold Triton X-100-soluble membrane fraction (Fig. 5C).
Deprivation of membrane cholesterol by cholesterol oxi-
dase decreased ACHA binding in both T-helper cells and
monocyte-macrophage cells, as assessed by flow cytometry
(Fig. 5A, B). Filipin, an antibiotic known to selectively com-
plex membrane cholesterol (23), also slightly decreased
AC8 antibody binding to T-cells (Fig. 5A); at the same
time, AC8 staining showed the filipin concentration-
dependent segregation of cholesterol into large clusters
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Fig. 3. Flow cytometric analysis of the binding of ACHAs to live murine and human lymphoid and
monocyte-macrophage cell lines. A, B: Binding of AC1 (A) and AC8 (B) to murine T-helper cells (2/13), as
detected by flow cytometry using Alexa488-conjugated ACHA. Histograms of isotype control (gray areas),
ACHA binding to cells without (top) or with 5 U/ml (middle) and 10 U/ml (bottom) papain treatment are
displayed. C, D: Binding of AC8 to the MonoMac6 human monocyte-macrophage cell line (C) and the MT-4
(HTLV-1+) human T-lymphoma cell line (D), without or with 10 U/ml papain treatment. Symbols are the
same as those used in A and B. E, F: Papain digestion results in a decreased expression of long, protruding
proteins, such as CD45R (B220) in B-cells (E) and CD44 in T-cells (F). Isotype controls in the absence (black
areas) or presence of papain (gray areas) and immunofluorescence in the absence (thick lines) or presence
of papain treatment (thin lines) are shown. G: AC8 binding to various cell types (human and murine B- and
T-cells, macrophages) correlates well with GM1 ganglioside expression of the cells. The correlation between
AC8 and CTX binding was strong (r 5 0.89) among seven different cell types. CTX, cholera toxin B; RMF,
relative mean fluroescence.
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(Fig. 5D–F). Depletion of membrane cholesterol by
methyl-b-cyclodextrin similarly reduced AC8 binding
(data not shown).
In quiescent 2/13 mouse TH cells, the patchy staining by
AC8 was uniform (ring-like) along the plasma membrane
(Fig. 5D), similar to cholera toxin B staining (Fig. 5G),
with a substantial colocalization of the two labels (Fig. 4J).
Activation of the TH cells with mitogen (concanavalin A)
had no effect on the amount of bound cholera toxin B
or ACHA (data not shown), although it resulted in a
remarkable cell surface redistribution of cholera toxin B,
indicating polarization of rafts in the plasma membrane.
More than 60% of the T-cells showed highly patchy or cap-
like ganglioside/cholera toxin distribution after 24 h of
activation (Fig. 5H). AC8 antibody was found highly co-
polarized with the rafts (cc, .0.85) in activated T-cells
(Fig. 5I), indicating that the novel IgG3 ACHAs can moni-
tor the redistribution of cholesterol-rich microdomains
in the plasma membranes of intact lymphoid cells upon
activation signals.
These data together suggest that the AC8 IgG3-type
monoclonal antibody, in addition to its preferential bind-
ing to cholesterol-rich raft microdomains at the cell sur-
face, is able to monitor the dynamic redistribution of
clustered cholesterol in the plasma membranes of im-
munocytes during their activation or signal transduction.
DISCUSSION
In this study, we demonstrated that production of not
only IgM but also IgG ACHAs can be induced in mice by
immunizing them with cholesterol-rich liposomes. In gen-
eral, IgG3 is primarily produced against antigens with
carbohydrate or repeated epitopes. Although the set of 11
generated ACHA clones is statistically insufficient, the fact
that we produced exclusively IgM and IgG3 but no other
IgG subtypes may indicate that the immunogenicity of
cholesterol is somehow related to these classes of epitopes.
This is supported by the structural similarities between the
3b-hydroxyl group and its environment in cholesterol and
some surface-associated carbohydrate structures of patho-
gens, as well as by the periodically repeated (clustered)
arrangement of cholesterol.
An earlier monoclonal IgM-type ACHA (monoclonal
antibody 2C5-6) showed selectivity in its binding to ag-
gregated cholesterol but not to strictly defined and
organized surfaces of cholesterol monohydrate crystals.
In contrast, other monoclonal IgMs selected against cho-
lesterol crystals, recognizing a given pattern of epitopes
present on the crystal faces. A cholesterol concentration of
10 mg/ml was reported as a critical threshold for obtaining
a significant amount of microcrystals (4). Although no
direct binding studies have been performed on crystalline
cholesterol, the affinity of our two novel IgG ACHAs did
not significantly depend on the cholesterol concentration
being in the range of 0.1–10 mg/ml. This suggests that the
IgG-type ACHAs AC8 and AC1 are less sensitive to the
aggregation state of cholesterol than the previously de-
veloped IgM isotype ACHAs.
Dijkstra and coworkers (19) reported that cholesterol-
immunreactive sera and a monoclonal anti-cholesterol
IgM (2C5-6) were both specific to cholesterol and struc-
turally similar sterols containing a 3b-hydroxyl group. In
accordance with this observation, we found that the anti-
Fig. 4. Binding of AC8 antibody to live cells, by confocal micro-
scopic analysis. Representative images of 2/13 mouse TH cells
labeled with isotype control antibody (A) and Alexa488-AC8 at high
(B) or low (C) zoom are shown. The images were acquired using
a 603 oil-immersion objective (numerical aperture, 1.45). Panels A,
B, D, E, G, H, and I are composites of the equatorial fluorescent
image slices and the differential interference contrast images of
the cells, and panels C and F are fluorescent images. Intracellular
staining of saponin-permeabilized 2/13 TH cells by AC8 is shown in
(D). Intracellular bound AC8 showed partial colocalization with a
marker of endoplasmic reticulum and the Golgi complex, BODIPY-
brefeldin A (E). Representative images show that AC8 colocalizes
strongly with CTX-B (GM1) (F), Thy1 antigen (G), and to a smaller
extent with anti-CD71/transferrin receptor (H) in T-cells, as well as
strongly with caveolin-1 (I) in macrophages. Colocalization indices
of fluorescent AC8 with various fluorescent membrane and intra-
cellularmarkers are summarized in( J) andexpressedasmeans6SD
from at least 100 regions of interest. CTX-B, cholera toxin-B.
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cholesterol IgG monoclonal antibodies bound efficiently
only to those cholesterol-like sterols that contain a 3b-
hydroxyl group. However, additional chemical moieties
or the polarity of the sterols may also influence antibody
binding, consistent with the lack of binding to 25-hydroxy-
cholesterol bearing the free 3b-hydroxyl moiety. The two
monoclonal ACHAs (AC8 and AC1) differed slightly in
their binding preference to the tested sterols, suggesting
that, in spite of the small epitope size, two antibodies with
different fine specificities could be generated.
Our monoclonal IgG ACHAs bound to human lipopro-
teins HDL, LDL, and VLDL alike. In contrast to previous
studies with IgM, no strict selectivity was found in the
binding to LDL and VLDL over HDL. Dijkstra et al. (19)
reached their conclusion about binding selectivity on the
basis of bound antibody per total (or free) cholesterol.
However, the total cholesterol content (free plus esterified
cholesterol) per particle mass, the particle size, the ratio
of surface free cholesterol to total cholesterol, and the
protein-to-lipid ratio may all vary strongly among the dif-
ferent lipoproteins. Moreover, these factors together may
influence the available surface area for antibody binding.
When the binding of our IgG ACHAs to the different lipo-
proteins was normalized for equivalent surface area, we
obtained similar values, and the avidity to HDL was only
slightly lower than that to LDL or VLDL. This is consistent
Fig. 5. AC8 binding to T-cells and macrophage cells is sensitive to membrane cholesterol/raft modula-
tions. A: Filipin (10 mg/ml; thick line) or cholesterol oxidase (1 U/ml; thin line) reduces AC8 binding to the
surface of papain-treated 2/13 TH cells. Immunofluorescence of isotype control (black area) or AC8-labeled
(gray area), papain-treated cells is also shown. B: Cholesterol oxidase dose-dependently reduces AC8
binding to papain-treated 2/13 TH lymphocytes (closed diamonds) and MonoMac6 (open inverted
triangles) human monocyte-macrophage cells. C: Immunodot blot analysis of detergent-resistant (gels 3, 4)
and detergent-soluble (gel 5) fractions isolated from TH cells and cholesterol (gels 1, 2) as a control. Samples
were untreated (gels 1, 3, 5) or treated with cholesterol oxidase (gels 2, 4) and dropped onto the nitro-
cellulose membrane in small (2 ml) amounts either directly or at 23 dilution. D–I: Treatment of T-cells with
5 mg/ml (E) and 10 mg/ml (F) filipin results in a gradual segregation of membrane cholesterol relative to
untreated control cells (D). 2/13 TH cells are stained in a uniformly ring-like, patchy manner with cholera
toxin B (G). Activation of TH cells with concanavalin A mitogen results in capping of cholera toxin B, as
shown by the representative image in (H). AC8 is strongly copolarized with cholera toxin B in the membrane
of mitogen-activated T-cells (I). Error bars represent SEM.
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with the higher surface density of proteins in HDL, be-
cause the proteins may shield part of the surface choles-
terol epitopes, and is also indicative of an important
difference between IgM- and IgG-type ACHAs.
High serum levels of low density lipoproteins and
low serum concentrations of HDL are independent risk
factors for atherosclerotic diseases (28–32). The previ-
ously reported monoclonal ACHA binding to LDL and
VLDL but not to HDL (19) led to the hypothesis (33)
that naturally occurring ACHAs may have a role in the
selective clearance of LDLs (“bad cholesterol”). That
the IgG ACHAs generated in this work also bind to
HDL, however, suggests that the role of natural ACHAs
in the pathogenesis of atherosclerosis cannot be simpli-
fied. This is further supported by the clinical findings
of high ACHA serum levels in patients with coronary
heart disease (9) but low ACHA levels in patients
with cerebrovascular diseases (29, 31) compared with
healthy individuals.
As cholesterol is a fundamental component of cell mem-
branes, it is an intriguing question whether natural ACHAs
can bind to cell surfaces under physiological or patho-
logical conditions. Previously, monoclonal IgM ACHAs
were reported to react with plasma membrane cholesterol
microdomains of macrophages responsive to changes in
cholesterol trafficking. These IgMs bound to the cells only
after artificial cholesterol enrichment by various treat-
ments, suggesting that they define cholesterol arrays that
are presumably not identical to lipid rafts (5, 24).
The novel IgG monoclonal antibodies AC1 and AC8
bound spontaneously, although weakly, to intact human
and murine lymphoid or monocyte-macrophage cells. A
limited papain digestion, removing some long extracellu-
lar protein domains from the cell surface, strongly en-
hanced their avidity, indicating that the IgG ACHAs bind
to “extremely small epitopes” that are mostly shielded by
the long, protruding membrane proteins. The higher level
of AC8 binding to monocyte-macrophage cells versus
lymphoid cells is likely attributable to the easier access to
cholesterol epitopes in “opened” caveolar structures com-
pared with the crowded surface of lymphocytes.
Exposure of cholesterol epitopes, however, may also
change during apoptosis and the budding of enveloped
viruses or under pathological conditions (e.g., tumors),
because all of these processes may alter molecular com-
position, curvature, or the “surface smoothness” of the
involved membrane regions. Recognition of the exposed
cholesterol epitopes by naturally occurring cholesterol-
specific antibodies may have further physiological con-
sequences, such as activation of the complement and/or
phagocytic system to eliminate dead cells as well as virus
particles. Such altered cholesterol exposure may also be
relevant in the increased level of ACHAs observed under
pathological conditions (8–10, 34).
The high degree of colocalization between the IgG
ACHA and cholera toxin B, anti-Thy1, or anti-caveolin-1
antibodies indicates that rafts or caveolae can be
considered preferential binding sites for ACHAs in the
plasma membrane. Although in lymphocytes and macro-
phages cholesterol can be found in fluid-phase mem-
brane regions as well, it is locally enriched (clustered) in
the noncaveolar and caveolar rafts or, to a lesser extent,
in other functional membrane domains, such as chla-
thrin-coated pit structures (6), consistent with our find-
ings. Aggregation of lipid rafts by T-cell activation signals
has been described (6). Thus, the strongly patchy nature
of membrane staining by ACHA and its copolarization
(capping) with the lipid raft marker cholera toxin B upon
T-cell activation, together with a substantial degree of co-
localization between ACHA and other lipid raft markers,
all suggest that AC8 antibody is capable of marking lipid
raft microdomains and even monitoring their activation-
induced redistribution in the plasma membranes of live
lymphoid cells.
In contrast to the IgM antibodies reported by Kruth
et al. (5), our data show that the IgG ACHAs bind to T-
or B-cell membrane microdomains displaying detergent
resistance and enriched in known markers of lipid rafts.
These properties of the new IgG ACHAs allow further
possible applications in the study of lipid raft functions.
In addition, the structural integrity of raft/caveola mi-
crodomains, stabilized by cholesterol, is essential in various
immunological functions, such as antigen presentation
(35–37), T-cell receptor-mediated signal transduction (36),
and the uptake of viral (e.g., human immunodeficiency
virus) and other pathogens or particles by phagocytes
(16, 37). This raises the question of whether binding of
ACHAs to the membrane microdomains of these cells can
modulate these processes and, if so, how. Our preliminary
results obtained with an antigen-presenting cell (APC)-TH
cell immunological synapse model (21), showing AC8-
augmented antigen presentation and an enhanced phago-
cytosis of opsonized yeast cells by macrophages upon AC8
antibody binding, suggest that AC8 may have potential to
modulate various immune functions dependent somehow
on cholesterol-rich lipid rafts. Such modulatory effects are
limited to those immunocytes to which ACHAs can bind
spontaneously to a sufficient extent (e.g., APCs, macro-
phages). Indeed, no modulatory effect of ACHA on T-cell
activation was observed in the APC-TH cell immunological
synapse if the TH cells were preincubated with ACHAs
instead of the APCs (38).
In conclusion, we generated two IgG3 isotype clones of
ACHAs, AC1 and AC8, that were characterized in detail in
both cell-free and cellular systems and have shown their
potential to mark and monitor changes in the cell surface
distributionof cholesterol-rich caveolar or noncaveolar lipid
rafts. Consistent with their substantially enhanced binding
to the surface of various immunocytes upon moderate
papain digestion, we propose that IgG ACHAs, in contrast
to IgM isotypes, may function by directly modulating
several lipid raft-dependent immune functions, especially
under specific physiological or pathological conditions,
altering the epitope accessibility of their target cells. Further
detailed investigations are required, however, to validate
this and other possible functions of ACHAs in modulat-
ing the immune response; these are currently running in
our laboratories.
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 Abstract
Lipid rafts are cholesterol- and glycosphingolipid-rich plasma membrane microdo-
mains, which control signal transduction, cellular contacts, pathogen recognition, and
internalization processes. Their stability/lifetime, heterogeneity remained still contro-
versial, mostly due to the high diversity of raft markers and cellular models. The corre-
spondence of the rafts of living cells to liquid ordered (Lo) domains of model mem-
branes and the effect of modulating rafts on the structural dynamics of their bulk mem-
brane environment are also yet unresolved questions. Spatial overlap of various lipid
and protein raft markers on live cells was studied by confocal laser scanning micros-
copy, while fluorescence polarization of DiIC18(3) and Bodipy-phosphatidylcholine
was imaged with differential polarization CLSM (DP-CLSM). Mobility of the diI probe
under different conditions was assessed by fluorescence correlation spectroscopic
(FCS). GM1 gangliosides highly colocalized with GPI-linked protein markers of rafts
and a new anti-cholesterol antibody (AC8) in various immune cells. On the same cells,
albeit not fully excluded from rafts, diI colocalized much less with raft markers of both
lipid and protein nature, suggesting the Lo membrane regions are not equivalents to
lipid rafts. The DP-CLSM technique was capable of imaging probe orientation and het-
erogeneity of polarization in the plasma membrane of live cells, reflecting differences in
lipid order/packing. This property—in accordance with diI mobility assessed by FCS—
was sensitive to modulation of rafts either through their lipids or proteins. Our com-
plex imaging analysis demonstrated that two lipid probes—GM1 and a new anti-choles-
terol antibody—equivocally label the membrane rafts on a variety of cell types, while
some raft-associated proteins (MHC-II, CD48, CD59, or CD90) do not colocalize with
each other. This indicates the compositional heterogeneity of rafts. Usefulness of the
DP-CLSM technique in imaging immune cell surface, in terms of lipid order/packing
heterogeneities, was also shown together with its sensitivity to monitor biological mod-
ulation of lipid rafts. ' 2007 International Society for Analytical Cytology
 Key terms
lipid rafts; live lymphoid cells; confocal polarization imaging; FCS; raft modulation
MICRODOMAINS enriched in cholesterol and glycosphingolipids (so called lipid
rafts) are expressed in the plasma membrane of most mammalian cells (1–6) and
involved in numerous membrane-associated cellular functions. Compartmentation,
spatiotemporal coordination and coupling or isolation of receptor-, signal-transdu-
cing, or regulatory proteins were shown to be controlled, in some ways, by lipid rafts
(3–6). Furthermore, these microdomains are supposed to be involved in the captur-
ing and internalization of some viruses (e.g. human immunodeficiency virus, HIV
and influenza virus), bacteria, or bacterial inflammatory molecules (e.g. toxins or
lipopolysaccharides) by host cells (6,7) in the immune system and in regulation of
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signal transduction in neuronal synapses (8). Moreover, a cor-
relation between cholesterol homeostasis and appearance/
composition of membrane microdomains in human mono-
cyte-macrophage cells (9), as well as a differential regulatory
role of E-LDL and Ox-LDL in the cholesterol- and ceramide-
rich microdomains of these cells have recently been shown
(10). Thus, lipid raft and caveola membrane microdomains
gained a widespread attention in the research of cellular com-
munication and signal transduction in general, and in the
immunological, virological, and neurobiological research areas
in particular.
Despite the extensive biochemical and biophysical char-
acterization on model membranes and cells, several basic
properties of these membrane microdomains on live cells (e.g.
size, stability, fine structure, or compositional diversity), as
well as the regulatory mechanisms controlling these properties
still remained controversial and less understood (2,6,11–13).
Since there is an ongoing debate on the size, size-distribution,
lifetime and stability of microdomains, many groups are
devoted to characterize different aspects of rafts by using vari-
ous versions of optical fluorescence or scanning probe ima-
ging. These approaches, focusing mostly on model membranes
with less complexity, include, among others, confocal fluores-
cence (FRET-) microscopy (11); single particle tracking video-
imaging (13); fluorescence correlation (FCS) microscopy
(14,15); two-photon microscopic imaging of laurdan general-
ized polarization domains (16) and atomic force imaging of
model membranes (17,18).
Various probes are used to mark these microdomains,
such as fluorescent antibodies against GPI-anchored proteins
(e.g. CD48, CD55, CD59, CD14, HA-R, AP, FR, etc.), GPI-
GFP reporters, the cholera toxin b subunit binding selectively
to GM1,3 gangliosides or fluorescent lipid analogs (6). We have
recently developed new IgG type monoclonal antibodies reac-
tive to clustered cholesterol in both cell-free systems, such as
lipoproteins, and in live immune cells (e.g. lymphocytes, mac-
rophages). These antibodies were shown capable of marking
cholesterol-rich membrane microdomains (rafts or caveolas)
or even their redistribution in the plasma membrane of acti-
vated lymphocytes (19).
The phase separation of Lo (liquid ordered) and Ld (liq-
uid disordered, fluid) domains has been quite extensively
studied earlier in various model membrane systems (6,20–22).
The imaging studies on such systems often applied fluorescent
lipid probes to mark these domains, such as the diIC18 or
diIC20 indocarbocyanine probes (diI) for Lo domains or Bod-
ipy-phosphatidylcholine (B-PC) for the Ld domains (20–22).
Although lipid rafts are often depicted as ordered lipid
domains, the diI probe, partitioning well into Lo domains in
model membranes of simple composition (e.g. GUVs) (20),
has been assumed as a non-raft lipid probe (23,24), based on
its weak miscibility with sphingomyelin (SM)-enriched
regions. In these GUV (Giant Unilamellar Vesicle) models
cholesterol was shown to increase separation of the Lo and Ld
phases in a concentration dependent manner, demonstrating
its capability to fine-tune dynamics of membrane phases and
microdomains. The question whether the phase-relations and
raft dynamics is similar in the plasma membrane of live cells,
however, is still debated (24).
The lateral contacts of raft microdomains to their neigh-
boring membrane areas, as well as the domain boundaries of
Lo phase regions are both poorly understood in live cells. In
order to investigate these questions we applied here a recently
introduced novel differential polarization laser scanning con-
focal microscopic approach (DP-CLSM) (25,26) to further an-
alyze the ordering of plasma membranes and lipid packing of
live lymphoid cells. For this purpose we used the aforemen-
tioned indocarbocyanine lipid probe, diIC18(3). The expected
membrane perturbation caused by this probe is certainly lower
than those appearing when a large fluorescent IgG antibody,
the very specific, but pentameric polypeptide, CTX-B, or large
immunogold labels are used. Moreover its dipole orientation
relative to the membrane surface was experimentally estab-
lished and shown to be preferentially tangential, at least in red
blood cells (27). Therefore it seems a suitable probe to study
changes of lipid order/packing and the effects of raft modula-
tions on their lipid neighborhood in live cells.
In the present study we addressed the following ques-
tions: (i) to what extent does the new marker of clustered cho-
lesterol (AC8 antibody) overlap with GM1,3 ganglioside-
enriched domains and with the diI lipid probe in a variety of
live immune cells; (ii) to what extent do the different protein
markers of rafts overlap with the above two lipid probes and
with each other; (iii) what can the differential polarization
(DP-CLSM) images of diI tell us about lipid raft dynamics and
the coupling of rafts with their lipid neighborhood. Our data
demonstrate that cholera toxin B and the new anti-cholesterol
antibody, AC8, as two lipid probes of membrane rafts, show a
highly matching membrane localization in all cell types inves-
tigated, confirming that the gangliosides and cholesterol may
indeed form a stable ‘‘nucleus/molecular skeleton’’ for mem-
brane rafts. In contrast, several raft-associated proteins (e.g.
MHC-II, CD48, or CD90) show a differential colocalization,
reflecting a compositional heterogeneity in the protein content
of co-existing lipid rafts on live immune cells. Usefulness of
the differential polarization CLSM method in imaging
immune cell surface in terms of lipid order/packing heteroge-
neities and detection of biological modulation of lipid rafts
are also demonstrated and discussed.
MATERIALS AND METHODS
Cells and Reagents
The human Kit225 K6 T-lymphoma cell line (kindly pro-
vided by T.A. Waldmann, Bethesda, MD) was cultured in
RPMI 1640 medium supplemented with 10% fetal calf serum
(FCS), penicillin, streptomycin, Na2CO3, and sodium pyru-
vate. Recombinant IL-2 (20 U/ml) was added in every 48 h
(28). For the experiments, cells were harvested, washed, and
resuspended in PBS, pH 7.4. JY human B lymphoblasts (HLA-
A2,B71) (29) were grown in RPMI 1640 1 10% FCS me-
dium, while 2PK3 (I-Ed 1, I-Ad 1) murine B-lymphoma cell
line of BALB/c origin (ATCC, TIB-203) and the L929 C3H/An
mouse fibroblasts (ATCC, CCL-1) were cultured in RPMI
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1640 medium with 0.05 mM 2-mercaptoethanol and 5% FCS,
in 5% CO2 atmosphere, at 378C (30). Ten-week-old male Spra-
gue-Dawley rats were decapitated, hearts were removed, rinsed
in isotonic saline solution (0.9% NaCl), blotted dry, and cham-
bers were separated from each other. Left ventricular tissue
samples were sliced and stained right before they were assayed.
MbCD and McCD (random methylated b and c cyclo-
dextrin) was purchased from CycloLab (Budapest, Hungary).
Alexa 488-(or 647-) cholera toxin B, diIC18(3) and Bodipy-
phosphatidylcholine were obtained from Molecular Probes-
Invitrogen (Eugene, OR). MEM-75 (against transferrin recep-
tor/CD71) and MEM-102 (against CD48) mAbs were kindly
provided by V. Horejsi (Institute of Immunogenetics, ASCR,
Prague, Czech Republic) and they were conjugated with Alexa
fluorophores according to the manufacturer’s instructions
(Molecular Probes-Invitrogen).
Cell Labeling
Cells were labeled with Alexa488-conjugated cholera
toxin B according to the manufacturer’s (Molecular Probes-
Invitrogen) instruction. Staining with diI (1.5 mg/ml) was per-
formed by incubating the cells for 2–3 min., at 378C, in HBSS
(15 mM glucose 1 1% BSA), using a sonicated, air-fuged,
and filtered stock solution of diI in ethanol. In case of double
labeling, cells were incubated sequentially in diIC18(3) and
then CTX-B for 10 min on ice. Cells were labeled with fluores-
cent antibodies for 40 min, on ice, and then washed twice
before measurement. Human CD71 specific Cy3-MEM-75
(mouse IgG1 Ab) and FITC-conjugated rat anti-mouse anti-
body G7.4 (IgG2c, from ATCC) was used to label transferrin
receptor and Thy1 (CD90), respectively. CD2 on T-cells were
labeled with FITC-conjugated anti-human CD2 mAb (Sigma,
St. Louis, MO, USA). ACHAs were applied either as Alexa488-
conjugated AC8 or biotinylated AC8 followed by Alexa647-
conjugated neutravidin and the cells were stained as described
recently (19). In case of double labeling, the lipid probes and
the antibodies were usually added to the cells simultaneously
for the appropriate time intervals. No competition or mutual
blocking of binding was observed with any pairs. For the fluo-
rescent antibodies appropriate isotype control antibodies (or
cell lines) were used as negative controls.
Depletion of Membrane Cholesterol by MbCD
Freshly harvested cells (1 3 106/ml) were incubated with
10 mM MbCD or MgCD (control) (Cyclolab, Budapest, Hun-
gary) for 15 min, at 378C, in PBS pH 7.4 and then washed.
Forty to fifty percent of plasma membrane cholesterol could
be removed with this treatment (28). MgCD a conformational
isomer incapable of cholesterol extraction was used as control.
After washing, the cells were labeled accordingly for further
analysis.
Membrane Modulation by Crosslinking of
Membrane Proteins
Cells were incubated with unconjugated MEM-75 (reac-
tive with transferrin receptor, CD71) or MEM-102 (reactive
with CD48) monoclonal antibodies on ice, for 40 min. After
washing, samples were incubated with polyclonal goat anti
mouse IgG for 30 min, on 378C, to crosslink the primary
antibodies.
CLSMMeasurements
The stained cells or tissue sections were mounted on cov-
erslip and imaged by Olympus FluoView500 confocal laser
scanning microscope, using the 488 nm argon-ion laser line to
excite Alexa 488 dye and the 543 nm He-Ne laser line for the
diIC18(3). In case of long wavelength probes, a 632 laser line
(He-Ne) was applied. The images (512 3 512 pixels) were
recorded by using a 603 oil-immersion objective (N.A.:1.25).
An SDM560 dichroic mirror and a BA505-525 bandpass emis-
sion filter was used for detecting Alexa 488 fluorescence
(channel 1), SDM630 dichroic mirror and BA560-600 bandpass
filter was used in channel 2 for detecting diIC18(3) emission
and a 660IF long pass filter was used in channel 3 for detecting
the fluorescence of long-wavelength probes Cy5 or Alexa647.
A sequential scanning mode was applied in colocalization
experiments to minimize the crosstalk between channels.
Pearson’s colocalization coefficients were calculated by
using the ImageJ software. The same experimental setup and
strategy was applied to investigate colocalization of various
double-stained lymphoid cells by CLSM.
FRET Measurements
FRET between membrane proteins, after their fluorescent
immunocytochemical labeling, was measured either by the
acceptor photobleaching FRET or the intensity-based FRET
method (31). FITC-Cy3, Cy3-Cy5, or Alexa546-Cy5 dye pairs
served as donors and acceptors, respectively. FRET efficiencies
were measured by recording 512 3 512 pixels images of the
double- or single (donor- or acceptor-) labeled cells in the op-
tical channels of the FluoView 500 CLSM system, selected
properly for the given dye pair by the appropriate emission fil-
ter combinations and dichroic mirrors. The images were eval-
uated for FRETefficiency as described previously (31,32).
FCS Measurements
FCS measurements were carried out on the fluorescence
fluctuation microscope (FFM) constructed by Prof. Jörg Lan-
gowski’s group at the DKFZ, Heidelberg. The setup combines
an FCS/FCCS module with a galvanometric laser scanner
attached to the video port of an inverted IX-70 microscope
(Olympus, Hamburg, Germany) with a UplanApo 603, 1.2
NA water immersion objective (33,34). Measurements were
performed at room temperature. DiI fluorescence was excited
with the 568 nm line of an Ar-Kr laser from Omnichrome
(Wessling, Germany). Emission was detected through a 590–
750 nm bandpass filter (OG5901700CSFP, Omega Optical,
Brattlerborn, VT) by an avalanche photodiode (SPCM-AQR-
13, Perkin-Elmer, Wellesley, MA). Confocal images of the cell
membrane were acquired, and the laser beam was positioned
at selected points of the membrane for FCS measurements.
Laser power at the objective was  0.8 mW. For calculating the
autocorrelation function from the signal of the photodiode,
an ALV-5000/E correlator card (ALV Laser GmbH, Langen,
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Germany) was used. Data acquisition time was always 60 s,
corresponding to 10 runs of 6 s, which were averaged. From
each sample 10 cells were measured. Autocorrelation func-
tions were fitted to a single component 2D diffusion model
with triplet term using the program QuickFit (written in the
laboratory of J. Langowski, DKFZ, Heidelberg):
GðsÞ ¼ 1
N






where N is the average number of molecules in the detection
volume, T is the fraction of diIC18(3) molecules being in the
triplet state within the detection volume, str is the phosphores-
cence lifetime of diIC18(3) and sd is the diffusion time, which
is the average time spent by the dye in the detection volume.
The diffusion coefficient, D can then be derived as: D 5
xxy
2 /4sD, where xxy is the lateral radius of the sensitive volume.
xxy at 568 nm excitation was estimated by measuring the dif-
fusion time of Alexa Fluor 568 dissolved in PBS (sd 5 60 2 ms
at 258C). Assuming inverse proportionality between the MW
and D, and using Rhodamine 6G as reference (Culbertson
et al., 2002, Talanta 56:365), we assessed the diffusion coeffi-
cient of Alexa Fluor 568 as DAlexa 568  DR6G 3 MWR6G/
MWAlexa 568 5 4.14 3 10
26 cm2/s 3 471/716 5 2.72 3 1026




 255  5 nm.
Differential Polarization Laser Scanning Microscopy
For recording P (the degree of polarization of the fluores-
cence emission) images we used a Zeiss LSM 410 laser scan-
ning microscope equipped with DP (differential polarization)
attachments. The overall schemes and technical details,
including calibration and correction procedures, taking into
account the polarization characteristics of the dichroic beam
splitter, have been published elsewhere (25,26). For P imaging
of the lymphocyte cells in the DP-CLSM (differential polariza-
tion confocal laser scanning microscope), the sample was
excited with either the 488 or 514 nm linearly polarized beams
of an Ar-ion laser. The polarization content of the fluorescence
emission was analyzed with the aid of a photoelastic modula-
tor (PEM, Hinds International) and a demodulation circuit,
which consisted of a programmable, gated digital phase-sensi-
tive detector (DPSD) constructed by Pawel Kamasza (SZFKI
KFKI, Budapest). The DPSD was locked at the modulation
frequency of PEM, at 100 kHz, and a low pass analog-digital
converter amplifier (ADC) was used to determine the average
intensity, Ia. The analyzer unit was adjusted in a manner to
detect the intensity difference DI 5 I1 2 I2, where the polar-
ized components are parallel (I1) and perpendicular (I2) to the
polarization direction of the laser beam. P was calculated as
DI/2Ia, with Ia 5 (I1 1 I2)/2.
5 3 105 Kit225 K6 T-lymphoma or JY human B lym-
phoma cells suspended in PBS were labeled with diIC18(3). After
washing, cells were resuspended in PBS and mounted on cover-
slip. The 514 nm laser line was used for excitation, an FT560
dichroic beamsplitter and an additional long pass 560 nm color
filter was used to separate the fluorescence; the PEM was
adjusted to 586 nm, which is the emission peak of diIC18(3).
When labeling with Bodipy-phosphatidylcholine, cells were
incubated at the same density with the probe (1.5 mg/ml) for 10
min, at room temperature. After washing, cells were mounted
on coverslip. Excitation of Bodipy fluorescence was at 488 nm,
using an FT510 beamsplitter and a long pass 510 nm filter; PEM
was adjusted to the emission peak (520 nm) of Bodipy-PC.
RESULTS
Staining Patterns of the Fluorescent Lipid Membrane-
Probes on Live Lymphoid Cells
In earlier studies the large diversity of the applied, sup-
posed raft markers, and cellular models resulted in a broad
spectrum of their localization and physicochemical properties
(6). Therefore here we tried to perform a systemic study on
cell types phenotypically closely related to each other, such as
T- and B-lymphoma cells of human or murine origin and to
apply the same lipid raft markers to all. First, we tested how
the staining pattern of these cells with various well defined
markers of lipid rafts (e.g. CTX-B, a new anti-cholesterol anti-
body, AC8) or with diIC18(3) and Bodipy-PC, lipid probes of
Lo and Ld phase domains, respectively (12,20,21). As the rep-
resentative intensity surface plots on Figure 1 show, the
human T lymphoma cells (Kit 225 K6) displayed a differential
staining pattern with these probes. While CTX-B, AC8, and
diIC18(3) all stained these cells in a pattern of discrete small
patches (Figs. 1A–1C), while the Bodipy-PC probe, enriched
in the fluid membrane regions, as expected, stained the plasma
membrane more homogenously (Fig. 1D). Similar staining
patterns were observed for these probes in human B lympho-
blast (JY) and macrophage (U937) cell lines (data not shown).
Membrane Domains Defined by diIC18(3) Match the
Domains of Classical Lipid Raft Markers Only Partially
in Lymphoid Cells
Despite that diIC18(3) was defined by model membrane
studies as nonraft marker (enriched in Lo phase domains)
(23,24), showed a typical patchy staining pattern on the sur-
face of lymphoid cells (see Fig. 1C), suggesting that these 200–
300 nm diameter patches define a certain type of membrane
microdomain in these cells. A substantial colocalization was
found between the new fluorescent AC8 anti-cholesterol anti-
body (19), and the CTX-B labeled GM1 gangliodies, the classi-
cal markers of rafts. A high level of matching of the AC8-la-
beled and GM1-CTX-B 1 domains was observed in both B-
and T-lymphocytes of human origin (cross correlation (cc):
0.68 and 0.67, respectively), similarly to murine TH cells and
macrophages (Table 1). The colocalization between diIC18(3)
and AC8, however, was significantly lower (cc: 0.4) in the
same cells. The spatial correlation between diIC18(3) and the
GM1/CTX-B domains was the lowest (28–34%), as assessed by
a CLSM analysis on cells of different origin (Figs. 1E–1H), and
it was independent of the cell type. These data suggest, that
the ‘‘clustered’’ cholesterol and GM1 have a high spatial corre-
lation in all cell types investigated, but the membrane regions
ORIGINAL ARTICLE
Cytometry Part A  73A: 220229, 2008 223
48
defined by diIC18(3) have a poor, but still non-negligible over-
lap with lipid rafts labeled with these two markers, on cells of
lymphoid origin.
Lipid Rafts of Lymphoid Cells’ Plasma Membrane
Show Some Compositional Heterogeneity
Among the GPI-anchored lipid raft marker proteins,
CD90 and CD59 are found mostly in T cells, while CD48 is
expressed on both T and B cells of lymphoid origin (4,6). In
contrast, CD2 is an abundant nonraft protein in T cells (35).
Key molecules of antigen presentation, the class I and class II
major histocompatibility antigens (MHC-I, MHC-II) are
expressed on both T- and B-lymphoma cells and a substantial
fraction of MHC-II was shown raft-associated on these cells
(30,36). Here we tried to map the mutual colocalization/prox-
imity of these membrane proteins with each other and with
the aforementioned lipid markers of raft domains, using
CLSM/FRET and colocalization analysis. As expected, CD48
and CD90 are firmly associated with the membrane domains
defined by both GM1/CTX-B and the anti-CHOL antibody,
AC8 (19), while the nonraft CD2 protein did not associate
with these domains (Table 1).
Concerning the MHC glycoproteins, colocalization and
FRET data consonantly show that MHC-II is associated with
raft marker GM1, in a much higher extent than MHC-I, in the
B- and T-lymphoma cells (Table 1). In addition, earlier data
have shown that MHC-II is partially detergent resistant and
that its homoassociation (clustering) on murine B lymphoma
cells was cholesterol-sensitive (30). In contrast, MHC-I clus-
ters on B lymphoma cells proved to be less sensitive to choles-
terol, but rather dictated by b2m-dependent protein–protein
affinity (37), consistent also with their very weak association
with the GM1/CTX-B-rich domains.
Despite its raft-association, MHC-II molecules show
rather weak if any colocalization/proximity with CD48. A
somewhat stronger colocalization with CD59 was observed on
the same cells. Taking these data together, the MHC-II enriched
lipid rafts of B and T lymphoma cells seem to be separate
microdomains from those enriched in CD48, but show some
degree of mutual compartmentalization with CD59. This can
be regarded as a piece of evidence for heterogeneity in protein-
composition of lipid rafts in lymphoid cells.
P-Imaging of diI-Stained Lymphoid Plasma
Membranes with Differential Polarization Microscopy
By combining the technique of differential polarization
(DP) with confocal microscopy a method has become avail-
able for imaging not only the fluorescence intensity but also
the polarization or anisotropy DP parameters. For linearly
polarized light, these include P, the degree of polarization of
the fluorescence emission, which characterizes the depolariza-
tion e.g. due to rotation of the molecules and/or due to excita-
tion energy transfer or migration in the system, linear dichro-
ism (LD) and fluorescence detected LD, which are given rise
by the anisotropic distribution of the absorbance dipoles, and
r, the anisotropy of the fluorescence emission, a quantity
which originates from the nonrandom distribution of the
Figure 1. Staining pattern of various lipid probes on human T
lymphoma cells and the colocalization of diIC18(3) with cholera
toxin B on various cell types. Alexa488-Cholera toxin B labeling
GM1,3 gangliosides (A), Alexa488-AC8 anticholesterol antibody (B)
and diIC18(3) (C) all stained Kit225 K6 T cells in a patchy fashion,
defining discrete microdomains. Membrane staining by Bodipy-
C5-phosphatidylcholine of the same cells (D) is much more ho-
mogenous. The fluorescence intensity surface plots were derived
from representative confocal microscopic equatorial optical sec-
tions (width: 0.3 mm) recorded by a 603 oil immersion objective
(N.A: 1.25). Colocalization of Alexa488-CTX B with diIC18(3) is
shown on 2PK3 murine B lymphoma (E), JY human B lympho-
blast (F), left ventricular tissue sections of raft heart (G), and L929
murine fibroblast (H) cells. The images were recorded by confocal
microscope as described earlier, the white bars indicate 10 mm.
The colocalization indices were 0.30  0.12 (E), 0.34  0.1(F), 0.26
 0.12 (G), and 0.32  0.18 (H), respectively.
ORIGINAL ARTICLE
224 New Faces of Membrane Microdomains
49
emission dipoles with respect to a coordinate system fixed to
the laboratory or the sample (26).
We applied diIC18 and Bodipy-PC to probe Lo and fluid
membrane regions (Fig. 2A) on live cells by DP-CLSM. As
shown by Axelrod et al. (27) on red blood cells, the long fatty
acyl chains of diIC18(3) are aligned preferentially parallel with
the membrane normal, keeping the orientation of the indocar-
bocyanin’s absorption dipole uniformly tangential with respect
to the surface of the plasma membrane. In perfect accordance
with the expectations, diIC18(3) probe shows a similar orien-
tational behavior in both B and T lymphoblastoid cells (JY
and Kit225 K6, respectively). In microscopic samples contain-
ing nonrandom orientation of the emission dipoles, i.e. in
samples which exhibit nonzero r, P contains information both
on the anisotropic distribution of the emission dipoles with
respect to the membrane plane and on the depolarization due
to the motional freedom of the lipid-dye molecular assemblies.
This is demonstrated by the color-coded P-images of JY cells,
which in the vertical and horizontal directions are dominated
by the preferentially parallel and perpendicular orientation of
the emission dipoles, resulting in positive and negative P
values, respectively (Fig. 2B). (Note: in macroscopic samples
this information is lost due to spatial averaging; in highly ani-
sotropic samples, however, P might contain contributions
from the residual anisotropy e.g. due to photoselection and/or
due to gravitational alignment of the particles (38)).
In contrast to diIC18, Bodipy-PC is preferentially
inserted into the fluid (Ld) regions of the plasma membrane
through much shorter fatty acyl chains and the fluorophore
ring is attached only to one of them. Thus, its absorption
dipole is expected to be aligned in a less ordered fashion with
respect to the membrane surface. The color-coded representa-
tive P-images of B-PC in JY B cells (Fig. 2B) indeed show that
B-PC fluorescence is much less polarized throughout the
membrane surface than that of the diIC18. Interestingly, as
shown by the intensity and P-images of diIC18 recorded on
membrane cholesterol-depleted JY cells, the diI staining
became less patchy/more uniform, but a few large diI clusters
are formed on the cells. The averaged P values became lower
upon cholesterol depletion.
A large scale statistical analysis of Bodipy-PC and diIC18
P-images recorded on large human T lymphoma cells (Kit225
K6) resulted in similar, heterogenous P-distributions (Fig. 3).
These distributions correspond to spatial averaging, at least
for the selected sections, and thus the mean values can be
compared with macroscopic measurements. The Bodipy-PC
P-histogram is quite narrow, and at the same time the mean
value (0.09) is rather small. This reflects a highly depolarized
emission from Bodipy-PC all over the cells, and indicates a
high rotational freedom with respect to the membrane normal
and small contribution from r. In contrast, the diIC18(3) P-
histograms are significantly broadened due to large contribu-
tions from the anisotropic distribution of the emission dipoles
with respect to the membrane planes, and inhomogeneities in
the local microenvironment of the probe over the cell surface.
This difference is consistent with the intensity surface plots of
the probes (see Figs. 1C and 1D).
Depletion of membrane cholesterol slightly decreased the
width of P-distribution and shifted its mean value toward 0,
consistent with results of macroscopic steady-state polariza-
tion data with DPH probes on the same Kit225 K6 T cells
(28). Extensive crosslinking of either raft-associated CD48
GPI-anchored proteins or a nonraft protein, the transferrin re-
ceptor (CD71) both resulted in a significant positive shift in
the mean value of P-distributions (smaller rotational freedom)
of DiIC18(3) in the Kit225 K6 T cells.
FCS Analysis of the Mobility of diIC18(3) in the Plasma
Membrane. Effects of Lipid Raft Modulations
The lateral mobility of diIC18(3) was analyzed by fluores-
cence correlation microscopy (23,33,34) upon various lipid
raft modulation treatments in human Kit 225 K6 T lymphoma
cells. Typical autocorrelation curves fitted to a single compo-
nent diffusion model including triplet correction are shown in
Figure 4. The average diffusion correlation time (sD, deter-
mined from 11 cells) was 24.1  13.4 ms for control cells (Fig.
4A) and increased to 33.7  7.8 ms (n 5 12) upon crosslink-
ing CD48, a constitutively raft-localized membrane protein
(Fig. 4C). These values of sD correspond to diffusion coeffi-
cients of (6.8 4)3 1029 cm2/s and (4.8 1.1)3 1029 cm2/s,









GM1 (CTX-B) AC8 mAb Murine TH-cells, macrophages 0.65  0.01 n.d. (19)
GM1 (CTX-B) CD48 Kit225 K6, TH-cells 0.64  0.02 0.29  0.06
GM1 (CTX-B) CD48 Kit225 K6, TH-cells (CHOL-depleted) 0.17  0.01 0.06  0.01
GM1 (CTX-B) CD2 Kit225 K6, TH-cells 0.04  0.02 n.d.
AC8 mAb Thy.1(CD90) Murine TH cells 0.56  0.09 n.d. (19)
AC8 mAb CD2 Murine TH cells 0.06  0.03 n.d. (19)
MHC-I/b2-microglobulin GM1 (CTX-B) JY B-, Jurkat T-lymphoma cells 0.11  0.04 0.09  0.04
MHC-II GM1 (CTX-B) JY B-, Jurkat T-lymphoma cells 0.54  0.05 n.d.
MHC-II CD48 JY B-, Jurkat T-lymphoma cells 0.1  0.06 0.07  0.03
MHC-II CD59 JY B-, Jurkat T-lymphoma cells 0.37  0.07 n.d.
aSome data from our recent work published in Ref. 19 are given for comparison.
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respectively. The average sD was even higher, 62.9  42 ms
corresponding to D 5 (2.6  1.7) 3 1029 cm2/s (n 5 10)
when cholesterol was depleted from the plasma membrane by
MBCD treatment (Fig. 4B). We note here that in some of the
cholesterol-depleted cells the diffusion of diIC18 was extre-
mely slowed down (sD[ 100 ms), while in other cells sD was
close to that of the control cells, resulting altogether in an ele-
vated average value. These data reflect decreased local diffu-
sion rates of diIC18(3) upon both types of lipid raft modula-
tion in randomly selected membrane areas of T cells.
DISCUSSION
In the present work, first we demonstrated that a new
anti-cholesterol antibody (AC8) labeling the clustered cell
membrane cholesterol is highly enriched in the membrane
domains defined by GM1,3 gangliosides (cholera toxin labels) in
human B- and T-lymphoid cells. Although quantitative cell
surface staining with AC8 can be assessed only by a standard
limited papain digestion, snapshot imaging of cells stained by
AC8 could monitor not only the level of membrane cholesterol,
but even redistribution of rafts in the plasma membrane, such
as raft polarization upon T cell activation (19). Thus, GM1,3
gangliosides and clustered cholesterol seem to be two essential
‘‘nucleating molecular skeletal elements’’ of lipid rafts existing
in various lymphoid (T- and B-lymphocytes) or myeloid (e.g.
monocyte-macrophage) cells of the immune system. The
strong correlation between CTX-B and AC8 binding (expres-
sion) in seven different immune cells (19) indicates that regula-
tion of their expression might be complex and not independent
of each other, as proposed recently (9). Their simultaneous
application might be a useful tool in a reliable detection of raft
(or caveola) microdomains by fluorescence imaging.
Our results have also shown that some protein markers of
rafts, such as CD48, CD59, or CD90 GPI-anchored proteins
all highly colocalize with both CTX-B and AC8 in B- and T-
lymphoid cells of mouse and human origin. On the other
hand, these GPI proteins differentially colocalize with each
other and with some transmembrane proteins, such as MHC-
II or MHC-I glycoproteins. While the MHC-II-enriched raft
domains (30,36) do not overlap with the CD48-enriched rafts,
some CD59 was found in these MHC-II-clusters. Microcom-
partmentation of MHC-II by rafts may have important func-
tional consequences, both in controlling the efficiency of anti-
gen presentation (30) or through their raft/dependent and
raft/independent signaling pathways (39). Similarly, Fas recep-
tor/CD95 signaling was found differentially regulated, depend-
ing on the receptor localization in CD48-rich rafts or CD55-,
CD59-rich microdomains (40). These results together pro-
vided a piece of evidence for coexisting lipid rafts with protein
compositional diversity in lymphocytes. Similar compositional
heterogeneity of membrane microdomains was reported on
myeloid (monocyte-macrophage) cells (41) and even lipid
domains distinct from cholesterol/SM-rich rafts were
described on fibroblasts (42). Such compositional heterogene-
ity of rafts and their differential cellular localization may serve
as a compartmentation mechanism providing a tool for spa-
tiotemporal coordination of protein functions in the plasma
membrane and various subcellular structures.
A detailed confocal colocalization analysis has also shown
that the microdomains defined by both GM1,3 gangliosides/
CTX-B and the AC8 anti-cholesterol antibody overlap only
partially (weakly) with membrane domains defined by the
diIC18 probe, proposed as a nonraft marker enriched in Lo
phase domains in model membranes (8,12,20–23). This low,
but not negligible (20–30%) colocalization of diI with both
Figure 2. Model system and analysis strategy of P-imaging on
live lymphoid cells by DP-CLSM. (A) Cells are excited by horizon-
tally polarized laser beam. The scheme shows the preferred (tan-
gential) orientation of dilC18 dipoles with respect to the mem-
brane plane. For Bodipy-PC free conical rotation with respect to
the tangential axis is allowed. (B) shows the fluorescence (gray
scale, upper panels) and P (yellow-blue, lower panels) images of
dilC18(3) in control (left), and MBCD-treated (middle) JY cells and
the Bodipy-PC stained JY cells (right). In the P patterns the yellow
color codes the horizontal, while the blue the vertical dipole orien-
tations; the more saturated the color the higher the P value is;
some quantitative P values derived from the numbered ROIs are
shown as an example. The indices of P values correspond to the
indicated membrane regions: in the dilC18(3) images the dipoles
are aligned tangentially to the membrane (horizontal and vertical
orientations from horizontal and vertical membrane regions,
respectively) with relatively high values, while the P values in the
Bodipy-PC image are rather small.
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classic lipid markers of rafts could be observed on lymphoid
and myeloid cells, as well as on other cell types, such as fibro-
blasts or heart muscle cells and did not show cell type-depend-
ence. This might mean that, in contrast to model membrane
systems, in live cells the raft domains may differ in their SM
content and a fraction of diI may partition into SM-poor raft
domains. Another alternative explanation is that the constitu-
tive protein content of rafts may partially shield the molecular
immiscibility of diIC18 and SM within these domains. Taking
all these together, we can say that in live cells the Lo-Ld phase
separation is likely smoothened relative to model membranes
by the numerous proteins interacting with the lipid compo-
nents of these domains.
The recently introduced DP-CLSM technique (25,26)
proved to be useful so far in detecting macroscopic ultrastruc-
tural changes in different plant (membrane) structures using
various measuring modalities offered by the method. Here we
used the P-imaging modality of DP confocal microscopy and,
by applying diIC18 probe, we concluded that technically DP-
CLSM is capable of monitoring either probe orientations or
pixel by pixel emission polarization heterogeneities all over the
cell surface in intact lymphoid cells. While the statistical analy-
sis of P-images for the fluid phase probe Bodipy-PC has
shown a relatively narrow and quite depolarized P-distribution
over tens of T lymphoma cells, the P-distributions for diIC18
were substantially broadened with a higher mean value. This
can be accounted for by the contributions from r and possibly
also from the existence of small scale ordered membrane
regions (including partly rafts), as compared with B-PC which
is homogenously labeling the fluid membrane regions.
Modification of lipid raft microdomains by either choles-
terol depletion (domain disruption) or by crosslinking of raft-
localized proteins, such as CD48 (domain aggregation), both
sensitively influenced the P-distributions derived from P-
images recorded on T cells. Aggregation of rafts through CD48
crosslinking and interestingly crosslinking of a nonraft protein
transferrin receptor (CD71), both shifted the mean of the P-
distribution toward a higher value (restricted rotational free-
dom). These changes might arise partially from the reduced
rotational freedom of ‘‘raft-captured’’ diI molecules and/or
from a dynamic coupling between the coalesced rafts and their
partially ordered lipid neighborhood, where binding of diIC18
to certain proteins may increase upon their aggregation. Such
phenomenon was reported earlier for FceRI on mast cells,
where antigens could induce a large scale coaggregation of
lipids with the clustered receptors (43).
This mechanism, as a model of raft-mediated membrane
reorganization was studied later in a relatively simple model
membrane system (44) and it was shown that crosslinking of a
raft lipid (such as GM1) or a single raft protein (such as Thy1/
Figure 3. Distribution of P values detected for diIC18(3) and Bodipy-PC on Kit225 K6 T lymphoma cells: effect of membrane raft modifica-
tions. The P values, indicated on the X axis, were measured for selected cells (810/graph) by recording DP-CLSM images. The Y axis
shows the normalized number of pixels with a given P value. Panels AD display diIC18(3) fluorescence P-histograms in control, MBCD
treated, CD48-crosslinked, and CD71-crosslinked T cells, respectively. Panel E shows P-histogram of Bodipy-PC probe in control, untreated
K6 T cells. TheM values on all panels display the mean P value while the w values display the width of Gaussian from a Gauss-Marquardt
fitting of data.
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CD90) may result in coexistence of phase separated Ld and Lo
domains, at least in such models. Our DP-CLSM imaging data
on diIC18 probe in live lymphocytes confirm that this might
be an operating mechanism, when raft proteins, e.g. CD48 are
crosslinked. The membrane reorganization induced by CD48
or CD71 crosslinking can also influence local diffusion proper-
ties of the investigated diIC18 probes either through the
increased size of obstacles against their free diffusion or
through an increase in the affinity of lipid–protein interaction
upon protein aggregation, consistently with our present FCS
microscopic data.
In conclusion, our data provided several pieces of evi-
dence for protein compositional diversity of lipid rafts in live
lymphoid cells. It was also shown that Lo (liquid ordered)
domains defined by the diIC18 probe weakly overlap with the
raft microdomains defined by GM1,3 gangliosides and the new
anti-cholesterol antibody reactive with clustered cholesterol.
Finally, we demonstrated usefulness of the DP imaging in live
human lymphoma cells. Using diIC18 probe, the P-images, in
accordance with FCS microscopic data revealed a dynamic
coupling between raft modulations and the neighboring lipid
regions. To elucidate the mechanistic details of the latter, how-
ever, requires further analysis.
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15. Brock R, Vámosi G, Vereb G, Jovin TM. Rapid characterization of green fluorescent
protein fusion proteins on the molecular and cellular level by fluorescence correlation
microscopy. Proc Natl Acad Sci USA 1999;96:10123–10128.
16. Parasassi T, Gratton E, Yu WM, Wilson P, Levi M. Two-photon fluorescence micros-
copy of laurdan generalized polarization domains in model and natural membranes.
Biophys J 1997;72:2413–2429.
17. Lawrence JC, Saslowsky DE, Edwardson JM, Henderson RM. Real-time analysis
of the effects of cholesterol on lipid rafts behavior using atomic force microscopy.
Biophys J 2003;84:1827–1832.
18. Giocondi M-C, Milhiet PE, Dosset P, Grimellec CL. Use of cyclodextrin for AFM
monitoring of model raft formation. Biophys J 2004;86:861–869.
19. Biro A, Cervenak L, Balogh A, Lorincz A, Uray K, Horvath A, Romics L, Matko J,
Fust G, Laszlo G. Novel anti-cholesterol monoclonal IgG antibodies as probes and
potential modulators of membrane raft-dependent immune functions. J Lipid Res
2007;48:19–29.
20. Korlach J, Schwille P, Webb WW, Feigenson GW. Characterization of lipid bilayer
phases by confocal microscopy and fluorescence correlation spectroscopy. Proc Natl
Acad Sci USA 1999;96:8461–8466.
Figure 4. Fluorescence autocorrelation curves of diIC18(3) meas-
ured on Kit 225 K6 cells. For each sample n  10 cells were meas-
ured; 10 runs lasting for 6 s each were carried out in every
selected point. Presented curves are the averages of 10 runs. Rep-
resentative curves from measurements on two control cells (A),
two MBCD-treated cells (B), and one CD48 crosslinked cell (C) are
shown. Autocorrelation curves were fitted to a model assuming a
single free diffusion component and triplet correction (smooth
curves). The average diffusion times for the control, MBCD-trea-
ted, and CD48-crosslinked samples were 24.1  13.4, 62.9  42,
and 33.7  7.8 ms, respectively.
ORIGINAL ARTICLE
228 New Faces of Membrane Microdomains
53
21. Feigenson GW, Buboltz JT. Ternary phase diagram of dipalmitoyl-PC/dilauroyl-PC/
cholesterol: Nanoscopic domain formation driven by cholesterol. Biophys J
2001;80:2775–2788.
22. Bacia K, Schwille P, Kurzchalia T. Sterol structure determines the separation of phases
and the curvature of the liquid-ordered phase in model membranes. Proc Natl Acad
Sci USA 2005;102:3272–3277.
23. Kahya N, Scherfeld D, Bacia K, Poolman B, Schwille P. Probing lipid mobility of raft-
exhibiting model membranes by fluorescence correlation spectroscopy. J Biol Chem
2003;278:28109–28115.
24. Bacia K, Scherfeld D, Kahya N, Schwille P. Fluorescence correlation spectroscopy
relates rafts in model and native membranes. Biophys J 2004;87:1034–1043.
25. Garab G, Pomozi I, Jörgens R, Weiss G. Method and apparatus for determining the
polarization properties of light emitted, reflected or transmitted by a material using a
laser scanning microscope. U.S. Pat. 6,856,391 (2005).
26. Steinbach G, Pomozi I, Zsiros O, Garab G. Imaging fluorescence detected linear
dichroism and emission anisotropy of plant cell walls in laser scanning confocal
microscope. Cytometry A 2008; in press (this issue).
27. Axelrod D. Carbocyanine dye orientation in red cell membrane studied by micro-
scopic fluorescence polarization. Biophys J 1979;26:557–573.
28. Matko J, Bodnár A, Vereb G, Bene L, Vámosi G, Szentesi G, Szöll}osi J, Horejsi V,
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 Abstract
The evolutionarily developed microdomain structure of biological membranes has
gained more and more attention in the past decade. The caveolin-free ‘‘membrane
rafts,’’ the caveolin-expressing rafts (caveolae), as well as other membrane microdo-
mains seem to play an essential role in controlling and coordinating cell-surface molec-
ular recognition, internalization/endocytosis of the bound molecules or pathogenic
organisms and in regulation of transmembrane signal transduction processes. There-
fore, in many research fields (e.g. neurobiology and immunology), there is an ongoing
need to understand the nature of these microdomains and to quantitatively characterize
their lipid and protein composition under various physiological and pathological con-
ditions. Flow and image cytometry offer many sophisticated and routine tools to study
these questions. In this review, we give an overview of the past efforts to detect and
characterize these membrane microdomains by the use of classical cytometric technolo-
gies, and finally we will discuss the results and perspectives of a new line of raft cytome-
try, the ‘‘high throughput screening assays of membrane microdomains,’’ based on
‘‘lipidomic’’ and ‘‘proteomic’’ approaches. ' 2008 International Society for Advancement of
Cytometry
 Key terms
rafts and caveolae; membrane microdomains; structure and composition; imaging rafts;
flow cytometry of membrane microdomains; lipidomics and proteomics of rafts
BRIEF HISTORY OF RAFT AND CAVEOLA MICRODOMAINS
Since the term ‘‘lipid raft’’ has been introduced by Simons and Ikonen (1), the
‘‘raft concept’’ proposing coexisting microdomains in the continuous fluid lipid
membrane has become widely accepted and revolutionized our view on biological
membranes. The origin of the raft hypothesis was the observed resistance of certain
membrane fractions to cold, nonionic detergents (2). Later on, flow and imaging
cytometric investigations, such as transmission electron microscopy (TEM), fluores-
cence confocal (CLSM), and near-field (SNOM) microscopies identified and charac-
terized the caveolae (3) and different forms of caveolin-free lipid rafts (4) by applying
a variety of molecular labeling.
Considering the major properties of lipid rafts, still a lot of controversy and
uncertainty remained, as demonstrated recently (5–8). According to the most recent
definition (9), lipid rafts are small, highly dynamic microdomain structures of eu-
karyotic cells’ plasma membrane, which are implicated mainly in molecular compart-
mentation of several membrane-associated cellular processes (1,10). In general, these
microdomains are enriched in glycosphingolipids, sphingomyelin, cholesterol, and
are preferentially associated with GPI-anchored and acylated proteins. Because of
their unique lipid and protein composition, they can be characterized by their special
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physicochemical properties and lateral segregation in the lipid
bilayer of biological membranes.
Caveolae, which are expressed in highly cell type-re-
stricted fashion, are small (50-80 nm diameter), flask-shaped
plasma membrane invaginations, occurring generally in cell
types with high capacity for endocytotic/transcytotic trans-
port, such as endothel, epithel cells, or phagocytes. Caveolae
have unique protein components, caveolins and flotillins, that
show high affinity for cholesterol and required for formation
and stabilization of these specialized membrane domains (11).
Caveolae are also implicated in signal transduction, endocyto-
sis, or uptake of certain pathogens (11,12).
Biological significance of membrane raft microdomains in
a number of essential processes have been demonstrated, such as
signal transduction (13–15), antigen presentation to lympho-
cytes (16,17), recognition and internalization of various patho-
gens (18), signaling to cell death (17,19), or neuronal communi-
cation/signal transduction (20). Thus, altered lipid composition
of membrane rafts may lead to changes in their functional prop-
erties through differential clustering of signaling molecules
within the domains, which might have relevance in several path-
ological disorders. For instance, modulatory effects of lipopro-
teins on cholesterol and ceramide content of plasma membrane
highlighted the role of these raft components in regulation of
the activation status and function of platelets and macrophages
presumably involved in the pathogenesis of atherosclerosis
(21,22). Such observations also raise the possibility of novel ther-
apeutic applications exploiting the pharmacological inhibition
of lipid rafts’ functions through modulating their protein con-
tent (23). Therefore, there is a continuously increasing interest
in detection of the compositional heterogeneity of rafts and its
changes, for example, under pathological conditions. It is sug-
gested that caveolae/lipid rafts are critical for the activation of
many signaling pathways associated with cardiovascular changes
that occur in hypertension (24), with certain types of diabetes
(25) or with autoimmune diseases (e.g., systemic lupus erythem-
atosus) (26). Defects in lipid raft formation, as in the case of gly-
cosphingolipid (GSL) or cholesterol storage diseases (e.g. Nie-
mann-Pick syndromes) (27), or when microdomains yield the
site of abnormal protein processing like in prion disorders or
Alzheimer disease (28,29), are adequate examples to show how
crucial is the appropriate function of these microdomains in
normal cellular functions.
Cytometry, as shown by the forthcoming examples, may
provide several reasonably good tools to investigate lipid rafts.
Because rafts are considered as highly dynamic microstruc-
tures (10), the large diversity of approaches and labels as well
as of cellular models makes exploration of their general prop-
erties difficult. Therefore, besides the specific analysis methods
developed for studies of their composition and dynamics, the
high throughput screening (HTS) assay methods are badly
needed for this purpose.
In the forthcoming chapters, we will briefly summarize
the major cell analytical efforts directed to analyze membrane
microdomains (rafts) in various cell types using flow and
image cytometric methods and also describe the future direc-
tions in HTS assays of the ‘‘raft’s proteome and lipidome.’’
CHEMICAL DEFINITION OF MEMBRANE MICRODOMAINS
The classical biochemical approach to isolate and charac-
terize membrane microdomains is based on the resistance of
these structures to solubilization with nonionic detergents,
such as Triton X-100, Brij, CHAPS, or Nonidet P40 (2,10,30–
32). During this typical procedure, the low density, detergent-
resistant membrane fraction (DRM) of the cell lysate is
extracted using 1% neutral detergent at 1 4 oC (or Brij at
37oC), followed by a subsequent separation step with sucrose-
gradient ultracentrifugation. The protein and lipid composi-
tion of the obtained floating (light buoyant density), deter-
gent-resistant (DRM), or detergent-soluble (DSM) membrane
fractions can then be analyzed using sodium dodecyl-sulphate
(SDS)-polyacrylamide gel electrophoresis (PAGE), immuno-
blotting or thin-layer chromatography, respectively. Although
this approach is still widely applied to identify molecular asso-
ciations to lipid microdomains, it should be emphasized that
the information obtained from this assay should be handled
with care (5,10,33). Several concerns have emerged in the liter-
ature about the capability of this method to identify in situ
composition of lipid microdomains existing in intact cells.
The concentration and chemical composition of the applied
detergent seems to be a key factor, because the protein content
of DRMs may be influenced by these parameters (33,34). One
of the central questions is whether the DRMs recovered during
the procedure are representing the real state of plasma mem-
brane microdomains or are partially artificial due to the deter-
gent extraction, itself. The obvious perturbing effects of deter-
gents on the lipid membranes were demonstrated in case of
Triton X-100, reported to induce reorganization of lipids, to
enhance formation of liquid-ordered (Lo) domains, or occa-
sionally to induce fusion of existing rafts to large confluent
membrane aggregates (33). Because protein-lipid interactions
may not be strong enough to resist detergent extraction, deter-
gent solubility does not exclude the possibility of weak asso-
ciations with microdomains (34). On the other hand, several
studies on model membranes suggest that detergent extraction
does not perturb significantly the domain composition and
the DRM fractions obtained only from Lo domain-containing
membranes (32,35).
Based on these uncertainties, several groups attempted to
introduce modifications in the basic protocol to avoid using a
detergent (7,33). Song et al. (36), for example, sonicated the
cell lysate in pH 11 carbonate buffer and used a subsequent
density gradient centrifugation to isolate caveolae. However,
the selectivity of this method is still questioned, because the
resulted raft/caveolae fractions are highly contaminated with
non-raft membranes (7,37). A more selective, but still extre-
mely time-consuming method by Smart et al. (38) is based on
plasma membrane fractionation, sonication to release lipid
rafts, and several density gradient ultracentrifugation steps.
The method provides relatively pure lipid raft preparation, but
with low yield. Moreover, the efficiency of separation of raft
membranes from plasma membrane appears to be strongly
influenced by the time of sonication. A procedure improved
by Macdonald et al. (39) requires just one short (90 min)
centrifugation step and omits the initial plasma membrane
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purification, omits EDTA from lysis buffer, but adds divalent
cations (Ca21 and Mg21) to the lysis buffer, which presumably
helps to maintain the integrity of lipid rafts. This protocol
leads to higher yields and more consistent results without the
discrepancies observed in Smart’s method during the compar-
ative analysis of different cell types, growth, and treatment
conditions. Although the method appears to yield a fairly
clean fraction of membranes that has all the characteristics of
lipid rafts, interestingly, caveolin was recovered from fractions
of significantly higher density than other raft marker proteins.
The reason of this is not known yet, but might be explained by
an association between caveolae and the actin cytoskeleton re-
sistant to cell-lysing conditions.
In conclusion, detergent insolubility assays can still pro-
vide a substantial tool for investigating biological membranes.
To define membrane microdomains, including cholesterol-
sphingolipid rafts, DRMs are undoubtedly the most useful
starting point (34).
LABELING OF LIPID RAFTS
In situ observation of lipid rafts by either flow or image
cytometry requires specific labeling with different fluoro-
phore-conjugated antibodies, lipid probes, or other reporter
molecules. One of the earliest probes used to label rafts is the
pentameric B-subunit of cholera toxin (CTX-B) derived from
the heat-labile enterotoxin of Vibrio cholerae and showing
high affinity to GM1 ganglioside (16,30,40,41). Because of the
pentavalent binding of cholera toxin, it generates patches of
GM1, therefore aggregates of rafts can be visualized by fluores-
cently labeled cholera toxin (30,42). Cholera toxin induces
small aggregates when labeling is performed on ice, but exten-
sive crosslinking and mobility are induced, if the labeling is at
37 oC. Flow and image cytometric analysis of the expression
level of total gangliosides (as a measure of raft content), using
fluorescently labeled CTX-B, should also be a matter of con-
sideration, because the toxin has some crossreactivity with
other type of gangliosides (43). These are pitfalls of cholera
toxin labeling, but in certain cases it can be valuable. However,
it was reported that CTX-B can be efficiently used in the clas-
sical biochemical DRM-isolation method (44) and for immu-
nophenotyping purposes, as well. Recently, it was shown that
GM1 positivity of freshly isolated and late apoptotic neutro-
phil granulocytes provides a new complementary marker of
this cell type besides the traditionally applied but easily misin-
terpretable protein markers (e.g., CD16 versus CD49d) used
to distinguish them from eosinophils (45). Monoclonal anti-
bodies raised against GM1 ganglioside (46) are also applied to
detect lipid rafts in intact cells.
Several fluorescent lipid derivatives have been used in mi-
croscopic studies with various degree of success to specifically
label lipid rafts (liquid-ordered phase) or the liquid-disor-
dered phase. Although Texas red-labeled dihexadecanoyl
phosphatidylethanolamine (TR-DHPE) (47), rhodamine- or
fluorescein-labeled dipalmitoyl phosphatidylethanolamine
(Rho-DPPE and Fl-DPPE) (48,49) or fluorophore-conjugated
dioleoyl-phosphatidylethanolamine (DOPE) (50) partition
very effectively into the liquid-disordered phase, NBD-DPPE
(49), Cy5-dimyristoyl-phosphatidylethanolamine (DMPE)
(50), and the aromatic hydrocarbon dye perylene (48) show
preferential accumulation in the liquid-ordered phase. It can
be seen that both the fluorescent label (NBD vs. fluorescein)
and the composition of the membrane (SM vs. DSPC)
strongly influence partitioning of the fluorescent probes.
The widely used indocarbocyanine dye diIC18 (3) prefer-
entially partitions in the liquid-disordered phase in dioleoyl
phosphatidylcholine (DOPC)/sphingomyelin (SM)/cholesterol
mixtures (48,51), but it favors the liquid-ordered phase in
DOPC/distearoyl phosphatidylcholine (DSPC)/cholesterol
membranes (52). Because its partitioning is never exclusive, it
can be used to probe the lipid environment in the liquid-
ordered phase even in DOPC/SM/cholesterol mixtures
(51,53). Although its tendency to partition into liquid-ordered
(Lo) lipid phases (54) predestined it as an ideal probe for lipid
raft detection, its weak miscibility with sphingomyelin-
enriched membrane regions does not permit it; moreover,
now it is assumed as a nonraft lipid probe (51,55,56). Interest-
ingly, in a cell-based study (56), a small, but nonnegligible
colocalization have been observed between the membrane
domains labeled with diIC18 (3) and with CTX-B or by speci-
fic antibodies for GPI-anchored proteins, suggesting that the
boundaries between the domains of ordered and fluid phases
in cell membranes are not as definite as we would expect from
model membrane-based experimental data. Supporting this,
fluorescence anisotropy of diIC18 (3) probe has been shown to
increase in cholesterol-rich domains after crosslinking of
FceRI in mast cells (53).
Another old, but less known probe of lipid rafts is Laur-
dan (57), which has two properties sensitive to membrane
phase:
1. It exhibits a blue-shift upon going from the liquid-dis-
ordered to the gel phase, because water penetrates less to the
gel phase, and, in less polar environments, a higher energy
locally excited state is the source of fluorescence. To quantify
the spectral shift of Laurdan, the excitation generalized polari-
zation (GPex) function was defined as
GPex ¼ IB  IR
IB þ IR
where IB and IR are the intensities measured at the blue and
red edge of the emission spectrum, respectively, using a given
excitation wavelength. The GPex function can be used to dis-
criminate between liquid-disordered and liquid-ordered, that
is, raft domains (58).
2. Laurdan is oriented strictly normal to the plane of the
membrane in the gel phase, whereas it is more randomly ori-
ented in the liquid crystalline phase, therefore polarized exci-
tation of Laurdan can be used to discriminate between the two
phases (57).
Laurdan has been used to visualize lipid rafts both in
model membranes (49) and living cells (59) using two-photon
microscopy. A novel derivative, C-Laurdan, exhibiting greater
sensitivity to membrane polarity and brighter two-photon
fluorescence reports on the membrane environment more
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accurately (60). Concerning the selectivity of probes, Laurdan
derivatives are in good position, because they are insensitive of
lipid composition, but they rather sensitive to lipid-packing
density.
For the same application, GPI-anchored membrane pro-
teins, such as CD48, CD59, Thy-1 (CD90), alkaline phospha-
tases (AP), or anticaveolin antibody for the detection of caveo-
lae (61) represent another major group of raft markers
(40,42,62–66). These proteins are usually visualized through
their immunocytochemical labeling with fluorophore-conju-
gated antibodies or their Fab fragments. It is noteworthy that
a remarkable heterogeneity may exist in cellular lipid rafts
regarding their protein composition and function (67,68).
The transmembrane protein influenza virus hemaggluti-
nin (HA) has an intrinsic ability to associate with lipid rafts
(69). Exploiting this molecular feature, expressing HA (e.g.,
genetically fused to GFP) in certain cell types can also be used
in studying lipid raft organization (40).
Previously, it was shown that lysenin, a toxin isolated
from the earthworm Eisenia foetida, specifically recognizes
sphingomyelin-rich membrane domains (70,71). Because
binding of lysenin to sphingomyelin is accompanied by the
oligomerization of the toxin, which leads to pore-formation in
the target membrane and a subsequent cytolysis, its suitability
for cellular analysis of lipid rafts is limited (72–75). Recently,
Kiyokawa et al. (76) have generated a genetically truncated
form of the toxin, eliminating its undesirable properties, even
toxicity, which makes it suitable for studying organization and
location of sphingomyelin-rich microdomains.
Because the main stabilizing constituent of lipid rafts is
cholesterol, antibodies against cholesterol may also be an effi-
cient tool to detect/study raft microdomains. Previously, only
IgM isotype antibodies were reported to react with plasma
membrane cholesterol domains of macrophages responsive to
changes in cholesterol trafficking. These IgMs bound to the
cells only after artificial cholesterol enrichment by various
treatments, suggesting that they define cholesterol arrays that
are presumably not identical to native lipid rafts (77).
However, Biro et al. reported on two new IgG isotype
monoclonal antibodies (ACHA) against cholesterol, AC1 and
AC8 (61). These ACHAs specifically detect cholesterol and
several structurally closely related sterols in ELISA assays, as
well as bind to human lipoprotein fractions. They bound
weakly to the surface of various murine and human lympho-
cyte and monocyte/macrophage cell lines. The binding was
substantially enhanced by limited papain digestion of long,
protruding extracellular protein domains (e.g., CD44 and
CD45), indicating that the small epitope of cholesterol is likely
masked by them at the cell surface. The membrane-bound
ACHA displays a strongly patchy staining (domains with 2-
400 nm diameter) and highly colocalized with both lipid
(cholera toxin B) and protein (Thy1, caveolin-1) markers of
noncaveolar and caveolar lipid rafts, as assessed by confocal
microscopy. All these properties suggest that AC8 preferen-
tially recognizes locally clustered membrane cholesterol, also
consistent with its intracellular colocalization with markers of
ER and Golgi complex (61). These properties of the new IgG
ACHAs allow their applications in studying lipid raft func-
tions, as well as in raft-ELISA or protein-chip HTS assay sys-
tems. Some selected widely used labeling strategies are shown
in Figure 1.
Different research groups have used non-pore-forming
derivatives of a cholesterol binding cytolysin perfringolysin O
(also known as y-toxin) from Clostridium perfringens to detect
cholesterol-rich membrane microdomains in intact cells
(78,79). An extensive review focusing on imaging approaches
of different cholesterol-binding molecules (e.g., cholesterol ox-
idases and filipin III) along with y-toxin, and photoreactive,
spin-labeled or fluorescent cholesterol analogues has recently
been published elsewhere (80).
Rafts appear to exist in both the outer and inner leaflets
of the membrane, with outer leaflet rafts harboring GPI-
anchored proteins and inner leaflet rafts containing acylated
proteins. The coupling of raft domains at the outer and inner
leaflets is thought to be important for signal transduction via
lipid rafts (81), but still remained controversial and poorly
known. It is commonly accepted that outer leaflet rafts are
enriched in cholesterol and sphingolipids, however, such
microdomains cannot be mirrored in the inner leaflet, because
sphingolipids are mainly concentrated in the outer leaflet.
Hayashi et al. constructed a fusion protein of Domain 4 (D4)
of the above-mentioned y-toxin and EGFP to visualize the
inner leaflet of lipid rafts (82). D4 is the smallest functional
unit that has the same cholesterol-binding activity as the full-
size toxin. They expressed EGFP-D4 inside MEF fibroblast
cells (a Tet-Off cell line) and showed that cholesterol-rich
microdomains also exist in the inner leaflet of the plasma
membrane. Pike’s group studied lipid raft heterogeneity in
Figure 1. Some widely used fluorescent cytochemical labeling
strategies of plasma membrane lipid rafts. Rafts can be visualized,
among others, by using lipid probes incorporating into the bilayer
or reacting with glycosphingolipids (e.g., cholera toxin B). Fluo-
rescent conjugates of antibodies against GPI-anchored proteins
(e.g., CD48, CD59, and PLAP) or with clustered membrane choles-
terol (ACHA) are also often employed. Characteristic lipid consti-
tuents of fluid (Ld) and ‘‘liquid-ordered’’ (Lo) phase of the plasma
membrane are also shown. Abbrevations: PC, phosphatidylcho-
line; PE, phosphatidylethanolamine; PS, phosphatidyl serine; GPI,
glycosyl phosphatidylinositol.
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terms of epidermal growth factor receptors (83). They ana-
lyzed the distribution of EGFR, other proteins, as well as lipids
in plasma membrane using different detergents and also com-
pared the fatty acyl chain length in the inner and outer leaflet
lipids. Outer leaflet rafts are stabilized by the interaction of
sphingomyelin (SPM) and cholesterol. By comparison, inner
leaflet rafts are significantly less stable because of the lack of
SPM in these leaflets and hence the absence of its stabilizing
interaction with cholesterol. Their data also suggest that inner
leaflet rafts are preferentially destabilized by treatment with
Triton X-100, giving rise to membrane preparations with a
preponderance of outer leaflet lipids. By contrast, inner leaflet
rafts were retained in both the detergent-free and Brij 98-re-
sistant raft preparations. In summary, composition analysis of
inner leaflet derived DRMs is an interesting and still poorly
investigated area of lipid raft research.
FLOW CYTOMETRIC APPROACHES FOR DETECTING
DETERGENT RESISTANCE
Although biochemical techniques are still valuable in
studying membrane microdomains, there is an increasing
demand to substitute them with a rapid, less time- and cell-
consuming, reliable, and reproducible assay of detergent re-
sistance, with less possible risks of artifacts mentioned before.
Earlier several works reported on adapting flow cytome-
try to analyze detergent resistance of cell surface proteins, such
as membrane immunoglobulin (84) lymphocyte membrane
proteins (85,86), major histocompatibility class II (MHC-II)
proteins (87), and integrins (88). The basic similarity among
these studies is the application of medium-strength nonionic
detergents (Nonidet-P40 or Triton X-100) in a relatively high
(0.5-1%) concentration. Although these attempts yielded use-
ful data about the detergent insolubility of the investigated
proteins, the mechanisms underlying the detergent resistance
were not revealed unequivocally.
As a novel alternative, Gombos et al. (16,89,90) developed
a flow cytometric assay of differential detergent resistance
(termed FCDR assay). The basic strategy of this approach and
data evaluation are summarized in Figure 2. Briefly, the cell
sample labeled with fluorescent antibodies specific for the
investigated plasma membrane proteins is treated with cold
nonionic detergent at low concentration (typically 0.05-0.1%)
for a short period of time (5 min). Confocal microscopy
revealed that this moderate, short-duration detergent treat-
ment did not result in loss of cellular integrity, the cells
remained intact particles, enabling them for flow cytometric
analysis. Comparing the fluorescence signals obtained before
and after detergent treatment provides information about the
detergent sensitivity of the given protein. Moreover, if a pro-
tein appears to be detergent resistant (the fluorescence signal
is unchanged), suggesting its possible association with DRMs
or with actin cytoskeleton, the background mechanism can be
easily resolved by selective cholesterol depletion with methyl-
b-cyclodextrin (MBCD) (91) or cholesterol deprivation (with
cholesterol oxidase), or as an alternative by pretreatment with
actin cytoskeleton-destabilizing agents (lantrunculin A, cyto-
chalasin-D) before applying the detergent (Fig. 2).
Among the major advantages of this method, it should be
highlighted that using flow cytometry of intact cells minimizes
artifacts concerning detergent-induced perturbation/rearrange-
ment of in situ protein assemblies, which is likely to occur when
the cells are fully lysed with high (typically 1%) detergent con-
centrations, at low temperature. The method requires low
amount of cells (104/sample) is marked with high reproducibil-
ity, and according to kinetic measurements, 5-min detergent
treatment is typically enough to resolve sensitive and resistant
proteins into two resolvable peaks, although minor differences
may appear among different cell types, as it has been demon-
strated for CD4, CD5, CD14, CD225, and ND5 (92). This publi-
cation also points out that in certain cases the intracellular pool
of the investigated protein should be also a matter of considera-
tion, because treatment with nonionic detergents results in per-
meabilization of the cells and thus makes the antigen accessible
for the detecting antibody. In contrast to the classical biochemical
approach, results obtained from FCDR assay are weakly influ-
enced by the type of nonionic detergent (90). Because the
method can be performed on all types of conventional bench-top
flow cytometers, the only parameter limiting the number of
acquired proteins is the number of the available optical channels.
As for the technical details of immunofluorescent labeling, it
should be taken into account that using Fab is preferred to whole
Figure 2. Basic principles of flow cytometric assay of detergent
resistance. Top: nonionic detergents, even at low (0.1%) concen-
trations, can rapidly dissolve detergent-sensitive membrane pro-
teins. This becomes detectable from the decreased mean fluores-
cence intensity of the immunocytochemically labeled sample,
upon the addition of the detergent. The kinetics of the dissolution
process can also be followed by flow cytometry in time-resolved
mode. Middle: proteins residing in raft microdomains or
anchored by the cytoskeleton show remarkable detergent resist-
ance. Bottom: to reveal the underlying mechanism of detergent
resistance, selective disruption of lipid rafts (by cholesterol deple-
tion or deprivation) or the cytoskeleton (by cytochalasin D or
latrunculin) can be applied before detergent treatment. A subse-
quent increase in detergent solubility of the protein is indicative
of its raft or cytoskeleton-association, respectively.
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immunoglobulin to avoid crosslinking-induced detergent resist-
ance effects (85). The major limitation of this approach is the
heterogenous sensitivity of membrane proteins to the applied
mild detergent treatment that may influence the resolution of de-
tergent-sensitive and detergent-resistant proteins quantitatively.
The FCDR technique served as a basis of several experimen-
tal works published recently. Among others, its usefulness was
demonstrated in investigating raft association of an ABC trans-
porter protein in human colon carcinoma cells (89), proving
raft-localization of transferrin receptor type 2 in hepatoblastoma
and erythroleukemic cells (93) and in studying detergent resist-
ance of surface antigens in human peripheral blood monocytes
(94,95). Its suitability to follow signal-induced association of
membrane proteins with lipid rafts was also demonstrated (90).
IMAGE CYTOMETRY OF RAFTS IN INTACT CELLS: RESULTS
AND LIMITATIONS
The classical definition of rafts is based on the density
and detergent insolubility of these domains. To investigate
these properties, the cell membrane has to be solubilized
excluding the in situ investigation of raft domains. Therefore,
alternative approaches abound including those based on mi-
croscopic investigation of cell or model membranes. These
imaging approaches are usually, but not exclusively based on
probes selectively partitioning into or excluded out of rafts.
Therefore, the success of these approaches hinges on the valid-
ity of the assumption that the probe specifically identifies raft
domains.
As an example, Harder et al. used cholera toxin-mediated
crosslinking of GM1 to show that GPI-anchored proteins and
GM1-rich domains copatch with each other. On the contrary,
a transmembrane protein, ErbB2, was found not to copatch
with cholera toxin, although it is colocalized with cholera
toxin-labeled domains in cells labeled on ice (Fig. 3). These
findings point to fundamental differences in the dynamics
with which peripheral and transmembrane proteins are asso-
ciated with rafts (42). Cholera toxin-mediated crosslinking of
GM1 implied that aggregation of lipid rafts accompanies T
cell receptor signaling. However, controversy exists over the
role of lipid rafts in T cell receptor (TCR) mediated signaling,
Figure 3. Demonstration of confocal microscopic colocalization and FRET analysis of ErbB2 protein clusters on tumor cells. A–B: SKBR-3
breast tumor cells were labeled with Cy3-tagged anti-ErbB2 Mab (trastuzumab, red channel) and FITC-labeled CTX-B (green channel) on
ice (A) or at 37 oC followed by imaging the top or bottom layer of cells by confocal microscopy. Image A shows strong correlation between
the two signals indicated by the presence of the yellow color, whereas image B implies that crosslinking of lipid rafts by CTX-B induced a
separation between ErbB2 clusters and lipid rafts. C–D: SKBR-3 breast tumor cells were labeled by a 1:1 mixture of FITC-tagged and Cy3-
tagged anti-ErbB2 Mab (trastuzumab), and ErbB2 homoassociation was measured by the donor photobleaching FRET technique. The fluo-
rescence image taken in the FITC channel and the FRET image are shown in C and D, respectively. The scale in D represents the color-
coded FRET efficiencies between 0 and 40%. The colocalization between ErbB2 and CTX was analyzed by ImageJ using the JaCoP plugin.
Pearson’s correlation coefficients for images of the control and CTX-treated samples are 0.933 and 0.472, respectively, corroborating the
previous conclusions.
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since others showed that GPI-anchored GFP is excluded from
the immunological synapse. Despite the controversy, the wide-
spread assumption is that lipid rafts are indeed recruited to
the immunological synapse and not only serve as platforms in
which signaling proteins are concentrated, but these microdo-
mains provide the means for regulating key elements in TCR
activation, for example, by segregating lck and fyn kinases
from each other in unstimulated cells.
One also has to bear in mind that rafts are also heteroge-
neous with respect to lipid composition, and GM1-free lipid
rafts will not be visualized by cholera toxin labeling (96). De-
spite the limitations and disadvantages of cholera toxin as a
raft marker, it has been shown that it highly colocalizes with
other lipid raft markers such as GPI-anchored proteins and
anticholesterol antibody (56,61).
Scanning near-field optical microscopy (SNOM) offers
superior resolution of fluorescent samples compared to con-
ventional microscopy (97). Hwang et al. reported on the pat-
chy distribution of Bodipy-labeled phosphatidylcholine in the
cell membrane, but they did not attempt to relate this phe-
nomenon to lipid rafts (98). Model membranes lend them-
selves easily to SNOM investigations for which a flat surface is
advantageous. Uneven distribution of TR-DPPE (99) and TR-
DHPE (47) has been observed in binary and ternary model
membranes implying phase separation. Electron microscopy
of immunogold-labeled cell membranes also implied the clus-
tered distribution of raft-associated membrane proteins
(100,101). Even the 3-dimensional distribution of caveolin la-
beled with ammonium nickel sulfate hexahydrate-intensified
diaminobenzidine-horseradish peroxidase staining was con-
structed by high-voltage electron microscopic tomography
(102). A slight drawback of both SNOM and electron micros-
copy is the need for expensive instrumentation and harsh sam-
ple treatment, although relatively recent developments in both
imaging modalities make imaging under more physiological
conditions possible.
Imaging approaches can also be used to investigate the
dynamic aspects of lipid rafts, that is, the mobility of raft-asso-
ciated proteins and lipids. Fluorescence correlation spectros-
copy (FCS) is suitable for the determination of the diffusion
constant of fluorescently labeled molecules (103). Being a dif-
fraction-limited technique, FCS cannot measure the diffusion
coefficient of molecules in domains smaller than its resolution
limit (103). FCS data from ternary lipid mixtures have been
used to create a phase diagram showing areas of coexisting liq-
uid-ordered and liquid-disordered phases characteristic of
lipid rafts floating in the membrane of living cells (51). The
measurement of the diffusion constant of fluorescent or gold-
labeled molecules is also possible with single particle tracking
(SPT). The diffusion constant of lipids was shown to be
reduced by a factor of 2 when entering the liquid-ordered
phase from the liquid-disordered phase (49). These results
indicate that diffusion is hindered by the more compact pack-
ing of lipids in raft domains. Lipid rafts not only reduce the
diffusion rate, but also confine the movement of molecules,
that is, both raft-associated lipids and proteins are locked into
transient confinement zones (TCZ) corresponding to lipid
rafts for several seconds, because the activation energy
required to cross the boundary of rafts is high (104). This con-
clusion was reached by Schütz et al. in a seminal paper in
which the trajectories of Cy5-DOPE (dioleoyl-phosphatidy-
lethanolamine) and Cy5-DMPE (dimyristoyl-phosphatidy-
lethanolamine) were compared. Cy5-DOPE, preferentially
labeling liquid-disordered domains, showed unhindered diffu-
sion, whereas Cy5-DMPE partitioning into liquid-ordered
domains showed hindered diffusion. The size of transient con-
finement zones was 700 nm, and the average residence time
of Cy5-DMPE in these domains was 13 sec (50). Tracking of
colloidal gold-labeled membrane proteins confirmed that
GPI-anchored proteins are transiently confined in areas with a
diameter of 100 nm (104). It is usually accepted that track-
ing fluorescent and colloidal gold-labeled proteins yields simi-
lar data, although gold is believed to slow the long-term diffu-
sion of the molecule it labels (105). These findings imply that
the lipid environment plays a pivotal role in determining the
mobility of membrane components. In contrast, several stu-
dies point to the fundamental role of protein–protein interac-
tions in restricting lateral diffusion. Douglass et al. observed
the diffusional trapping of T-cell signaling proteins (e.g., Lck
and LAT) by CD2 protein complexes and show that this con-
finement is maintained by protein–protein interactions and
do not require interactions with the actin skeleton or lipid
rafts (106). Another twist to the story is the observation that
membrane proteins anchored to the cytoskeleton act as ‘‘rows
of pickets’’ creating a barrier hindering the diffusion of both
lipids and proteins (41,107). Trapping beads bound to GPI-
anchored or transmembrane proteins by a laser beam the vis-
cous drag experienced by these proteins was measured and it
was concluded that rafts are long-lasting entities with a mean
diameter of 25 nm (108).
The morphology of lipid rafts can be studied by atomic
force microscopy (AFM), which is exquisitely suited for the
investigation of the surface topography of objects. Membrane
pits with a mean diameter of 100 nm were identified, and
these indentations coincided with caveolin-1-GFP fluores-
cence indicating that they corresponded to caveolae (109).
AFM can also detect that the gel phase of the membrane is
usually 1-2 nm higher than the coexistent fluid phase (110). In
an interesting study, secondary ion mass spectroscopy was
combined with AFM imaging of model membranes. The
authors claim that quantitative information about the chemi-
cal composition of lipid domains can be obtained (110).
Imaging approaches provide a valuable alternative for
classical biochemical approaches to study lipid rafts. However,
one has to be aware of certain limitations of these techniques.
Imaging studies often aim to measure the size of lipid raft
microdomains. Because the reported size cannot be smaller
than that permitted by the resolving power of the microscope,
the resolution of the technique must not be forgotten. There is
a nagging discrepancy between domain sizes observed in
model and cell membranes, because the former are usually in
the several hundred nanometer to micrometer range (49),
while the latter are much smaller (108). Model membranes are
much simpler, protein-free mixtures of 2–3 lipid species in
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thermodynamic equilibrium. Cell membranes, on the other
hand, are complex and dynamic structures of several types of
lipids and proteins, which never reach thermodynamic equi-
librium due to continuous transport of material to and from
the membrane. The presence of proteins (111,112), the cyto-
skeleton (41), active vesicular transport, and the lack of equi-
librium (113,114) have significant impact on the properties of
microdomains explaining at least some of the conflicting
results. Indeed, preliminary studies on proteins incorporated
into model membranes suggest that raft-associated proteins
show relatively weak preference for the liquid-ordered phase,
which can be increased by crosslinking, showing that model
membranes do not fully reproduce the selectivity of protein
distribution (62,103). The complex protein and lipid mixture
in cell membranes probably generates an environment, which
is on the boundary favoring the formation of lipid rafts, and
subtle changes in the local composition of the membrane
caused by active cellular processes create transient nucleation
centers for raft formation.
FRETTING RAFTS
As described in the previous sections, methods, including
detergent extraction and cholesterol depletion, rely on harsh
interference with the composition of the membrane. This cir-
cumstance casts some doubt on the correspondence between
rafts in living cells and the detergent-resistant domains defined
by these methods. This uncertainty calls for alternative, less
destructive approaches in raft research. One such family of
methods relies on the measurement of fluorescence resonance
energy transfer (FRET), which is a radiation-less interaction
between a fluorescent molecule (donor) and an acceptor.
FRET is an inexpensive method, which can be used in fluoro-
metry, flow cytometry, and fluorescence microscopy (115–
118). Its utility in biological applications stems from the fact
that the rate of the process changes as the inverse sixth power
of the separation between the donor and the acceptor dyes.
Because FRET takes place when the interacting molecules are
1-10 nm apart, its application essentially extends the resolu-
tion limit of diffraction-limited approaches from 200-300 nm
to the nanometer range. Extensive literature is available for a
general introduction to FRET and to aid in the selection of
suitable experimental conditions (115–124); therefore, we
resort to a brief summary of the principles only.
In a conventional, hetero-FRET interaction, an excited
fluorophore (donor) transfers energy to a nearby, spectrosco-
pically different acceptor molecule, which is usually, but not
necessarily fluorescent too. In mathematical terms, the proba-
bility of FRET, defined as FRETefficiency, is the fraction of the
energy of excited donor fluorophores tunneled to acceptors in
FRET interaction. FRET efficiency is the function of the do-
nor–acceptor separation distance, the orientation factor (the
relative orientation of the donor and the acceptor), the donor
quantum yield in the absence of the acceptor, the index of
refraction of the medium and the overlap integral between the
donor emission and acceptor absorption spectra. In most
cases, all of these parameters except for the distance can be
expressed as a single parameter (Ro), which is constant for a
specific donor–acceptor pair under given experimental condi-
tions. Using this simplification, the FRET efficiency can be





where Ro is the distance at which FRET efficiency is 50% and
R is the separation distance between the donor and the accep-
tor. Ro can be expressed as
Ro ¼
h
const n4 Q j2 J
i1=6
where n is the index of refraction of the medium, Q is the
quantum efficiency of the donor in the absence of the accep-
tor, j2 is the orientation factor, and J is the overlap integral.
The most important assumption in this simplification is that
the donor and the acceptor molecules are randomly oriented
relative to each other and that they rotate fast during the
excited state lifetime, which turns j2 to a constant equal to
two-third. The validity of this assumption has to be verified.
For most donor–acceptor pairs Ro is 3–8 nm setting the dis-
tance range amenable for FRET investigations to 1–10 nm
(125).
The excited donor can also interact with another donor
molecule, if the absorption and emission spectra of the donor
overlap. Because this is the case for most fluorophores, such an
interaction, termed homo-FRET, is very common (126,127). In
this interaction, the donor and acceptor fluorophores are spec-
troscopically identical. The only manifestation of homo-FRET
is the decreased fluorescence anisotropy of the fluorophore, a
phenomenon observed as early as the 1930s by Perrin. Anisot-
ropy is defined according to the following equation:
r ¼ IVV  IVH
IVV þ 2IVH
where IVV and IVH are the vertical and horizontal, respectively,
components of fluorescence emission excited by vertically
polarized light. In order for homo-FRET to achieve a measur-
able decrease in anisotropy, the fluorophore (‘‘donor’’) needs
to have sufficiently high anisotropy to begin with, and the
fluorophores (‘‘acceptors’’) have to be randomly oriented rela-
tive to the donor, so that their fluorescence emission loses the
preferential orientation of the donor.
Both homo- and hetero-FRET measurements have been
used extensively to study the structure and dynamism of rafts.
The question asked in most of these studies was whether GPI-
anchored proteins are concentrated in clusters or are ran-
domly distributed in the membrane. By examining the de-
pendence of FRET efficiency on acceptor density (fluorophore
density in the case of homo-FRET), clustered and random dis-
tribution can be detected. Because FRETefficiency (anisotropy
in the case of homo-FRET) is independent of acceptor density,
the fluorophores are concentrated in clusters, whereas these
parameters change as a function of fluorophore density, if the
distribution is random. We stress again that by examining the
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concentration dependence of FRET efficiency, it is possible to
detect subpixel clusters, that is, clusters with a diameter below
the resolution limit of conventional fluorescence microscopes.
Using such an approach, Varma et al. concluded that GPI-
anchored proteins are clustered in domains likely to be smaller
than 70 nm in diameter (128). Although the existence of such
clusters was further supported by an independent study using
chemical crosslinking (129), two consecutive papers from the
Edidin laboratory questioned the existence of GPI-anchored
microdomains (63,130). Although the homo-FRET approach
used by Varma et al. is somewhat more sensitive for the detec-
tion of small clusters compared to hetero-FRET applied in the
later publications, a common denominator was reached by
assuming that only a small fraction of GPI-anchored proteins
are enriched in clusters, with the majority of molecules being
randomly distributed at low densities outside these domains
(63).
Using hetero-FRET measurements, GPI-anchored pro-
teins were shown to be unclustered both in resting T cells, and
they were not concentrated into clusters even in the immuno-
logical synapse after antigen challenge (131,132). Depending
on the context the term ‘‘clustering’’ refers to several distinct
phenomena: a) increase in the fluorescence intensity of a raft
marker due to membrane convolution resulting in a higher
membrane surface area/pixel, that is, higher fluorescence in-
tensity/pixel even without a higher density of the raft marker
in the membrane; b) increased concentration of the raft
marker in the membrane without increased FRET. This can
happen if microdomains harbor only few proteins, and their
size is well below the resolution limit of confocal microscopy.
If such microdomains are recruited, but they do not fuse with
each other, the FRET efficiency reporting molecular proximi-
ties will not change. c) Increased molecular association of raft
markers indicated by increased FRET. Although currently it is
not possible to conclude what happens in the immunological
synapse in terms of raft recruitment, one can envisage that
diminishingly small rafts are recruited into the immunological
synapse. Depending on how close the microdomains get to
each other and whether they fuse with each other, FRET
between raft markers will either increase or not.
By following the time-dependent decay of anisotropy,
even more sensitive detection of clustering is possible (133).
Combining steady-state and time-dependent homo- and het-
ero-FRET experiments, Sharma et al. provide conclusive evi-
dence that GPI-anchored proteins, albeit a small fraction
thereof, are indeed concentrated in clusters composed of at
most four proteins with the rest of the GPI-anchored mole-
cules being randomly dispersed in the membrane. They
showed that different types of GPI-anchored proteins float in
the same rafts and crosslinking induces raft reorganization by
segregating the crosslinked species from preexisting clusters
(134). This latter observation is in apparent contradiction
with the results of Harder et al., who reported comigration of
noncrosslinked raft markers with the crosslinked raft-asso-
ciated protein (40). However, one has to make note of the dif-
ferent scales of the two measurements: segregation of the
crosslinked species was observed with FRET measurements,
whereas comigration was seen in confocal microscopic experi-
ments.
FRETmeasurements have proved valuable in bridging the
gap between the submicron resolution of conventional mi-
croscopy and the world of single molecular interactions driv-
ing signal transduction in living cells and provided evidence
for the existence of diminishingly small raft microdomains
floating among the majority of unclustered molecules, ran-
domly distributed in the membrane. Such preexisting rafts are
recruited to larger associations upon crosslinking to form the
signaling platforms corresponding to clusters seen in confocal
microscopy. However, both the small and the large rafts are
detergent-resistant indicating the indispensible nature of
FRETmeasurements to elucidate the dynamic processes taking
place in lipid rafts (134–136).
Besides the distribution of GPI-anchored proteins, the
target of the investigations described earlier, FRET has been
used to study the size of lipid microdomains in binary (phos-
phatidylcholine/cholesterol) and ternary (phosphatidylcho-
line/sphingomyelin/cholesterol) protein-free large unilamellar
vesicles (LUV) (137). Model calculations were performed to
find the size of lipid rafts, with which the theoretical curves fit
the time-resolved FRETmeasurements. It is worth noting that
lipid rafts exist in the phase coexistence region, where liquid-
ordered and -disordered phases are mixed. It has been shown
that by increasing the fraction of the liquid-ordered phase in
the phase coexistence region by increasing the molar fraction
of cholesterol or sphingomyelin, the size of rafts increased.
GM1 ganglioside and CTX-B increased the size of lipid rafts in
accordance with confocal microscopic results (40,42).
The acceptor concentration dependence of hetero-FRET
has been used to demonstrate that acyl chain-modified GFP
derivatives are concentrated in clusters probably correspond-
ing to inner leaflet rafts, but prenyl modification was insuffi-
cient to induce clustering (138). Inner leaflet rafts serve as sig-
naling platforms for Ras proteins. Single-molecule FRET ima-
ging was used to follow the binding of Bodipy-TR-GTP
(acceptor) to YFP-Ras (donor). Binding coincided with an
increase in the immobile fraction of Ras corresponding to the
formation of large aggregates serving as signaling platforms
(139).
FRET can be used for the detection of alterations in
transmembrane-signaling complexes in diseases. CD14, the
GPI-anchored membrane receptor of lipopolysaccharide and
other lipids, has been shown to recruit a signaling complex
with distinct composition depending on the stimulating lipid
molecule (140). It was concluded that clustering of CD14 may
reflect the condition of monocytes, and it has a potential as a
diagnostic marker in sepsis and atherosclerosis (22).
Rafts not only harbor peripheral, but also transmembrane
proteins. A representative of raft-associated transmembrane
proteins is ErbB2, a member of the epidermal growth factor
receptor family (141). We have shown using microscopic het-
ero-FRETmeasurements that the homoassociation of ErbB2 is
proportional to the local density of ErbB2, inversely correlated
with the local density of ErbB3 and of the raft-specific lipid,
GM1 (42). These results implied that local densities of ErbB2
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and ErbB3, as well as the lipid environment profoundly influ-
ence the association properties and biological function of
ErbB2. We have also studied the dynamics of raft-associated
membrane protein clusters by measuring the kinetics of pro-
tein exchange between clusters (142). We labeled one-cell sam-
ple with donor-tagged antibody, the other with acceptor-
tagged antibody against the same protein and recorded the
appearance of FRET after fusing the donor- and acceptor-la-
beled cells. FRET reappeared in the case of several raft-asso-
ciated peripheral (CD48) and transmembrane proteins
(IL2Ra, MHC-I) after cell fusion indicating that these protein
clusters are dynamic and exchange partners with each other.
We found a notable exception to the rule, MHC-II, which did
not allow the development of FRET after cell fusion implying
that MHC-II molecular associations are static. We also fol-
lowed the intermingling of donor- and acceptor-tagged clus-
ters with confocal microscopy. These experiments showed that
large-scale protein clusters visualized by confocal microscopy
exchange components with the same type of clusters.
HIGH THROUGHPUT SCREENING (HTS) ASSAYS OF RAFTS:
TOWARDS SYSTEMS BIOLOGY
For isolation of lipid rafts, widely accepted methods are
available based on cold nonionic detergent- (or high pH-)
extraction of DRMs combined with sucrose gradient ultracen-
trifugation (SGUC). After separation of these microdomains,
the protein and lipid composition can be analyzed by different
methods. Traditionally, proteins have been studied with con-
ventional protein analysis techniques (e.g., SDS-PAGE and im-
munoblot analysis), where qualitative evaluation is limited for
only a few proteins at a time. For lipids, the classical extraction
is possible by using organic solvents, such as methanol-chloro-
form or hexane-isopropanol (143–145). Lots of modified ver-
sions of this method were reported in the literature. Neverthe-
less, no standard method for lipid extraction from biological
samples has been established. Therefore, results between
research groups may vary, and this should be taken into
consideration.
The next step is lipid class separation, generally relying
on analysis by thin-layer chromatography (TLC), which is
however, not as sensitive as other methods. It offers a rapid
and comprehensive screening tool before more sensitive and
sophisticated techniques. High-performance liquid chroma-
tography (HPLC) and gas chromatography are also well-
assumed techniques, requiring optional prior derivatization
and availability of known standards. These conventional
approaches are, however, time-consuming and require rela-
tively large sample volumes for accurate separation (146–148).
By visualization, analysis, and identification of lipid raft
components by flow and image cytometry (i.e., fluorescence
and electron microscopies), Western-blot analysis, etc., the
conception emerged that cholesterol-rich microdomains are
dynamic and heterogeneous structures in the membrane of
eukaryotic cells (96,149–151). This heterogeneity in the pro-
tein and lipid content as well depends on the type and devel-
opmental stage of a cell and also on the different stimuli it is
exposed to. Systems biology, an iterative application of biolog-
ical knowledge with mathematical and computational techni-
ques, seems to be a new field to study complexity of biological
systems, including physiological role of heterogeneous lipid
rafts in cell communication and signaling networks. It is well
accepted that two main criteria can be defined for systems
biology: (i) quantitative measures, multiple components of a
cell simultaneously and (ii) rigorous data integration with
mathematical models. The models, once developed and vali-
dated, can be used to study a vastly greater range of situations
and interventions than would be possible by applying classical
reductionist experimental methods that usually involve
changes only in a small number of variables.
Here, we focus on two main subsets of analysis of lipid
raft composition and its changes, namely proteomics and lipi-
domics. Using 2D-gel electrophoresis, a large number of pro-
teins could be separated and visualized by staining with Coo-
massie blue, silver, or fluorescent stains, as well as autoradiog-
raphy, if the proteins have been labeled before sample
collection. Identification of proteins is possible by excision of
spots and digestion with trypsin followed by mass spectrome-
try (MS). However, the problem with this approach is that
many proteins are excluded by their size (too small or too
large) or by their solubility/hydrophobicity, such as lot of
membrane proteins. To avoid gel-electrophoretic separation,
HPLC seems to be a sufficient tool to purify protein fragments
following in-solution digestion approach (152).
To improve precision of the quantitative proteome analy-
sis by liquid chromatography tandem spectrometry (LC-MS/
MS), the proven technique of stable-isotope dilution has been
applied. This method makes use of the facts that pairs of che-
mically identical analytes of different stable-isotope composi-
tion can be differentiated in a mass spectrometer owing to
their mass difference and that the ratio of signal intensities for
such analyte pairs accurately indicates the abundance ratio for
the two analytes. To this end, stable-isotope tags have been
introduced to proteins via transfer of 18O by enzymes from
water to peptides (153,154), via chemical reactions using iso-
tope-coded affinity tags (ICAT) (155), or via metabolic label-
ing using heavy salts or amino acids (156). The recently devel-
oped ICAT technology is a quantitative proteomic approach
to evaluate changes occurring in lipid rafts (157–159). ICAT
reagents consist of three functional elements: a thiol-reactive
group for the selective labeling of reduced Cys residues, a bio-
tin affinity tag to allow for selective isolation of labeled pep-
tides, and a linker synthesized either in an isotopically normal
(‘‘light’’) or a ‘‘heavy’’ form (utilizing 2H or 13C) that allows
for the incorporation of the stable isotope tags. In a typical
experiment, protein disulfide bridges are reduced under dena-
turing conditions, and the free sulfydryl groups of the proteins
from the two related samples to be compared are labeled
respectively with the isotopically ‘‘light’’ or ‘‘heavy’’ forms of
the reagent. However, ICAT allows the use of protein material
from nonliving sources but requires chemical modification
and affinity steps (ion exchange and affinity chromatography).
For the complex lipid raft proteomic analysis by liquid chro-
matography electrospray ionization tandem mass spectrome-
try (LC-ESI-MS/MS) of anti-IgM stimulated and control
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human Ramos cell line or splenic cells of Balb/c mice, Gupta
et al. has adopted this procedure (157). They compiled a list of
some of the proteins that were identified in lipid rafts and
grouped these into functional categories. The list includes
cytoskeletal proteins, transmembrane receptors, cell surface
glycoproteins, Src family kinases, small G proteins, heterotri-
meric G proteins, motor proteins, and trafficking proteins.
Besides the B-cell receptor (BCR), the other proteins that
showed altered localization to lipid rafts upon stimuli were all
related to the cytoskeleton, including the nonmuscle myosin
type 2A and myosin regulatory light chain, enriched in rafts.
In contrast, ezrin, a linker protein between membrane proteins
and actin filaments was dissociated from rafts after BCR
engagement. As it has been suggested earlier that aggregation
of lipid rafts may be controlled by cytoskeletal remodeling, all
of these proteins are likely candidates to be involved in this
process.
Another isotope-labeling, convenient, and inexpensive
method is SILAC (stable isotope labeling by amino acids in
cell culture). Labeled, essential amino acids are added to
amino acid deficient cell-culture media and are therefore
incorporated into all proteins as they are synthesized,
‘‘encoded into the proteome.’’ No chemical labeling or affinity
purification steps are performed, and the method is compati-
ble with virtually all cell culture conditions, including primary
cells (37,160,161). Foster et al. has applied this method to
study the lipid raft proteome of HeLa cells. They used two raft
isolation schemes (based on detergent and pH/carbonate re-
sistance, respectively) and three cholesterol-disrupting drugs
(nystatin, filipin and MBCD) followed by LS-MS/MS, for
quantitative proteomic analysis, and found that nystatin and
filipin were less efficient in depleting proteins in detergent-
resistant fractions than MBCD. In the MBCD experiments,
241 proteins were identified as raft proteins, the majority of
which were signaling proteins, but a number of structural pro-
teins were found as well (37).
For high-throughput screening of lipids from any biolog-
ical source with high sensitivity, ESI-MS and matrix-assisted
laser desorption/ionization-time of flight (MALDI-TOF) mass
spectrometry methods have been developed (162). A novel
approach to the computational analysis of global pattern
changes in membrane lipid composition is the lipid array
technology, when MS outputs are in an arrayed organization.
The goal of this analysis is the rapid, objective identification of
statistically significant differences in mass spectra between two
biological conditions (163). The strategic scheme of different
HTS methods based on chromatographic separation and MS
analysis are summarized on Figure 4.
Microarray techniques are widely used in genomics
(DNA-chips and -arrays) and proteomics; however, lipid
microarrays are still under ongoing development and awaiting
for reaching a reasonable level of sensitivity and reproducibil-
ity. Lipid microarrays fall into the category of protein
detecting microarrays (PMDs). Current PMD technologies,
including proteomic arrays, microspot ELISA and antibody
arrays, reverse arrays, and single capture antibody arrays, were
currently reviewed (164). However, probing the interaction of
a lipid aggregate structure with their protein targets in a high-
throughput fashion would not be addressed by the current
generation of lipid microarrays. Lipids complexed with pro-
tein and sugars and other lipid structures, such as lipid vesicles
and lipid rafts, are beyond the capacity of current microarray
technologies (165).
For study, the compositional heterogeneity of rafts, a
novel approach, raft-ELISA, has also been developed (166).
George et al. have designed a cell-free assay (sandwich ELISA)
that provides a simple and quick way to examine the simulta-
neous presence of two proteins in the lipid rafts and has the
potential to estimate trafficking of molecules in and out of the
lipid microdomains during cell signaling on a single deter-
gent-resistant lipid raft basis. Extrapolating from these limited
studies, we expect that combining different proteomic and
lipidomic results obtained from the same biological system
will substantially increase our understanding of complex bio-
logical processes, including the complexity and heterogeneity
of lipid raft microdomains. More specifically, the systems biol-
ogy studies based on diverse and high-quality proteomic data
will define functional biological modules reveal previously
unrecognized connections between biochemical processes and
modules and may also help in modeling the interacting pro-
tein networks (i.e., to identify the cellular protein ‘‘interac-
tomes’’).
Developments in this area may lead to new hypotheses
that can be tested either by traditional methods or by the new
generations of proteomic and lipidomic technologies.
There are several attempts to combine classical cytometric
methods (e.g., flow cytometry, slide-based cytometry, and
Figure 4. Strategic scheme of high-throughput assay of lipid raft
composition. Widely used proteome and lipidome analysis meth-
odologies are based on high-performance chromatographic
separation of the molecular components of membrane microdo-
main fractions followed by mass spectrometric (MS) analysis.
From the ionized molecular fragment spectra detected by MS, the
protein or lipid molecules can be identified using software data
bases. For proteins, 2D-gelelectrophoretic separation (2DIGE)
with differential fluorescent staining is also widely used. To
improve the precision of the quantitative proteome analysis,
stable-isotope protein-labeling methods (broken line) can be
inserted into the protocol.
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Table 1. Methods for analysis of properties and composition of lipid rafts
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fluorescence microscopy) with proteomics or genomics. One
is combination of cell sorting with rapid protein-profiling
platforms (mass spectrometric analysis) that can offer an auto-
mated and rapid technique for greater clarity, accuracy, and ef-
ficiency in identification of protein expression differences in
mixed cell populations (167). Another concept is to increase
throughput and content of the above-mentioned fluorescence-
based multiparametric methods. This can be executed by au-
tomatization of sample loading, handling acquisition, and
analysis. HyperCyt1 interfaces a flow cytometer and autosam-
pler (168) and with this, up to 14 optical parameters can be
collected simultaneously from billions of cells in less than 3
min. For example, in a multiparameter lymphocyte immuno-
phenotyping microassay at analysis rates of 1.5 s/sample was
reached in a 96-well plate, and results were comparable to
manual analysis (169). Another way to combine cytomics and
systemic approach is hyperchromatic slide-based cytometry
(170). Mittag et al. traversed how hyperchromatic cytometry
can increase the amount of analyzed antigens, and this way
making possible a high content and high-throughput single-
cell analysis of slide-touched samples. Mixing of iterative
restaining and differential photobleaching, photoactivation,
photodestruction, photoconversion, or photocaging using re-
spective fluoprophores provides facilities to measure up to 100
antigens. High-throughput screening with fluorescence mi-
croscopy is an enormous challenge for engineers and research-
ers (171,172). To get more and more data from cells in a very
short time, by decreasing the screening time with multibeam
imaging, automatized sample handling using multiwell plates
and autofocusing and autoscreening mode are required. The
time limitation of microscopy is, however, moving from one
cell to another that requires the movement of the stage relative
to optical axis, either by stage or beam scanning. Flow cytome-
try, with its other advantage of the ease of sample handling, is
about 100 times faster than imaging cytometry, so incorporat-
ing special optical/electrical capturing devices (e.g., optoflui-
dic microscopy or a cell rotator) into the flow cytometer seems
to be a good solution for increasing the throughput of ima-
ging. Such novel strategies provide possibility to immobilize
cells in flow and this way taking snapshot images (171). Never-
theless, the synthesis of these techniques are not yet adopted
to investigate the nature of lipid rafts, so as a great goal in the
future it can open up a new area for proteomic or even lipido-
mic analysis of rafts.
CONCLUSIONS AND PERSPECTIVES
As discussed throughout this review, the classical cytoa-
nalytical methods, such as flow cytometry and the different
forms of image cytometry, lead to a continuous and significant
clarification of our view on the complex structure of biological
membranes, particularly, the structure and function of raft
and caveola microdomains (Table 1). We learned that these
microdomains are small (several tens of nanometers diameter)
and highly dynamic molecular assemblies in the plasma mem-
branes, where signaling processes often lead to their aggrega-
tion forming larger (sometimes 0.5-1 micrometer diameter)
and more stable signal platforms. Many questions about their
compositional heterogeneity, lifetime, etc., however, still
remained controversial. Introduction of new probes and tech-
niques, such as Laurdan derivatives for 2-photon microscopic
imaging, anticholesterol and antiphosphatidylinositol bis-
phosphate (PIP2) antibody probes (conjugated with fluores-
cent dyes or quantum dots) may reveal new faces of these
microdomains. The novel fluorescence imaging technique
with highly improved resolution, stimulated emission deple-
tion (STED) microscopy, resulting in 20-30-nm lateral resolu-
tion, may also contribute to such progress. The future trend is,
however, clearly the system biology approach, including high-
throughput screening assays of raft composition. Here,
automatization and optical developments on classical cell
analytical techniques (e.g., flow cytometry or slide-based laser
scanning microscopy) may also result in a new milestone. In
addition, such analyses may be coupled to system biology
modeling approaches and can reveal altered raft composition
and ‘‘protein interactome’’ in diseases.
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Anticholesterol antibodies (ACHAs) naturally occur in 
the sera of most healthy individuals with yet unknown 
functions ( 1). Recently, we reported on new IgG-type 
monoclonal antibodies, AC1 and AC8, which are highly 
specifi c to clustered cholesterol and some 3  -OH-
containing sterols and do not cross-react with other lipids 
(2). These antibodies, in contrast to the IgM-type ACHAs 
reported earlier, have a unique property of spontaneous 
binding to live phagocytes and T-cells. Furthermore, their 
binding to the cell surface was substantially sensitive to the 
epitope accessibility, e.g., it was greatly enhanced by lim-
ited papain digestion of membrane proteins with long ex-
tracellular domains. Their spontaneous binding to intact 
cells also showed cell-type dependence. The preferential 
binding sites for these new cholesterol-specifi c mAbs were 
identifi ed as cell surface or intracellular membrane com-
partments enriched in clustered cholesterol, such as lipid 
rafts, caveolas, or Golgi complexes ( 2).
Lipid rafts are dynamic, glycosphingolipid-, and choles-
terol-rich membrane microdomains considered to make 
“some order into the chaos” of biological membranes ( 3,
4). Many pieces of experimental evidence indicate that the 
human immunodefi ciency virus type 1, HIV-1, enters tar-
get cells through these lipid rafts ( 5–7). The last stage of 
 Abstract  The importance of membrane rafts in HIV-1 in-
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IgG1, cells were washed with FACS (fl uorescence activated cell 
analysis and sorting) buffer containing 0.1% BSA and then 
stained as described elsewhere ( 2). Occasionally, prior to recep-
tor staining, U937 human macrophages (ATTC, maintained in 
RPMI 1640 medium + 10% FBS) and MT-4 T-cells were preincu-
bated with ACHA or the Ka40 isotype control Ab (specifi c to 
tobacco mosaic virus) at 37°C for 60 min. 
In the CXCR4 receptor internalization assay, U937 cells were 
incubated (or not) with ACHA as described above. After washing, 
cells were treated with 300 nM SDF-1  chemokine ligand or, al-
ternatively, with 100 ng/ml of the phorbol ester PMA, at 37°C, 
for 0–60 min. Cells were then washed, FcR-blocked, and labeled 
with APC-anti-CXCR4 as described above. Before measurement, 
cells were fi xed with 3% paraformaldehyde. CXCR4 expression 
on the cell surface was measured and evaluated by fl ow cy-
tometry.
Data from 10,000 stained cells/sample were acquired in a 
Becton-Dickinson FACSCalibur fl ow cytometer using CellQuest 
Pro software (Becton-Dickinson, San Jose, CA) and then analyzed 
with FCS3 Express software (De Novo Software, Los Angeles, CA). 
 Surface plasmon resonance 
Surface plasmon resonance measurements were performed 
using a BIACORE X instrument (Biacore, Uppsala, Sweden) at 
25°C. AC8 ACHA and anti-CD8 control IgG (30 μg/ml) were im-
mobilized onto the surface of a carboxymethylated dextran chip 
(CM5) using standard amine-coupling chemistry in 10 mM so-
dium acetate, pH 5.0, according to the manufacturer’s instruc-
tions. The mean amount of immobilized protein was  7000 
resonance units. Cholesterol-rich (1,2-dimiristoyl- sn -glycero-3-
phosphocholine, 1,2 dimiristoyl- sn-3-phosphoglyerol and choles-
terol, in a 9:1:25 molar ratio) and cholesterol-free control 
liposomes were prepared as described earlier ( 2), reconstituted 
in 10 mM HEPES, pH 7.2, 150 mM NaCl solution (running buff er)
at a concentration of 1 mM total lipid, and were passed over the 
chip surface at a fl ow rate of 10  l/min. The results were ana-
lyzed by BIAevaluation 4.1 software (Biacore). The correspond-
ing association and dissociation regimes of sensorgrams were 
fi tted to a builtin Langmuir binding model, and the equilibrium 
dissociation constant, K D, was calculated as the ratio of dissocia-
tion to association rate constants. 
 Confocal microscopy 
U937 human macrophages were treated with AC8 (or Ka40 
isotype control) antibodies as described above and, as a negative 
control to raft-associated proteins, with anti-CD71 (transferrin 
receptor) mAb (MEM-75; a kind gift from Vaclav Horejsi, Prague, 
CZ). Alternatively, cells were treated with monovalent Fab frag-
ment of AC8 IgG, generated by the method of Adamczyk ( 14).
The enzyme reaction was stopped by adding iodoacetamide, the 
digested protein was separated on Sephadex G-100 column 
(Pharmacia Fine Chemicals, Uppsala, Sweden), and the homoge-
neity of the Fab-containing fractions was analyzed by SDS gel 
electrophoresis.
Cells were then washed, FcR blocked, and stained with 
 fl uorophore-conjugated anti-CD4, anti-CXCR4, and Alexa488- or 
Alexa647-CTX (Invitrogen-Molecular Probes, Eugene, OR) in 
different combinations. After washing and fi xing in 3% para-
formaldehyde, labeled cells were mounted on quartz-glass bot-
tomed microplates (Lab-Tek, Nalge Nunc, Rochester, NY) and 
assayed with an Olympus Fluoview 500 confocal microscope 
(Hamburg, Germany) equipped with four optical channels, using
a 60× (numerical aperture of 1.45) oil immersion objective. 
Colocalization indices were determined from 100 cells 
(200 regions of interest/sample, in four independent experi-
the multistep process of HIV-1 entry, the fusion of the vi-
rus with the target cell membrane, entails multifocal inter-
actions between virus shell glycoproteins and lipids and 
their receptor/coreceptor and lipid raft counterparts on 
target cells ( 8). Lipid rafts were also implicated in the bud-
ding of the progeny virus ( 9, 10 ).
HIV-1 was shown to use the CD4 receptor and CCR5 or 
CXCR4 chemokine receptors for productive entry into 
CD4+ cells. CD4 and CCR5 are constitutively raft associ-
ated, while CXCR4 molecules are mostly recruited to lipid 
rafts after the initial binding of the virus ( 11). However, 
the exact molecular mechanism of this entry is still under 
debate ( 9, 12 ). Since the new cholesterol-specifi c mAbs se-
lectively bind to cholesterol-enriched lipid raft or caveola 
microdomains of intact HIV-1 permissive cells, it is plausi-
ble to assume that they may interfere somehow with the 
mechanisms leading to membrane attachment or internal-
ization of the virus. 
Therefore, this study aimed to investigate whether the 
new ACHAs can modulate the receptor or microdomain 
architecture at the surface of target cells, such as human 
macrophages and T-cells: namely, the distribution/inter-
action pattern, accessibility, internalization, mobility, or 
raft association of CD4 and chemokine receptors. These 
properties are all critical for membrane attachment and 
internalization of the virus. 
Since in a recent work ( 13) another antilipid antibody, 
a mAb against phosphatidylinositol-4-phosphate, was re-
ported to inhibit infection of peripheral blood mononu-
clear cells (PBMCs) with two HIV-1 primary isolates, we 
also investigated whether the new cholesterol-specifi c anti-
bodies can affect in vitro HIV-1 infection/production of 
primary monocyte-derived macrophages (MDMs) and 
 T-cells in cultures. 
The new IgG-type cholesterol-specifi c antibodies caused 
a remarkable lateral clustering of membrane rafts upon 
binding to both cell types and remodeled the interaction 
pattern of CXCR4 chemokine receptors with both CD4 
and lipid rafts. The membrane-bound antibodies substan-
tially inhibited production of two different HIV strains in 
MDM and T-cells in vitro. In contrast, no signifi cant inhi-
bition was achieved when the virus strains themselves were 
preincubated with the antibodies before infection. Thus, 
these data demonstrate a novel type of inhibition of HIV-1 
infection by lipid (cholesterol)-specifi c mAbs, which is 
linked to their primary membrane remodeling effect on 
target cells. This, in turn, can prevent the effi cient multi-
step virus anchorage. 
 MATERIALS AND METHODS 
 Cells, immunofl uorescence labeling, and fl ow cytometry 
The monoclonal IgG 3 Abs to cholesterol, AC1 and AC8, were 
generated, characterized, and applied for cell labeling as de-
scribed previously ( 2). Cell surface binding of Alexa488-ACHA, 
PE/Cy5-anti-CD4 (ImmunoTools, Friesoythe, Germany), or APC-
anti-CXCR4 (R and D Systems, Minneapolis, MN) was assayed by 
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Target cells and HIV-1 strains 
 HIV-1 IIIB permissive H9 cell line (for virus propagation) and 
MT-4 T cells (ATCC) were maintained in complete RPMI 1640 
medium (cRPMI; 10% FBS, 100 U/ml penicillin, 100 μg/ml 
streptomycin, and 1 mM L-glutamine; Gibco BRL, Gaithersburg, 
MD). The primary MDM cells were separated from peripheral 
blood mononuclear cells of healthy, HIV-1 seronegative donors 
using PHA stimulation as described earlier ( 19). The MDM cul-
tures were used for HIV-1 infection in all experiments on day 7 
after separation. 
The ×4 phenotype IIIB strain of HIV-1 ( 20) was grown in H9 
cell line, while the R5 characteristic Ada-M strain of HIV-1 ( 19)
was propagated in primary MDM cultures, then harvested and 
stored in liquid nitrogen. 
 Infection and measurement of HIV-1 production 
Different protocols for antibody treatment, infection, and 
washing prior to virus production measurement were used for 
assaying with which stage of the HIV-1 infection and virus cycle 
(attachment, fusion, entry, or budding) the ACHAs interfere. 
Protocol 1: Prior to infection with the appropriate virus strains, 
either the target cells or the viruses were pretreated with ACHAs 
for 60 min at 37°C. Then, the untreated or ACHA-pretreated 
cells in culture were infected with untreated or ACHA-pretreated 
virus for 1 h at 37°C. Infection was followed by culturing T-cells 
or MDM cells for 4 or 14 days, respectively, before measurement 
of virus production. 
Protocol 2: Target cells were treated with the appropriate 
ACHAs for 1 h at 37°C, infected with HIV-1 strains for 1 h at 
37°C, and then washed out carefully (or not). The samples were 
then left in culture for 4 or 14 days, respectively, before measure-
ment of virus production. 
Protocol 3: Since during the assay period a continuous decline 
of ACHA concentration in the supernatant was observed, a third 
strategy was applied to investigate ACHA’s effects on virus pro-
duction. Cells were preincubated with ACHAs according to pro-
tocol 1, washed, and infected, and a continuous supplementation 
of ACHA was applied during the 4 or 14 day assay periods to 
maintain a constant level of ACHAs in the extracellular fl uid. 
This strategy aimed to reveal any effect of the antibodies on the 
budding phase. 
Untreated and Newcastle Disease Virus-specifi c isotype control 
antibody treated cells were also used as controls in all infection 
experiments.
HIV-1 infection was carried out with 100 μl of IIIB or Ada-M 
strains of HIV-1 with 15,000 cpm reverse transcriptase activity in 
all protocols. Target cells (in 300 μl cRPMI) were incubated with 
the virus at 37°C for 60 min, washed (or not) with medium, and 
then completed up to 1 ml with fresh cRPMI medium. 
HIV-1 production was measured by reverse transcriptase assay 
(21) with a Packard 2200CA TRI-CARB Liquid Scintillation Ana-
lyzer (Packard Instrument, Meriden, CT) and corrected to dpm 
values.
 Cellular cytotoxicity assay 
MT-4 and MDM cells were treated with different concentra-
tions of ACHA and incubated in the appropriate medium for 4 
or 14 days, respectively. Cells were assayed periodically for in 
vitro cytotoxicity of the ACHAs. Viability of cells was determined 
by the CellTiter 96 ® AQ ueous nonradioactive Cell Proliferation As-
say (Promega, Madison, WI) ( 22) according to the manufac-
turer’s protocol. The assay is based on MTT-formazan reaction of 
metabolically active cells. In each experiment, the survival rate 
and the standard deviation were calculated from triplicates of 
samples.
ments) by ImageJ software (http://rsbweb.nih.gov/ij) using the 
appropriate colocalization plug-in. The Pearson’s colocalization 
index (CI) provides a reliable estimate on the extent of protein 
colocalization: CI values close to zero indicate no or a very low 
degree, while CI 0.5 refl ects a high degree of colocalization, 
whereas the CI = 1 value would correspond to a full overlap be-
tween the two colors in each pixel of the image ( 15).
Fluorescence resonance energy transfer 
For ratiometric intensity-based fl uorescence resonance en-
ergy transfer (RiFRET) measurements, U937 macrophages were 
treated with AC8 or Ka40 isotype control antibodies and stained 
with Alexa546-conjugated anti-CD4 (donor only sample), with 
APC-conjugated anti-CXCR4 (acceptor only sample), or with 
both antibodies as described above. After washing, labeled cells 
were mounted on quartz-glass bottomed microplates treated 
with BD Cell-Tak cell and tissue adhesive (Becton-Dickinson), 
according to the manufacturer’s protocol. RiFRET measure-
ments on a pixel-by-pixel basis were performed at room tem-
perature on an Olympus Fluoview 500 confocal microscope 
using a 60× (numerical aperture of 1.45) oil immersion objec-
tive. The Alexa546-conjugated antibody was excited with a 532 
nm HeNe laser and detected through a 560–600 nm emission 
fi lter, and the Alexa647-labeled protein was excited with a 633 
nm HeNe laser and detected through a 660 nm long-pass fi lter. 
FRET effi ciency was calculated from  30 cells by the ImageJ 
RiFRET plugin ( 16). 
 Fluorescence correlation spectroscopy 
For fl uorescence correlation spectroscopy (FCS) measure-
ments, U937 human macrophage cells were treated with AC8 or 
Ka40 isotype control antibodies and stained with Alexa488- 
conjugated anti-CD4 or APC-conjugated anti-CXCR4 as described 
above. As control, cells were labeled with Alexa647-anti-CD2 
(Exbio, Praha, CZ) or Alexa488-AC8 antibodies for 30 min on 
ice. After washing, labeled cells were mounted on quartz-glass 
bottomed microplates. 
FCS ( 17) measurements were carried out at room tempera-
ture, in a fl uorescence fl uctuation microscope set on an Olym-
pus FluoView 1000 confocal microscope base, with a two-channel 
FCS extension. Desired points were selected for FCS analysis 
from confocal sections of the sample. Fluorescence fl uctua-
tions were detected by avalanche photodiodes (Perkin-Elmer, 
Wellesley, MA), and the autocorrelation function was calcu-
lated by an ALV-5000E hardware correlator card (ALV Laser, 
Langen, Germany) in real time. From each sample n > 22 cells 
were measured, and 10 × 5 s runs were recorded per cell. 
Data were fi tted to a single-component two-dimensional 
diffusion model with a triplet term using the program 








G τ = 1+
N 1 T τ
where N is the average number of molecules in the detection 
volume, T is the fraction of dyes being in the triplet state within 
the detection volume,  tr is the phosphorescence lifetime, and  d 
is the diffusion time, which is the average time spent by the dye 
in the detection volume. The half-decay time  1/2 was used to de-
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 Measurement of anticholesterol antibodies in cell culture 
supernatants by ELISA 
Concentration of anticholesterol antibodies in cell culture su-
pernatants was measured by the ELISA method as described pre-
viously ( 2).
 Statistical analysis 
Diffusion coeffi cients in control and ACHA-treated cells were 
compared using Student’s t-test (the number of individual cells 
for each sample is given in Table 1 ).
 RESULTS 
 Binding properties of ACHAs to cholesterol-rich surfaces 
assessed by surface plasmon resonance 
To quantitate binding of ACHA to highly homogenous 
cholesterol-rich liposomes used in generating these anti-
bodies ( 2), as an optimal epitope, we used surface plas-
mon resonance experiments. AC8 ACHA and anti-CD8 
control IgGs were immobilized in different fl ow channels 
on the surface of the same CM5 sensor chip. As depicted 
on the representative binding curves of Fig. 1A , liposomal
presentation of cholesterol resulted in a signifi cant bind-
ing to the AC8 ACHA but not to the anti-CD8 control an-
tibody. Cholesterol-free liposomes exhibited no binding 
to the IgGs, as expected. The dissociation phase of the 
binding reaction can be fi tted to a single exponential, 
yielding a dissociation rate, k off = 1.6 ± 0.5 × 10 
 5 s  1 (n = 
3). The association phase can be estimated kinetically only 
if the concentration of the analyte (binding partner in so-
lution) is known. ACHA is expected to interact with the 
cholesterol-rich liposome as a whole rather than with indi-
vidual cholesterol molecules. Since the lipid was presented 
as a 1 mM solution (regarding total lipid concentration), a 
rough estimate of analyte concentration is 10 μM, assum-
ing 100 lipids/liposome (based on average liposome 
size). Using this analyte concentration, the fi t yielded an 
association rate, k on = 205 ± 8 M 
 1 s  1 (n = 3). The equilib-
rium dissociation constant estimated from these rate con-
stants is Kd = k off /k on = 78 ± 27 nM. 
These data, completing recent semiquantitative results 
showing low/medium affi nity ACHA binding to isolated 
 Fig. 1. AC8 mAb bound to HIV-permissive T-cells and mac-
rophages neither masks the accessibility of CD4 and CXCR4 recep-
tors nor affects internalization of CXCR4. A: Surface plasmon 
resonance measurement of the interaction between ACHA and 
cholesterol-rich liposomes. Liposomal presentation of cholesterol 
resulted in binding to immobilized AC8 ACHA but not to anti-CD8. 
Cholesterol-free liposomes exhibited no binding to the IgGs. Fit-
ting of a Langmuir binding model to AC8 data yielded an equilib-
rium dissociation constant Kd = k off /k on = 78 ± 27 nM. Typical traces 
of three to four experiments are shown. B: The AC8 antibody spon-
taneously binds to the surface of MT-4 T and U937 macrophage 
cells, respectively. C: Flow cytometric histograms of untreated or 
AC8-treated MT-4 or U937 cells stained with PE/Cy5-anti-CD4 or 
APC-anti-CXCR4, respectively, are shown. D: SDF-1  or PMA- 
induced internalization of CXCR4 is shown for untreated or AC8-
pretreated U937 cells. Cell surface expression of CXCR4, measured 
by fl ow cytometry 45 min after stimulation, is displayed as mean ± 
SD from three independent experiments. The time course of inter-
nalization is also shown in the insert. The expression level of 
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Binding of AC8 antibody to these cells caused an 
 2-fold increase of the colocalization between CXCR4 
and CD4 as well as between CXCR4 and GM 1 rafts, 
while leaving CD4 raft colocalization unchanged. Nei-
ther the engagement/cross-linking of a nonraft pro-
tein, the transferrin receptor (CD71) with its specific 
mAb, nor the isotype control antibody affected these 
colocalization patterns. The monovalent Fab fragment 
of AC8 antibody, without cross-binding capacity, had 
no effect on the colocalization between HIV receptors 
(Fig. 4A ).
The increased proximity/interaction between CXCR4 
and CD4 was further confi rmed by intensity-based FRET 
measurements. Mean FRET values (±SD) were 0.17 (±0.02) 
membrane raft fractions of T-cells ( 2), suggest that the op-
timal affi nity of ACHAs to clustered cholesterol is medium, 
meanwhile the binding is highly selective. 
 Binding of AC8 does not alter the accessibility or 
internalization of HIV-1 receptors on target cells 
Earlier, we demonstrated the spontaneous binding of 
the new cholesterol-specifi c antibodies to several mouse 
and human lymphoid and myeloid cell types ( 2). Here, we 
show that AC8 can also bind to HIV-1 permissive human 
MT-4 T cells and U937 macrophages ( Fig. 1B ), the poten-
tial target cells of the IIIB and Ada-M HIV-1 strains, respec-
tively. In addition, AC8 does not mask the extracellular 
domains of CD4 or CXCR4 receptors on these cells, since 
the binding of antibodies against these epitopes remained 
unchanged after AC8 binding ( Fig. 1C ).
The HIV-1 coreceptor CXCR4 was shown to rapidly in-
ternalize upon binding chemokine ligand SDF-1  or after 
PMA treatment, and a mechanism involving the cytoskel-
eton and motor proteins (myosin IIa) was also proposed 
for this process ( 23). It was supposed that internalization 
of the chemokine receptor may also infl uence HIV-1 inter-
action/entry to target cells. Therefore, the SDF-1 or PMA-
induced internalization of CXCR4 was also followed in 
context with the possible effects of the AC8 antibody. Re-
sults with human U937 macrophage cells showed that the 
cholesterol-specifi c antibody AC8 does not signifi cantly af-
fect internalization of CXCR4 induced either by SDF-1 or 
PMA ( Fig. 1D ).
Binding of AC8 to the target cells’ surface induces lateral 
lipid raft clustering 
Interestingly, binding of AC8 to U937 macrophages in-
duced several remarkable changes in their global plasma 
membrane organization. The cell surface ganglioside 
(GM1-rich raft) pattern was markedly altered as indicated 
by the increased fraction of highly patchy cells (from 10 to 
67%) and the increased average GM1 raft size (from 200–
300 nm to 0.5–1 m in diameter) ( Fig. 2 ). Similar changes 
were observed on T-cells as well (data not shown). 
 The AC8 antibody remodels the lateral plasma membrane 
interaction pattern of chemokine receptor CXCR4 with 
CD4 and lipid rafts on target cells 
First, the interaction pattern of CD4 HIV-1 receptor and 
the CXCR4 coreceptor with each other and with the lipid 
rafts was investigated in human U937 monocyte- 
macrophage cells by means of confocal microscopy colo-
calization analysis. The chemokine receptor CXCR4 
colocalized only weakly with CD4 (CI: 0.2), in accor-
dance with earlier reports on other cells ( 6, 24 ), and also 
moderately (CI: 0.2–0.3) with GM 1 ganglioside rafts 
marked with fl uorescent cholera toxin B subunit. In con-
trast, the CD4-cholera toxin B subunit colocalization was 
high (CI: >0.6), similar to many other cell types ( Fig. 3 ). 
This indicates the lack of signifi cant association between 
CD4 and CXCR4 on these target cells and is also consis-
tent with their localization in distinct membrane microdo-
mains in the absence of the virus. 
 Fig. 2. Binding of monoclonal ACHA to human macrophages 
alters the size distribution of GM 1-rich rafts. Untreated (A) or 
ACHA-pretreated (B) U937 cells were stained with Alexa488-chol-
era toxin B and assayed by confocal microscopy. Representative 
images and surface intensity plots refl ect an AC8-induced microag-
gregation/coalescence (see arrows) of lipid rafts. The average size 
of GM 1 rafts increased from 200–300 nm to 0.5–1 m in diameter. 
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 Cholesterol-specifi c AC1 and AC8 monoclonal 
antibodies inhibit in vitro HIV-1 production by T-cells 
and macrophages 
Next we investigated whether these substantial changes 
in the membrane organization of HIV-1 permissive target 
cell types have any effect on their infection and virus pro-
duction. First, it was observed that the presence of ACHAs 
in cell cultures of MT-4 or MDM cells, at the time of infec-
tion, resulted in signifi cant inhibition of the virus produc-
tion of these cells (data not shown). Analyzing the details 
of this inhibitory effect, cultured MT-4 T-cells and primary 
MDM cells were preincubated with ACHAs prior to infec-
tion with IIIB and Ada-M strains of HIV-1, respectively (see 
protocol 1 in Materials and Methods). Such preincubation 
resulted in a signifi cant (up to 50–60%) dose-dependent 
inhibition of virus production by both mAbs in both cell 
types relative to the control (untreated) cells ( Fig. 6A, B ). 
The isotype control antibody left the infection unchanged 
(data not shown). 
Importantly, much less if any inhibition was observed 
when the virus strains were preincubated, at the same con-
ditions, with the ACHAs prior to infection ( Fig. 6C, D ).
 ACHAs interfere mostly with the attachment phase of 
HIV-1 infection 
To reveal with which stage of HIV-1 infection (attach-
ment/entry/budding) the ACHAs interfere, we compared 
their inhibitory effects under different experimental con-
ditions (concerning antibody treatment, infection, wash-
ing, and culturing). 
When ACHA was washed out from the sample after virus 
infection (see protocol 2 in Materials and Methods), the 
extent of inhibition remained the same as in case if it was 
not washed out from the culture after infection ( Fig. 7A ). 
This indicates that the postinfection presence of ACHAs 
did not decrease the virus production further. 
Since the level of ACHAs in the culture medium grad-
ually declines during the relatively long assay period 
(Fig. 7B ), we also tested if a continuous supplementation 
of ACHA after infection (see protocol 3 in Materials and 
Methods) can infl uence the observed inhibition. Such 
supplementation, however, did not result in any signifi -
cant change in the fi nal HIV-1 production ( Fig.7B), sug-
gesting that the inhibitory effect is not coupled to inhibition 
of the later, budding phase. 
 Monoclonal ACHAs are not cytotoxic to MT-4 T and 
MDM cells 
Finally, it was tested if the observed inhibition is due 
to any signifi cant cytotoxic effect of the anticholesterol 
mAbs exerted on the target cells. MT-4 cells and 
monocyte-derived macrophages were treated with serial 
dilutions of ACHAs and cultured for 4 and 14 days, 
respectively. ACHAs proved to be nontoxic to the inves-
tigated cell types, since their survival rate remained 
above 90% over the whole experimental period (the 
cells retained both their metabolic activity and prolifera-
tion capacity) at any ACHA concentrations examined 
(Fig. 7C ). 
in control cells, while it elevated to 0.28 (±0.06) upon AC8 
binding of target cells ( Fig.  4B ).
 The AC8 antibody selectively reduces the lateral mobility 
of CXCR4 but not that of CD4 
In order to see whether AC8 has any infl uence on the 
molecular mobility of plasma membrane HIV-1 receptors, 
the diffusion properties of CXCR4 and CD4 were assessed 
by FCS imaging. AC8 binding to macrophages signifi cantly 
reduced two-dimensional diffusion of CXCR4 but not that 
of CD4 ( Fig. 5A, B ). Diffusion of a nonraft protein, CD2, 
was not affected by ACHA treatment either in macrophages 
(Fig. 5C ; Table 1 ) or in T-cells (data not shown). The aver-
age diffusion coeffi cient of CXCR4 decreased by   40% 
(P < 0.01). Fab fragment of AC8 did not show this effect 
(data not shown). The AC8 mAb bound to the cell mem-
brane diffused remarkably slower (diffusion coeffi cient, D: 
0.2  m 2/s) than small fl uorescent cholesterol probes (e.g., 
Bodipy cholesterol) do in model membranes with high 
cholesterol content (D: 0.5  m 2/s) and almost 10-fold 
slower than cholesterol does in fl uid membrane phases 
(25). This indicates that the cell-surface-bound ACHA dif-
fuses in large molecular clusters ( Table 1 ).
 Fig. 3. Colocalization pattern of CD4, CXCR4, and GM 1 -enriched 
lipid rafts in HIV-1 permissive human macrophage cells. Represen-
tative confocal images of U937 cells double labeled with Alexa488-
cholera toxin B subunit (CTXB) (green) and APC-anti-CXCR4 
(red) (A), RPE-anti-CD4 (green) and Alexa647-CTXB (red) (B), 
and RPE-anti-CD4 (green) and APC-anti-CXCR4 (red) (C) are 
shown. Colocalization indices for CD4, CXCR4, and CTXB in dif-
ferent combinations (D) were derived from 100 cells ( 250 re-
gions of interest) of three independent samples and displayed as 
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face patches, but with no overlap with GM 1 rafts ( 28).
Since cross-linking of CD71 in our cells did not change the 
receptor distribution pattern, it seems that the AC8 anti-
body similarly to the viral gp120 ( 6) induces selective, 
cholesterol-rich raft-targeted effects on the membrane or-
ganization of HIV-1 receptors. The lack of such effect by 
the monovalent Fab fragment of AC8 on the target cells 
further confi rms this notion. 
Receptors and coreceptors in the cell membranes are 
usually not randomly distributed, and, among others, their 
lipid environment can also control their movement and 
interactions. As shown by a body of data, cholesterol is 
indeed required for the interaction between gp120/gp41 
trimers on the surface of HIV-1 and their receptor/core-
ceptor counterparts on the target cells. It seems that 
cholesterol is a critical lipid for stabilization of raft micro-
domains and often of clusters of coreceptor proteins with 
multiple membrane-spanning helices ( 29), such as most, 
but not all chemokine receptors. 
In the plasma membrane of the investigated cell types, 
CD4 is constitutively and highly localized, whereas CXCR4 
is much more weakly raft localized. Their localization and 
clustering in distinct membrane microdomains on HIV-1 
permissive target cells was proposed earlier ( 30, 31 ). Bind-
ing of the cholesterol-specifi c mAb (AC8), but not of its 
 DISCUSSION 
We report here the inhibition of HIV-1 infection/ 
production of human monocyte-macrophage and T-cells 
by two new cholesterol-specifi c IgG antibodies, AC1 and 
AC8. As a novel aspect, this study points out that antilipid 
antibodies may act effectively not only on the virus but also 
on the target cell membrane, in contrast to the principle 
considered earlier in context of most neutralizing antibod-
ies ( 26, 27 ).
The new cholesterol-specifi c monoclonal antibodies 
bind to cholesterol- and ganglioside-rich microdomains in 
the membrane of various immune cells, as reported re-
cently ( 2, 18 ). They strongly colocalize with GM 1 ganglio-
sides as well as with GPI-anchored raft proteins (e.g., CD48 
and Thy-1). Moreover, as shown here, upon binding to 
lipid rafts (or caveolas), these antibodies, without masking 
the CD4 and CXCR4 HIV-1 receptors or affecting their 
internalization, can remarkably remodel the plasma mem-
brane microdomains and the spatial proximity of the 
above two receptor proteins. 
These effects were clearly initiated by a lateral clustering 
(coalescence) of lipid rafts induced by binding of the 
mAbs to the cell surface. Cross-linking of CD71 (a nonraft 
protein) with mAbs was also reported to induce cell sur-
 Fig. 4. AC8 substantially enhanced colocalization and FRET between CXCR4 and CD4 on human U937 
macrophages. A: Colocalization indices (derived from 100 cells/250 regions of interest of both untreated 
and AC8-treated cell samples) are shown as mean ± SD for CXCR4, CD4, and CTXB in different combina-
tions. Cells untreated or treated with AC8, isotype control Ab, Fab fragment of AC8, or anti-CD71 are dis-
played for comparison. B: Cells were incubated with AC8 or left untreated prior to staining with antibodies 
specifi c to CD4 and/or CXCR4. FRET measurement was carried out by confocal microscopy. Correction 
factors (S1, S2, S3, and S4) and factor  were calculated from only donor and only acceptor labeled samples 
and determined by the ImageJ RiFRET plug-in. Representative images and FRET histograms of control and 
AC8-treated cells are shown, respectively. FRET effi ciency between CD4 and CXCR4, derived from  30 cells, 
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observed in macrophages and T-cells equally ( 2). Although 
cholesterol was shown to be essential to trigger events lead-
ing to membrane fusion between the target cell and the 
virus, it is not required for the Env-mediated membrane 
fusion itself ( 32). Interestingly, immunization with a pep-
tide corresponding to the caveolin-1 binding domain of 
gp41 virus glycoprotein was able to elicit effi cient neutral-
izing antibodies, which act predominantly on the virus to 
prevent HIV-1 infection ( 33).
So, our view is that, in contrast to such primarily neu-
tralizing antibodies, the cholesterol-specifi c antibodies 
may interfere mostly with the cholesterol-dependent 
virus-target cell interaction by modifying the membrane 
organization of the latter. Similarly, reorganization of 
ErbB membrane proteins was reported upon cross-
linking of gangliosides through cholera toxin B in breast 
tumor cells ( 34). Here, we conclude that the antibodies 
Fab fragment, to the cells increased both CD4-CXCR4 co-
localization and the raft association of CXCR4 by  2-fold. 
These observations, confi rmed by FRET data, together 
suggest a view that ACHAs may induce lateral clustering of 
cholesterol-rich lipid rafts (or caveolas) and thus modu-
late the interaction pattern between raft gangliosides, CD4 
and CXCR4, which are all critical in membrane attach-
ment/entry of the virus. 
The cell surface targets of both the HIV-1 virus and the 
new ACHAs can be the caveolin  and caveolin + lipid rafts 
alike, depending on the type of HIV-1 permissive cell. A 
strong association of ACHA with these microdomains was 
 Fig. 5. Lateral mobility of CXCR4, but not of CD4 receptor, is 
markedly reduced upon AC8 mAb binding to macrophages. Cells 
were incubated with AC8 or left untreated prior to staining with 
antibodies specifi c to CD4 (A), CXCR4 (B), or a nonraft protein 
CD2 (C), and the lateral mobility of the molecules at 22°C was 
monitored by FCS imaging. Figures show representative fl uores-
cence autocorrelation curves for CD4, CXCR4, and CD2 in  control/
untreated (dashed line) and AC8-treated cells (solid line), 
respectively. 
 TABLE 1. Translational mobility of HIV receptors on target cells 
assessed by FCS imaging 
Epitope/Marker
Diffusion Coeffi cientD ± SD (  m 2 /s)
Control + AC8 ACHA
CXCR4/APC-anti-CXCR4
mAb
0.17 ± 0.05* (n:26) 0.10 ± 0.02* (n:32)
CD4/Alexa 488-anti-CD4 
mAb
0.10 ± 0.01 (n:22) 0.12 ± 0.03 (n:34)
CD2/Alexa 647-anti-CD2 
mAb
0.15 ± 0.02 (n:23) 0.16 ± 0.03 (n:18)
Membrane cholesterol/
Alexa488-AC8
NA 0.20 ± 0.04 (n:16)
*The difference is signifi cant between control and ACHA-treated 
cells ( P < 0.01). Numbers in parentheses denote the number of cells 
measured. NA, not applicable .
 Fig. 6. Monoclonal ACHAs substantially inhibit in vitro HIV pro-
duction of human T-cells and macrophages. MT-4 cells (A, C) and 
MDM cells (B, D) were infected with IIIB and Ada-M strains of 
HIV-1, respectively. Either the cells (A, B) or the viruses (C, D) 
were incubated with different concentrations of monoclonal 
ACHAs (black columns for AC1 and white columns for AC8) or left 
untreated (gray columns) for 1 h, prior to virus infection (see 
protocol 1 in Materials and Methods). Virus production, measured 
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membranes with high cholesterol content or the same 
probes in fl uid membrane phases, respectively ( 25). The 
size of the antibody label may partly be responsible for 
these differences. However, since the diffusion of mem-
brane cholesterol is mostly controlled by the membrane 
environment rather than the extracellular aqeous phase 
(where the antibody is located), the slower diffusion also 
indicates that the AC8 cholesterol complexes diffuse in 
large, cholesterol-enriched microdomains. 
In untreated control cells, the HIV-1 receptor CD4 
diffused slower than the nonraft membrane protein CD2, 
and the diffusional rate of CXCR4 was signifi cantly higher 
than that of CD4. The lateral mobility of CXCR4 but 
not of CD4 decreased substantially upon AC8 binding. 
The selectivity of AC8 effect on CXCR4 mobility is also 
demonstrated by the unaffected mobility of CD2 nonraft 
protein on the same cells. These data, and the similarity 
in diffusion coeffi cients of CD4 and CXCR4 after AC8 
binding, are consistent with the picture that AC8 colocal-
izes the chemokine receptor and CD4 into the same 
compartment.
Based on these substantial changes in the dynamic 
membrane organization of HIV-1 receptors, it is postulated
restrict somehow CXCR4 mobility and seemingly bring 
together the two critical HIV-1 receptor proteins into the 
same membrane microdomain, resulting in a crowding 
of these proteins. This may prevent attachment of the 
virus by “pulling together the carpet” necessary for mul-
tiple binding of viral glycoproteins to the surface of tar-
get cells. 
The lateral diffusion properties of the molecules in-
volved in HIV-1 entry, i.e., cholesterol, CD4, and CXCR4, 
gave further support to this view. The AC8 antibody bound 
to membrane cholesterol diffused moderately and strongly 
slower than small fl uorescent cholesterol probes in model 
 Fig. 7. The presence of ACHAs postinfection is not required for 
the inhibition and the antibodies are not cytotoxic. The virus pro-
duction under different conditions (see protocols 2 and 3 in Mate-
rials and Methods) is shown in panels A and B. A: MT-4 cells and 
MDM cells were infected with IIIB and Ada-M strains of HIV-1, re-
spectively. Monoclonal ACHAs were either not added to the cells 
(left columns), were preincubated with the cells and washed out 
(middle columns), or not washed out (right columns) after viral 
infection. B: ACHA level decreased in the culture supernatant of 
MT-4 cells postinfection as assessed by ELISA. MT-4 cells in the ab-
sence (left column) or presence (middle and right columns) of 
ACHA were infected with HIV-1. In order to maintain a constant 
level of ACHA (5 μg/ml) postinfection, the culture medium was 
continuously supplemented with the Ab (right column). Virus pro-
duction, measured by RT assay, is displayed in dpm units as mean ± 
SD from three independent measurements. C: Viability of MT-4 
cells and MDM cells treated with serially diluted concentrations of 
ACHA was determined after the whole assay period by Cell Titer 
assay and displayed as survival percentages (calculated from tripli-
cates of cell samples). Viability of the untreated target cells was 
taken as 100%. 
 Fig. 8. A schematic model of the interference between ACHAs 
and HIV-1 attachment to T-cells and macrophages. A: HIV-1 enters 
the target cells through cholesterol-enriched membrane micoro-
domains (lipid rafts or caveolas). Interactions between viral glyco-
protein, gp120, and raft-associated CD4 molecules result in 
conformational changes in gp120/gp41. Then, recruitment of 
CXCR4 chemokine receptors into the lipid rafts, near CD4-gp120 
complexes, enables interactions of gp120 with coreceptors and for-
mation of multimolecular complexes, resulting in attachment and 
internalization. B: Binding to HIV-1 permissive cells, the monoclo-
nal cholesterol-specifi c IgG antibodies (ACHAs) cross-link smaller 
microdomains, and remodel the HIV-1 receptor-coreceptor inter-
action pattern. Molecular crowding of the receptors/coreceptors 
into the same larger microdomain may prevent a proper spatial 
juxtaposition of viral glycoproteins (gp120/gp41) to CD4 and 
chemokine receptors, necessary for formation of supramolecular 
complexes essential for HIV internalization. This may lead to inhi-
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cholesterol also has a major role in these processes, 
cholesterol-specifi c antibodies may also merit consideration. 
In conclusion, the new cholesterol-specifi c mAbs, AC1 
and AC8, inhibit HIV-1 production of human T-cells and 
macrophages by acting on the plasma membrane and 
HIV-1 receptors of target cells ( Fig. 8 ), and not on the vi-
rus, as most known neutralizing antibodies do. They in-
terfere most likely with the virus attachment. Although 
some mechanistic details of their action on target cells 
remain open, we believe that the inhibitory effect and 
the basic background mechanisms described herein may 
be helpful in further studies to clarify the cholesterol de-
pendence of the attachment/entry mechanism, as well as 
may serve as a molecular basis for the development of 
new, combined lipid raft-oriented approaches in HIV-1 
therapy ( 26).
The authors are grateful to Erzsebet T. Veress for the skillful 
technical assistance. 
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a b s t r a c t
The GL7 epitope was originally described as part of a late lymphocyte activation antigen expressed in
mouse and widely used since then as a marker of germinal center. Here we report on its differential
expression by rat and human immune cells and lymphoid organs. Expression pattern of the GL7 epitope
in rats is similar to that described earlier in mice, namely that GL7 antigen appears only on lymphocytes
after 48 h activation. In humans lymphocytes, but not the differentiated cells of myeloid origin, express
this epitope. The GL7 epitope is up-regulated upon in vitro activation of primary T cells, while a slightly
decreased expression is found on B lymphocytes. Fluorescent immunohistochemistry shows discrete
location of GL7hi cells in human tonsil. GL7 antibody intensely stains CD19+, IgD+, IgMlow B lympho-
cytes found at the margin of B cell follicles. The GL7 epitope is constitutively and highly raft-associated
in human lymphoid cells. Strong neuraminidase- and partial papain-sensitivity of the GL7 epitope on
human lymphocytes indicates a sialic acid-containing epitope linked either to one (or more) membrane
protein(s) or to lipids. The lymphocyte-restricted GL7 epitope expression and the activation-dependent
bi-directional change in the amount of the epitope suggest a functional role for GL7 epitope linked to
carbohydrate-based immunoregulation.
© 2009 Elsevier B.V. All rights reserved.
1. Introduction
Glycosylation is an enzymatic process producing a diverse
repertoire of glycans linked to proteins, lipids or other saccha-
rides. An increasing number of studies show the importance of
glycosylation in pathogen recognition, in controlling homeostasis
and inflammation or in the maturation and activation of adaptive
immune cells [1,2]. Sialic acid (Sia) is a general term for a diverse
family of nine-carbon sugars that are all derived from neuraminic
acid (Neu) or keto-deoxynonulosonic acid (KDN). They are typically
found on the exposed termini of mammalian oligosaccharide chains
attached to cell surface proteins or lipids [3]. Sias are transferred
using 2–3, 2–6 or 2–8 linkages to subterminal sugars by a fam-
ily of about twenty sialyltransferases [4,5]. Siglecs are a family of
sialic acid binding proteins with immunoglobulin like domains, that
are known to influence various functions of mammalian immune
cells [6,7]. Most of them contains ITIM- and/or ITIM-like motifs,
just as CD22, indicating a negative regulatory role. Although sig-
naling and function of siglecs is still controversial, this question is
an intensely examined field of nowadays immunology.
∗ Corresponding author. Tel.: +36 1 381 2175; fax: +36 1 381 2176.
E-mail address: glorial@elte.hu (G. László).
1 They contributed equally to this work.
GL7, a rat monoclonal IgM antibody was produced against in
vitro activated mouse B lymphoblasts and described to bind to a
35 kDa late activation antigen expressed by mouse B and T lym-
phocytes [8]. All tested DNA, RNA and protein synthesis inhibitors
strongly prevented the expression of the GL7 epitope [8]. In lymph
node and spleen the GL7 staining pattern was found very similar to
that of peanut agglutinin (PNA) and so the GL7 epitope has become
a frequently used marker of germinal centers [9–12]. The epitope
has also been found on a small subpopulation of thymocytes [13].
In the mouse bone marrow the GL7 epitope is detectable as early
as on the pro-B/early pre-B cell stages and its expression becomes
very high on large pre-B cells but it is completely down-regulated
on mature naive resting B cells, so it may define the cycling stage
of B cell maturation [14,15]. In a study that compared functional
capacities of sorted and activated spleen and lymph node B lym-
phocytes, only the GL7+ cells proliferated and produced antibodies
[8,14]. Later the antibody was shown to recognize the Neu5Ac2-
6Gal1-4GlcNAc1-3Gal1-4Glc carbohydrate epitope [16]. Since
no single protein could be identified clearly as a well defined anti-
gen, the question arises whether the epitope is linked to a single
protein or a mixture of various cell surface glycosylated proteins
and/or lipids.
Maturation and activation of B cells are accompanied with an
elevated -galactoside 2,6-sialyltransferase (ST6Gal I) level. This
enzyme is responsible for the attachment of 2,6-linked Sias to
0165-2478/$ – see front matter © 2009 Elsevier B.V. All rights reserved.
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Gal1,4-GlcNAc-R termini in lymphoid cells [17,18]. CMP-Neu-
5Ac hydroxylase (CMAH) was shown to convert N-actylneuraminic
acid (Neu5Ac) to N-glycolylneuraminic acid (Neu5Gc). These two
enzymes are considered as key players in regulation of GL7 level in
mice. Due to a mutation that occurred after our segregation from
the great apes, CMAH hydroxylase activity had been lost in humans
and significant changes in binding preferences and expression pro-
file of certain siglecs have also been resided [19,20].
The present study thus aimed at comparing GL7 epitope expres-
sion and membrane localization in rat and human immunocytes
and lymphoid tissues, with the purpose to understand how the
appearance of this epitope at discrete sites of the immune system
may correlate with the major events of immune cells activation
and function. Our results show that although human peripheral
lymphocytes constitutively express the GL7 epitope due to the
absence of CMAH activity, the expression level of GL7 epitope can
further increase or decrease upon activation of T and B lympho-
cytes, respectively. The correlation pattern between GL7 epitope
expression and binding of various lectins to the surface of human
immunocytes further confirms that the 2,6-linked Neu5Ac is
involved in the GL7 epitope in human as well. The expressed GL7
epitope (possibly attached to protein or lipid molecules) is highly
raft-associated in lymphoid cells. This and the spatially and tem-
porally selective expression pattern, which differs from that of
rodents, suggest a possible regulatory or adhesion functions of the
GL7 epitope-linked molecule(s) in human.
2. Materials and methods
2.1. Cells
Rat cell suspension was prepared from spleen after removing
erythrocytes with ACK lysing buffer (155 mM ammonium chloride,
10 mM potassium bicarbonate, 102 M disodium ethylenediamine
tetraacetate, pH 7.2) then culturing in DMEM (Sigma–Aldrich, St.
Louis, MO) supplemented with 2-mercapthoethanol and 10% FCS.
Ramos and Daudi human B lymphomas (American Type Cell Cul-
ture/ATTC), Jurkat human leukemic T cell line and THP-1 human
leukemic monocyte cell line were cultured in RPMI 1640 medium
supplemented with 10% FCS. Tonsils were obtained from St. Imre
Hospital and the buffy coat, obtained from healthy donors, was
provided by the Hungarian National Blood Transfusion Service.
Human B cells were isolated from tonsils using Ficoll-Hypaque
(Amersham, Uppsala, Sweden) and depletion of T cells with
2-aminoethylisothiouronium bromide (AET)-treated sheep ery-
throcytes. Human CD4+ T lymphocytes were isolated from buffy
coat with RosetteSep® Human CD4+ T Cell Enrichment Coctail
(StemCell Technologies, Vancouver, BC, Canada) according to the
manufacturer’s protocol. Isolated primary lymphocytes were main-
tained in RPMI 1640 medium supplemented with 10% FCS and
gentamycin. Peripheral blood mononuclear cells (PBMCs) were
isolated from buffy coat with Ficoll-Hypaque. DCs were differen-
tiated from blood monocytes as described by Csomor et al. [21].
Human granulocytes were purified from buffy coat by combining
the dextran sedimentation method with a Ficoll-Hypaque gradi-
ent procedure as described previously [22]. All experiments with
human samples were in accordance with national regulations and
were authorized by the ethical committee of the institute.
2.2. Activation of cells
To activate cells, rat splenocytes were cultured in the presence of
5 g/ml ConA (Sigma–Aldrich), or of 10 g/ml LPS (Sigma–Aldrich).
Primary B cells were activated with 10 g/ml F(ab′)2 fragment
of goat anti-human IgG + IgM (Jackson ImmunoResearch, Suffolk,
UK). T lymphocytes were stimulated with 10 g/ml of anti-human
CD3 on coat (ImmunoTools, Friesoythe, Germany).
2.3. Immunofluorescence labeling of cells and flow cytometry
Activated or control rat spleen cells were also analyzed in
terms of the GL7 epitope expression. To distinguish rat splenic
cell populations, cells were stained with FITC-conjugated anti-rat
CD3 (Invitrogen-Caltag, Eugen, OR) and mouse biotin-conjugated
anti-rat IgM (MAR2/2 clone from Eotvos Lorand University, ELU,
Budapest, Hungary) followed by incubation with avidin-FITC
(Sigma–Aldrich).
Lymphocytes and myeloid cells were incubated with mono-
clonal GL7 antibody (GL7 clone from Gloria Laszlo, ELU), washed
and incubated with FITC-conjugated mouse anti-rat IgM (MAR2/2
clone from ELU) or Alexa Fluor647-conjugated goat anti-rat IgM
(Invitrogen-Molecular Probes, Eugene, OR). To distinguish blood
cell populations, PBLs were stained with antibodies specific to
different cell types: anti-human CD4-FITC (ImmunoTools) and
anti-human CD8-PE (ImmunoTools) for T cell subpopulations,
biotin-conjugated anti-human CD19 (BD Pharmingen, San Jose, CA)
and avidin-FITC (Sigma–Aldrich) as secondary reagent for B cells,
and anti-human CD14-PE (Santa Cruz Biotechnology, Santa Cruz,
CA) for monocytes. The purity of granulocytes was determined by
staining with anti-human CD66abce-FITC (Dako, Glostrup, Den-
mark), and the purity of DCs was monitored using anti-human
CD11c-Alexa Fluor647 (AbD Serotec, Oxford, UK). In some experi-
ments, cells were stained at first with biotinylated Sambucus Nigra
Lectin (SNA), biotinylated Maackia Amurensis Lectin II (MAA) (Vec-
tor Laboratories, Burlingame, CA) or biotinylated Peanut Agglutinin
(PNA) (Sigma–Aldrich) lectin, and washing was followed by incu-
bation with avidin-FITC.
Activated lymphocytes were labeled with different activation
marker-specific antibodies. Activated B cells were labeled with GL7
Ab in combination with the following antibodies: Alexa Fluor647-
conjugated cholera toxin B-subunit (CTX-B) (Invitrogen-Molecular
Probes), anti-human MHCII-FITC (BD Pharmingen) and anti-human
CD86 (ImmunoTools)/Alexa Fluor488-conjugated goat anti-mouse
IgG1 (Invitrogen-Molecular Probes). Activated T lymphocytes were
stained with GL7 antibody and CTX-Alexa Fluor647, anti-human
CD69-APC (BD Pharmingen), anti-human CD25-APC (BD Pharmin-
gen). All incubation steps were performed at 4 ◦C for 20 min. The
washing was carried out with ice-cold FACS buffer (PBS sup-
plemented with 1% FCS). Isotype control antibodies were used
as negative controls in all experiments: rIgM (ROX4, clone from
ELU), mIgG1-FITC (PPV-06, ImmunoTools), mIgG1-PE (PPV-06,
ImmunoTools), mIgG1-biotin (PPV-06, ImmunoTools), mIgG1-APC
(MOPC-21, BD Pharmingen) and affinity purified mIgG1 (15H6,
Southern Biotech, Birmingham, AL).
Twenty thousand cells were collected and analyzed in a FAC-
SCalibur flow cytometer (Becton-Dickinson) using CellQuest Pro
software, and then analyzed with FCS Express 3 software (De Novo
Software, Los Angeles, CA).
2.4. Enzymatic treatment of cells
In some assays cells were exposed to a limited papain digestion
(Sigma–Aldrich) (20 U/ml) for 20 min at 37 ◦C in Hank’s balanced
salt solution (HBSS, pH 6) (Sigma–Aldrich). This treatment served
to remove long protruding extracellular domains of glycoproteins.
Cells were then washed extensively with ice-cold FACS buffer and
stained as described previously.
To remove sialic acid residues from cell surface, cells were
incubated with 50 mU/ml neuraminidase form Vibrio cholerae
(Sigma–Aldrich) for 30 min at 37 ◦C in HEPES buffered saline (HEBS)
buffer (20 mM HEPES, 140 mM natrium chloride, 1 mM calcium
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Fig. 1. Expression of GL7 is activation dependent in rat lymphocytes. GL7 epitope
expression of freshly prepared rat spleen cells (A) or activated T and B lymphocytes
(B) were analyzed by flow cytometry. Representative flow cytometric histograms of
three independent measurements are displayed. Thick line shows GL7 Ab binding
and thin line corresponds to the isotype control.
chloride, pH 7). Washed cells were then stained as described pre-
viously.
2.5. Flow cytometric detergent resistance measurements (FCDR)
Detergent resistance of some cell surface molecules were deter-
mined by the method of Gombos et al. [23]. Briefly, Ramos B
cells (106 ml−1) were treated or not with 10 mM methyl-beta-
cyclodextrin (MBCD) (Cyclolab, Budapest, Hungary) for 15 min
at 37 ◦C in phosphate buffered saline (PBS). After washing, cells
were labeled with biotinylated GL7 antibody and Alexa Fluor647-
conjugated streptavidin (Invitrogen-Molecular Probes), CTX-Alexa
Fluor647 or anti-human CD71 and Alexa Fluor647-conjugated
goat anti-mouse IgG2a (Invitrogen-Molecular Probes) as described
previously. Labeled cells were measured on a FACSCalibur flow
cytometer before and 10 min after mixing cells with 0.1% (final con-
centration) cold Triton X-100 (Sigma–Aldrich). The calculation of
detergent resistance (FCDR) is detailed elsewhere [23].
2.6. Confocal microscopy
Activated rat lymphocytes or human cell lines and primary T
or B cells were labeled with GL7 antibody in combination with
CTX-Alexa Fluor647. Cells were also incubated with anti-human
CD71-Alexa Fluor488 (Exbio, Prague, Czech Republic) as described
previously. Stained cells were mounted on coverslips and assayed
with an Olympus Fluoview 500 confocal microscope (Hamburg,
Germany) equipped with four optical channels, using a 60× (N.A.:
1.45) objective.
Fig. 2. GL7 is expressed only by lymphocytes among human blood cells. Different blood cell populations were stained for GL7 in combination with cell-type specific antibodies.
Flow cytometric histograms of lymphoid (A) and myeloid (B) blood cells are shown. Relative mean of fluorescence (RMF) was calculated from mean fluorescence intensity
(MFI) of GL7 Ab staining (thick line) divided by the MFI of isotype control binding (thin line). Plots are representatives of three independent measurements.
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Colocalization indices were determined from ∼100
ROIs (region of interest)/sample using the ImageJ software
(http://rsbweb.nih.gov/ij), with the appropriate colocalization
plugin. The Pearson’s colocalization index (CI) provides a reliable
estimate on the extent of protein colocalization: CI values close
to zero indicate no or a very low degree, while CI ≥ 0.5 reflects a
high degree of colocalization; CI = 1 corresponds to a full overlap
between the two colors in each pixels of the image.
2.7. Fluorescence immunohistochemistry
Five m thick cryosections of human tonsil samples were placed
on Superfrost Ultra Plus slides (Thermo Scientific, Walthem, MA),
fixed with 4% paraformaldehyde and kept at 4 ◦C in PBS until stain-
ing.
Unspecific antibody binding was blocked with 10% FCS in
PBS (30 min at room temperature). Samples were incubated
for 45 min at room temperature with the following antibod-
ies and reagents in different combinations: affinity purified or
biotinylated GL7 antibody (eBiosience, San Diego, CA), anti-human
CD19 (BD Pharmingen), biotinylated anti-human IgD (Southern
Biotech) antibodies, and SNA-biotin or MAA II-biotin in PBS con-
taining 1% FCS. Washing was followed by incubation (45 min
at room temperature) with secondary antibodies and reagents
or directly labeled antibodies: FITC-conjugated anti-rat IgM for
GL7 Ab, Alexa Fluor647-conjugated anti-mouse IgG1 (Invitrogen-
Molecular Probes) for anti-CD19, streptavidin-Alexa Fluor488
or -Alexa Fluor647 (Invitrogen-Molecular Probes) for biotiny-
lated antibodies/lectins, anti-human CD3-PE (ImmunoTools) and
anti-human IgM-Cy5 (Jackson ImmunoResearch). Isotype control
antibodies were used as negative controls: previously specified
(see Section 2.3) antibodies and rIgM-biotin (R4-22, BD Pharmin-
gen). Washed samples were assayed with an Olympus Fluoview
500 confocal microscope using a 10× objective.
3. Results
3.1. GL7 shows similar expression profile among rodents
Neu5Ac, part of a recently shown carbohydrate epitope recog-
nized by GL7 Ab is commonly expressed in mammals. GL7 mAb
was originally produced in rats so we were interested if the anti-
body binds to rat cells. Neither T nor B cells of freshly prepared rat
spleen were GL7+ (Fig. 1A). However 48–60 h after in vitro activa-
Fig. 3. High amount of GL7 expressing human tonsillar cells are IgD+, IgMlow B cells. Cryosections of human tonsils were stained with GL7 Ab and anti-human IgD (A) or
anti-human IgM (B), and assayed by confocal microscopy. Visualization of IgD+ and IgM+ cells is also shown (C). Images are representatives of three independent experiments.
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tion a high GL7 epitope expression was observed on both B and T
lymphocytes (Fig. 1B), similarly to the earlier finding in mice.
3.2. In human GL7 is expressed only on lymphocytes but not on
cells of myeloid origin
Previously it was demonstrated that GL7 epitope is expressed
by various human B cell lines [16]. In order to see which human
immunocytes express the antigen, PBMCs and granulocytes were
isolated from buffy coat and their GL7 expression was monitored
by flow cytometry. In addition, DCs, differentiated from monocytes,
were also analyzed. Among human blood cells, B and T lymphocytes
are GL7+ (Fig. 2A), while monocytes, granulocytes and DCs (Fig. 2B),
even in mature stage, do not express the GL7 epitope on their sur-
face. Furthermore, B cells express approximately fourfold more GL7
epitope than T cells (Fig. 2A). Thus, in human the GL7 epitope seems
to be constitutively expressed, but exclusively on lymphocytes.
3.3. GL7 antibody firmly stains the border of germinal centers in
human tonsil
Since the expression profile of GL7 epitope differs among human
and rodent immune cells under normal conditions, as a next step,
we analyzed the presence of GL7 epitope and other carbohydrate
patterns in human lymphoid organs. Therefore, tonsil cryosections
were incubated with GL7 antibody or various lectins in combination
with antibodies specific to different cell types. The immunocy-
tochemically stained samples were then assessed by confocal
microscopy. The GL7 epitope is not homogenously expressed in
the human tonsil. GL7hi cells are located in the border of B cell
follicles, as these cells are CD19+, IgD+ IgMmed B cells (Figs. 3 and
4A). Comparing the staining pattern of GL7 antibody and differ-
ent lectins in the human tonsil, GL7 Ab and MAA II (2–3 sialic
acid specific) lectin showed disparate staining with a preferential
binding of MAA II to CD3+ T lymphocyte regions (Fig. 4B). In con-
trast, GL7 Ab and SNA (2–6 sialic acid specific) lectin displayed
an overlapping staining with their preferential binding to CD19+ B
cell regions over T lymphocytes (Fig. 4C). Nevertheless SNA has a
broader binding spectrum by intensive staining of whole germinal
centers. PNA lectin, dominantly recognizing the galactosyl-1-3-N-
acetylgalactosamine motif, intensely stained germinal centers and
small capillary vessels (data not shown) showing a staining pat-
tern distinct from that of GL7 Ab. These data together indicate that
the GL7 epitope in human also contains the dominant 2,6-linked
Neu5Ac residue.
3.4. Further insight into the nature of the GL7 epitope in human
lymphoid cells
We also examined whether there is correlation between the
binding of GL7 Ab and different lectins to cell surface. This is an
interesting question, since the glycan expression profile is usually
cell-type specific. Binding of GL7 Ab and SNA lectin to 6 different
human T and B cell lines and primary lymphocytes showed strong
positive correlation, whereas MAA II lectin and GL7 Ab displayed a
strong negative correlation in staining of cells. The PNA lectin lack-
ing sialic acid specificity showed no correlation at all with GL7 Ab
staining (Fig. 5A).
In order to characterize the nature of the GL7 epitope, the diges-
tion profile of neuraminidase and papain was compared for GL7 Ab
and various lectins. Treatment of cells with neuraminidase from
Vibrio cholerae completely abrogates binding of GL7 Ab and MAA
II lectin, while only a partial decrease of SNA lectin binding was
observed. The carbohydrate motif recognized by PNA lectin became
more exposed upon neuraminidase digestion (Fig. 5B). Papain with
a cleavage site of Phe-X–Y (X: non-specific, preferably Arg or Lys;
Fig. 4. GL7 Ab strongly stains the border of B cell follicles showing distinct staining
pattern compared to plant lectins. Tonsillar cryosections were stained with GL7
Ab (A), simultaneously with anti-human CD3 and anti-human CD19 and visualized
by confocal imaging. Binding of 2–3 specific MAA II lectin (B) and 2–6 specific
SNA lectin (C) is also displayed. Images are representatives of three independent
experiments.
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Fig. 5. Correlation of GL7 expression with lectin binding to the cells surface and
enzyme sensitivity of the GL7 epitope. (A) Six different cell types (primary human
T and B lymphocytes, Ramos and Daudi human B lymphomas, Jurkat T and THP-1
monocyte cell lines) were stained with GL7 Ab, SNA lectin, MAA II lectin and PNA
lectin. GL7 expression shows strong positive correlation with SNA binding (upper
diagram). There is a strong negative correlation between binding of GL7 Ab and
MAA II (middle diagram), while no correlation is detected between GL7 Ab and
PNA binding (lower diagram). The data were fitted to linear regression program (R:
regression coefficient). (B) Human tonsillar B cells were treated with neuraminidase
from Vibrio cholerae, with papain from Papaya latex or left untreated, and binding
of GL7 Ab, SNA, MAA or PNA and anti-CD71 was analyzed. RMF values of controls
were taken as 100%.
Y: non-specific amino acid residue) almost fully removed the cell
surface CD71 from human B lymphocytes, while had only a par-
tial (25–30%) effect on the level of bound GL7 Ab, similarly to SNA
lectin. This suggests that the GL7 epitope cannot be linked to a single
papain-sensitive protein.
Fig. 6. GL7 is highly raft-associated in the membrane of human lymphocytes. Dif-
ferent human lymphocytes were stained with GL7 Ab and CTX-B or anti-CD71 and
analyzed by confocal microscopy. Representative confocal images of stained Daudi
cells are displayed (A). Colocalization indices (derived from ∼100 ROIs/cell type) are
also shown as mean ± SD for GL7 Ab and CTX-B or anti-CD71 (B).
3.5. GL7 is highly raft-associated on the lymphocyte surface
Since there are several sialoglycoproteins known to associate
and function with lipid rafts (e.g. CD24, CD44), the membrane local-
ization of the GL7 epitope was also analyzed by staining Ramos and
Daudi B cell lines and Jurkat T cells as well as primary T and B lym-
phocytes with GL7 antibody and CTX-B bound to GM1 ganglioside,
as a lipid raft marker. Anti-CD71 antibody was used to visualize
non-raft membrane regions. The GL7 epitope displayed a consti-
tutive and high extent of raft-association in the examined cells,
as indicated by the high colocalization index, whereas CD71-GL7
colocalization was weak or moderate (Fig. 6A and B). Furthermore,
activated rat and mouse lymphocytes also have high GL7-CTX-B
colocalization (data not shown). Flow cytometric detergent resis-
tance (FCDR) measurements were also carried out on Ramos B cells.
The FCDR index of GL7 falls between those of GM1 ganglioside
and CD71 (Table 1). MBCD treatment of cells, removing approx-
imately 40–50% of the plasma membrane cholesterol, made GL7
almost completely detergent soluble, which further confirms the
raft-association of the epitope.
Table 1
FCDR values of GL7 epitope, GM1 ganglioside and CD71 transferrin receptor mea-
sured on Ramos B cells.a.
Cell surface molecule FCDR
Control cells MBCD-treated cells
GL7 0.503 0.064
GM1 (raft resident) 1.000 0.449
CD71 (non-raft protein) 0.192 0.030
a Values are means of three independent measurements (S.E.M.: 0.3–8.5%).
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Fig. 7. Expression of the GL7 epitope is increased in human T lymphocytes and decreased in B cells upon activation. (A) Human periferal blood T cells were stimulated or not
with anti-CD3 and expression of the GL7 epitope was monitored by flow cytometry (left diagram). Simultaneously changes in the expression of CD69 and CD25 activation
markers and GM1-gangliozide was also monitored (right diagram). (B) Human tonsillar B lymphocytes were activated or not with anti-IgM + G and expression of the GL7
epitope was analyzed by flow cytometry (left diagram). Simultaneously changes in the expression of CD86, MHCII and GM1-gangliozide was also measured (right diagram).
Relative RMF values, taking expression levels 1 at 0 h (dashed line), are shown.
3.6. Activation bi-directionally affects GL7 expression in
lymphocytes
It was discussed by many papers [24,25], that glycosylation is
determined by differentiation and activation stage of a given cell
type. We were interested whether the expression of the GL7 epi-
tope is altered upon activation of human lymphocytes. In vitro
stimulation of human primary T and B lymphocytes was carried out
with anti-CD3 and anti-IgM + G, respectively. Expression of GL7 and
activation markers was assayed simultaneously, by flow cytome-
try. Interestingly, in activated T lymphocytes GL7 expression was
elevated, while in B lymphocytes the expression of the GL7 epitope
slightly decreased relative to the control/quiescent cells (Fig. 7).
When naïve (CD27−) B cells were activated and analyzed, we got
the same result (data not shown). This result shows that although
human lymphocytes constitutively express GL7, the epitope den-
sity is cell-type and activation dependent.
4. Discussion
Mammalian cells are covered by the so called glycocalyx,
consisting of glycoproteins, glycolipids and proteoglycans. The
biosynthesis of these glycan chains involves more than sixty
glycan-modifying enzymes the expression of which is differen-
tially regulated in various tissues and changing during ontogenesis
and/or activation. Sias are typical monosaccharide units on the
glycan chains of glycoproteins or glycolipids [1,3]. Siglecs are a
growing family of lectins with selective binding to Sia-containing
carbohydrate motifs and are thought to play an important role in
immune regulation [7]. Most cells in the mouse and also in the
human immune system express one or more siglecs. Each siglec
has a unique specificity for sialylated ligands and most of them
contain intracellular signaling motifs suggesting mediation of dis-
tinct or partially overlapping regulatory or adhesion function [6].
CD22, an 2,6-sialylated glycan binding siglec undoubtedly plays
an important role in regulating B cell activation, however the exact
mechanism of this regulation is still unclear [26].
GL7, a rat monoclonal IgM was also shown to recognize 2,6-
sialylated glycans, but in contrast to CD22 it prefers Neu5Ac but
not Neu5Gc in mice [16]. GL7 showed differential staining pattern
in mice and recently, a negative correlation between GL7 and CD22
epitope expression in activated mouse B cells was demonstrated
[14,16]. This is due to the inactivation of CMAH enzyme, convert-
ing Neu5Ac to Neu5Gc, in activated lymphocytes. Since a mutation
occurred in the Cmah gene during evolution, Neu5Gc is not found
in human [20]. As a result of this mutation, in contrast to rodents,
human lymphocytes constitutively and exclusively express the
Neu5Ac-containing GL7 epitope among peripheral immune cells
and its level bi-directionally changes upon activation. Contrary to
mouse CD22, human CD22 equally well binds either Neu5Ac or
Neu5Gc but the binding capacity is also dependent on underlying
sugar motifs. It was published that CD22 but not GL7 Ab binding
prefers sulfated glycans [27]. This suggests that the preferential
epitope in human is also different for GL7 Ab and for CD22. It was
also demonstrated that B lymphocytes in germinal centers almost
completely lack the sulfated determinants, but weakly expressed
the non-sulfated ones [27]. This finding is in good correlation with
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our results showing weak GL7 staining of germinal center B cells
but strong staining in the surrounding IgDhi area. Interestingly, in
mice GL7 and IgD expression showed strong negative correlation
in the spleen [17].
In humans not only the glycosylation pattern (caused by changes
in enzyme levels and activities) but the expression profile and
the specificity of certain carbohydrate binding receptors show sig-
nificant changes compared to rodents [16]. Also, the structure of
human secondary lymphoid organs show detectable histological
alterations [14]. Expression of GL7 epitope cannot be regulated
only by ST6Gal I and CMAH enzymes implicated in regulation of
GL7 level. Since Cmah gene is inactive in human, and ST6Gal is also
expressed by GL7− monocytes and DCs [20,28], further yet uniden-
tified enzymes should also be assumed to modulate the amount of
the epitope.
The characteristic signaling motifs in the intracellular part of
siglecs strongly suggest their role in cell signaling however the
ligands may also mediate inverse signals. CD22 was also shown
to influence T cell activation upon binding not fully characterized
ligands [29]. CD24 is a sialylated phosphatidyl-inositol anchored
membrane protein that is able to provide co-stimulatory signals
to T cells [26,30]. Moreover the newly identified siglec10 (siglec
G in mice) was recently shown to bind CD24 [31], although their
signaling function is completely unknown yet. The high and consti-
tutive raft-association of GL7 epitope observed on mouse, rat (data
not shown) and human lymphocytes suggest that GL7 epitope-
containing proteins may receive and transmit signals through lipid
raft.
Although previous precipitation results suggested a 35 kDa
membrane glycoprotein on activated mouse B cells [8], the nature
of the GL7 epitope bearing molecules is still unclear, consistent with
the full neuraminidase- and partial papain-sensitivity shown by the
present data. The GL7 carbohydrate epitope can be linked to either
one or more glycoproteins or glycolipids as well, depending on the
cell type.
In conclusion, the presented data clearly demonstrate that the
expression profile of GL7 is different in human and rodents. The
constitutively expressed GL7 epitope in human is lymphocyte-
restricted and shows an activation dependent bi-directional
regulation, up- and down-regulation in T and B cells, respectively.
The regulated expression and the strong raft-association of GL7 epi-
tope on either murine or human lymphocytes allow us to suggest a
functional role for GL7 epitope and/or some supposed counterpart,
however this function may be different in rodents and humans.
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The immunogenicity of cholesterol had been debated for long, because of its 
widespread distribution in mammalian cell membranes and lipoproteins and of its 
important and multifaceted biological role. Since 1977 several laboratories have 
reported on the complement system activation with involvement of cholesterol-
specific antibodies in mice and rabbit (Alving et al., 1996; Swartz et al., 1988). 
Furthermore, an interesting and surprising discovery was made that naturally 
occurring antibodies against cholesterol, with yet unknown functions, are present in 
normal human sera (Alving et al., 1989). Therefore, many workgroups started to work 
on generating monoclonal cholesterol-specific antibodies for investigating the role of 
natural ACHAs in cholesterol-dependent cell functions and diseases. Swartz et al. 
found cholesterol to be surprisingly immunogenic when they immunized mice with 
cholesterol-rich liposome together with lipid A as an adjuvant. The generated 
cholesterol-specific 2C5-6 mAb bound to crystalline cholesterol and lipoproteins, and 
had complement-fixing capacity (Dijkstra et al., 1996; Swartz et al., 1988). This 
antibody was later applied to visualize cholesterol in the skeletal muscle of rats 
(Clarke et al., 2000). Perl-Treves and co-workers used another strategy to produce 
monoclonal ACHAs. They have implanted cholesterol monohydrate crystals in the 
spleen of mice (Perl-Treves et al., 1996). The produced 58B1 monoclonal antibody 
did not recognize the cholesterol molecule itself, but rather defined molecular motifs 
exposed on some of the crystal faces. Direct visualization of plasma membrane 
clustered cholesterol with the 58B1 mAb could also be obtained, but only when cells 
were artificially enriched with cholesterol (Kruth et al., 2001). However, these 
monoclonal antibodies were all IgM type and none of them were capable of binding to
intact cell surface. 
In contrast, our novel IgG monoclonal antibodies, AC1 and AC8, bound with 
low/intermediate avidity to the membrane of murine and human lymphocytes and 
macrophage cell lines (Chapter 4, Figure 3). Their cell surface binding could be 
further enhanced by a limited papain digestion of long, protruding, extracellular 
protein domains (Chapter 4, Figure 3), indicating that the accessibility of the 
supposedly small epitope is a critical factor for Ab binding. When surface plasmon 
resonance experiments were utilized, a medium affinity binding of AC8 Ab was 
measured to cholesterol-rich liposomes used in generating the antibody (Chapter 7, 
Figure 1). These liposomes do not completely represent a cell membrane, but are 
suitable for estimation of the antibody’s affinity. Exposure of cholesterol epitopes 
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may change during apoptosis or under pathological conditions (e.g. tumors, pathogen 
infections, cardio-vascular diseases) possibly due to the alteration of molecular 
composition, curvature or ’surface smoothness’ of the involved membrane regions or 
other cholesterol-containing structures. In accordance with this, elevated ACHA level 
in human sera has been revealed in atherosclerosis, chronic viral infections (HIV-1 
and HCV) and cancer (Biro et al., 2003; Egri and Orosz, 2006; Horvath et al., 2001a; 
Horvath et al., 2001b). 
The high degree of colocalization between the IgG ACHA and CTX-B or anti-
caveolin-1 antibodies indicates that rafts and caveolae can be considered as 
preferential binding sites for ACHAs in the plasma membrane (Chapter 4, Figure 4; 
Chapter 5, Table 1). In lymphocytes and macrophages cholesterol is locally enriched 
in lipid rafts or, to a lesser extent, in clathrin-coated pits (Matko and Szollosi, 2005), 
consistent with our findings. The AC8 Ab intracellularly colocalized with markers of 
Golgi complex and ER and more weakly with marker of lysosomes (Chapter 4, 
Figure 4).  These organelles have relatively high cholesterol content, since transport 
of cholesterol occurs through them (Smart et al., 1996; Underwood et al., 1998). 
Specificity of our antibodies was further confirmed using cholesterol-modulating 
agents. Either cholesterol oxidase or filipin III could substantially reduce binding of 
AC8 to either treated cells or DRMs (Chapter 4, Figure 5). These results all suggest 
that AC8 Ab is capable of marking cholesterol-rich lipid raft microdomains (reviewed 
in Chapter 6). Binding properties of the new IgG ACHAs allow further possible 
applications in the study of lipid rafts in functions of immune cells, such as antigen 
presentation by APCs (Gombos et al., 2004; Poloso and Roche, 2004), receptor-
mediated signal transduction in lymphocytes or myeloid cells (Pizzo and Viola, 2004) 
and the uptake of various pathogens and particles (e. g. influenza virus, apoptotic 
bodies) by phagocytes (Rosenberger et al., 2000; Yoshizaki et al., 2008). The question 
is whether binding of ACHAs to the membrane microdomains of these cells can 
modulate raft-dependent processes and, if so, how. However, such modulatory effects 
are most likely limited to those cells to which ACHAs can bind to a sufficient extent. 
The ability of monoclonal IgG ACHAs to modulate immune functions was 
demonstrated by our collaboration partner, who found that target cell-bound AC1 and 
AC8 antibodies could inhibit in vitro HIV-1 (x4 T-tropic IIIB and R5 Ada-M strains) 
production (Chapter 7, Figure 6). This inhibition might be dependent on cell type, 
the nature of the virus strain, and the assay conditions. The inhibitory effects of AC1 
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and AC8 cholesterol-specific antibodies on monocyte-derived macrophages and MT-
4 T cells were comparable to those previously reported for anti-PIP antibody 
exhibiting neutralizing activity and blocking infection of PBMCs by two primary 
isolates of HIV-1 (Brown et al., 2007). Washing out of ACHAs prior to (or after) 
infection or their continuous supplementation throughout culturing did not 
significantly affect the final HIV-1 production. This suggests that the most likely 
phase that is inhibited is the attachment/anchorage of the virus to the target cell 
surface (Chapter 7, Figure 7).
Receptors, co-receptors in the cell membranes are usually not randomly 
distributed and, among others, their lipid environment can also control their 
movement and interactions. As shown by a body of data, cholesterol is indeed 
required for the interaction between gp120/gp41 trimers on the surface of HIV-1 and 
their receptor/co-receptor counterparts on the target cells. It seems that cholesterol is 
a critical lipid for stabilization of co-receptor protein clusters with multiple 
membrane-spanning helices in raft microdomains, such as most, but not all 
chemokine receptors (Pucadyil and Chattopadhyay, 2006). 
In the plasma membrane of the investigated cell types, CD4 is constitutively 
and highly, whereas CXCR4 is much more weakly raft-localized (Chapter 7, Figure 
3). Their localization and clustering in distinct membrane microdomains on HIV-1 
permissive target cells was proposed earlier (Kozak et al., 2002). Binding of the 
cholesterol-specific mAb (AC8), but not of its Fab fragment or antibodies against 
non-raft membrane proteins, to the cells increased both CD4-CXCR4 colocalization 
and the raft-association of CXCR4 by approximately two-fold (Chapter 7, Figure 4).
These observations, confirmed by FRET data (Chapter 7, Figure 4) and ganglioside 
staining (Chapter 7, Figure 2), together suggest a view that ACHAs may induce 
lateral clustering of cholesterol-rich lipid rafts (or caveolas) and thus modulate the 
interaction pattern between raft gangliosides, CD4 and CXCR4, which are all critical 
in membrane attachment/entry of the virus. Lateral diffusion features (assessed by 
FCS measurements) of the HIV-1 receptors, CD4 and CXCR4, gave further support 
to this view. In untreated control cells the CD4 diffused slower than the non-raft 
membrane protein CD2, and the diffusional rate of CXCR4 was significantly higher 
than that of CD4. The lateral mobility of CXCR4 but not of CD4 decreased 
substantially upon AC8 binding, having thereby these two recpetors similar diffusion 
coefficients (Chapter 7, Figure 5 and Table 1). The 2D diffusion of CD2 has been 
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left unchanged that substantiates the selectivity of AC8 effect on CXCR4 mobility 
(Chapter 7, Figure 5). All these data are consistent with the picture that AC8 
colocalizes (engages) the chemokine receptor and CD4 into the same compartment. It 
has been revealed earlier that the diffusion of CD4 could be restricted by elevated 
expression of GM3 ganglioside in a mouse T cell line (Rawat et al., 2008). This, in 
turn, reduced HIV-1 Env-mediated fusion by interfering with the lateral association 
of HIV-1 receptors (Rawat et al., 2004). 
Based on these substantial changes in the dynamic membrane organization of 
HIV-1 receptors without masking the CD4 and CXCR4 HIV-1 receptors (Chapter 7, 
Figure 1), it is postulated that the AC8 mAb can ’mimic’ the action of viral 
glycoprotein gp120 in terms of co-aggregating HIV-1 receptors and co-receptors 
(Chapter 7, Figure 8). These data also concur with the findings that gp120-CD4 
engagement leads to a cholesterol-sensitive lateral redistribution of membrane 
microdomains and a subsequent assembly of the virus internalization complex 
(Manes et al., 2000). Furthermore, Nguyen et al. demonstrated that anti-CD4 beads 
occurred dynamic reorganization of chemokine receptors and lipid rafts to the site of 
CD4 engagement (Nguyen et al., 2005). Similarly, substantial reorganization of ErbB 
membrane proteins was reported upon cross-linking of gangliosides through cholera 
toxin B in breast tumor cells (Nagy et al., 2002). 
Induction of broadly neutralizing antibodies is an essential prerequisite of an 
effective anti-HIV-1 vaccine. These antibodies can be specific to Env glycoproteins 
of the virus, such as 2F5, 4E10 or 2G12 (Calarese et al., 2003; Kunert et al., 2004; 
Zwick et al., 2004). However, alternative approaches for interfering with HIV-1 entry 
to target cells utilizing drugs or antibodies against cellular structures (CD4, 
chemokine receptors, HLA class I and II, adhesion molecules) involved in the entry 
process seem to be equally important (Phogat et al., 2007). Since cholesterol also has 
a major role in these processes, cholesterol-specific antibodies may also merit 
consideration.
 Not just cholesterol, but several glycoconjugates in the mammalian cell 
membrane are also involved in the immune response. Sialic acid is frequently the 
glycan terminal sugar and it may modulate immune interactions. It can be found on 
both glycoproteins or glycolipids (Taylor and Drickamer, 2003). Siglecs are a 
growing family of lectins with selective binding to Sia-containing carbohydrate 
motifs and are thought to play an important role in immune regulation (Varki and 
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Angata, 2006). Most cells in the mouse and also in the human immune system 
express one or more siglecs. CD22, known to regulate B cell activation, is an 2,6-
sialylated glycan binding siglec, preferring Neu5Gc (Walker and Smith, 2008). GL7, 
a rat monoclonal IgM was also shown to recognize 2,6-sialylated glycans, but in 
contrast to CD22, it binds to a Neu5Ac-containing epitope in mice (Naito et al., 
2007). The CMAH enzyme, which converts Neu5Ac to Neu5Gc, may conversely 
regulate level of CD22 ligand and GL7 epitope. The other important enzyme that is 
implicated in the regulation of the GL7 epitope is the sialyltransferase ST6Gal I 
generating an 2,6-linkage of sialic acid to underlying N-acetyllactosamine 
(Weinstein et al., 1982). The amount of these and other enzymes, involved in sialic 
acid metabolism, is activation dependent. It has been demonstrated, that strong 
CMAH and moderate ST6Gal I repression occures in activated mouse B cells (Naito 
et al., 2007) that might contribute to the activation-dependent expression of GL7. 
Another workgroup found the upregulation of ST6Gal I gene expression upon B 
lymphocyte activation (Comelli et al., 2006), which also supports the appearance of 
the epitope. The inconsistency of the ST6GL I enzyme levels in the two experiments 
might be explained by the different assay conditions. 
An exon deletion in the Cmah gene eliminated human expression of Neu5Gc 
(Chou et al., 1998). As a result of this mutation, in contrast to rodents, human 
lymphocytes constitutively and exclusively express the Neu5Ac-containing GL7 
epitope among blood leukocytes (Chapter 8, Figure 2). Contrary to mouse, human 
CD22 equally well binds either Neu5Ac or Neu5Gc but it prefers sulfated glycans 
(Kimura et al., 2007). This suggests that the preferential epitope in human is also 
different for GL7 Ab and for CD22. Expression of GL7 epitope cannot be regulated 
only by ST6Gal I and CMAH enzymes, since active CMAH is absent in human, and 
ST6Gal I is expressed by GL7- immune cells as well, like monocytes and DCs (Chou 
et al., 1998; Videira et al., 2008). Therefore, further yet unidentified enzymes should 
also be assumed to modulate the amount of the epitope. 
In humans not only the glycosylation pattern (caused by changes in enzyme 
levels and activities) but the expression profile and the specificity of certain 
carbohydrate binding receptors show significant changes compared to rodents (Naito 
et al., 2007). Also, the structure of human secondary lymphoid organs shows 
detectable histological alterations (Cervenak et al., 2001). This finding is in good 
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correlation with our results showing weak GL7 staining of germinal center B cells but 
strong staining in the surrounding IgDhi area (Chapter 8, Figure 3), whereas in mice 
GL7 and IgD expression showed strong negative correlation in the spleen (Hennet et 
al., 1998). Interestingly, GL7 Ab and SNA lectin, known to be specific to 2-6 sialic 
acid, displayed an overlapping staining with their preferential binding to CD19+ B cell 
regions over T lymphocytes (Chapter 8, Figure 4). Nevertheless, SNA has a broader 
binding spectrum by intensive staining of whole germinal centers. This indicates that 
although GL7 Ab and SNA have 2-6 sialic acid epitope/ligand in common, but 
underlying sugar motifs or supposed amino acid or lipid moieties of the GL7 epitope 
determine binding of the Ab. 
The characteristic signalling motifs (usually ITIM) in the intracellular part of 
most siglecs strongly suggest their role in cell signalling and they ligands may also 
mediate inverse signals. CD24 is a sialylated GPI-anchored membrane protein that is 
able to provide costimulatory signals to T cells (Hubbe, 1994, 24, 731). Moreover the 
newly identified siglec10 (siglec G in mice) was recently shown to bind CD24 (Chen, 
2009, 323), although their signalling function is yet unknown. The high and 
constitutive raft-association of GL7 epitope observed on rodent and human 
lymphocytes (Chapter 8, Figure 6) suggest that GL7 epitope-containing proteins may 
receive and transmit signals through lipid rafts. 
Although previous precipitation results suggested a 35 kDa membrane 
glycoprotein on activated mouse B cells (Laszlo et al., 1993), the nature of the GL7 
epitope-bearing molecules is still unclear, consistent with the full neuraminidase- and 
partial papain-sensitivity shown by the present data (Chapter 8, Figure 5). Therefore, 
the GL7 carbohydrate epitope can be linked to either a single protein or to a mixture 
of various cell surface glycosylated proteins and/or lipids. 
In conclusion, the similarity between IgG ACHAs and GL7 antibody is that 
their specificity is unconventional, since both antibodies recognize epitopes other than 
amino acid residues of proteins. The monoclonal cholesterol-specific IgG antibodies 
are capable of marking lipid rafts and modulating cholesterol/raft-dependent functions 
of immune cells. One nice demonstration of it is that in vitro HIV-1 production of 
human T cells and macrophages could be inhibited by action of these antibodies on 
the plasma membrane and HIV-1 receptors of target cells. Therefore, the novel 
ACHAs, recognizing ’properly clustered membrane cholesterol only’, seem useful to 
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investigate the eventual role of cholesterol in the process of virus entry, as well as 
may serve as a molecular basis for the development of new, combined lipid raft-
oriented approaches in HIV-1 therapy.  Beside this inhibitory effect, IgG ACHAs may 
modulate other immune functions as well. In case of GL7 antibody, recognizing a 
Neu5Ac-containing epitope, the presented data clearly demonstrate that the 
expression profile of GL7 is different in human and rodents. Although, the presence 
of the epitope in human is also lymphocyte-restricted but it is constitutively 
expressed, while in mouse GL7 is a late activation antigen. The specific expression of 
the GL7 epitope and its high degree of raft-association on lymphocytes allow us to 
suggest a functional role for GL7 epitope and/or some supposed counterparts. 
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Summary
For their normal functions, cells require membrane integrity. Beside proteins, 
lipids and carbohydrates are also important cell membrane components. Using 
monoclonal antibodies, we studied the role of membrane cholesterol and sialic acid in 
the function of mammalian immunocytes. 
The new cholesterol specific IgG mAbs (AC1 and AC8), generated by us, 
bound to intact mouse and human immunocytes and they strongly colocalized with 
different lipid rafts markers, reflecting recognition of clustered cholesterol in live 
cells. A medium affinity binding of AC8 mAb to cholesterol-rich liposomes was 
estimated by surface plasmon resonance. The new monoclonal IgG ACHAs may thus 
serve as novel probes of membrane microdomains. This implicates further on the 
potential of ACHAs to modulate various raft-dependent functions of immune cells. In 
collaboration we have shown that these mAbs were able to inhibit in vitro HIV-1 
infection/production of virus permissive human cells. In human T cells or monocytes, 
AC8 mAb induced lateral lipid raft clustering and promoted the association of 
CXCR4 co-receptor with both CD4 HIV-receptor and the lipid rafts. Thus, the IgG 
ACHAs can alter the receptor/microdomain architecture at the surface of human 
macrophages and T cells. Further investigations are required to elucidate the 
modulatory role of IgG ACHAs in other immune functions. 
Using GL7 antibody that recognizes a sialic acid-containing epitope (GL7), 
our results show that this epitope is exclusively expressed by lymphocytes among 
human blood cells. In contrast to rodents, where GL7 is a late activation antigen, in 
human the epitope is constitutively expressed. In human tonsil, the GL7 epitope 
shows the highest expression in the B cell follicles by naïve B lymphocytes. 
Furthermore, in both B and T cells the epiotpe strongly colocalized with lipid rafts. 
The heterogeneous expression of GL7 on different B lymphocyte subsets and its 
lymphocyte-restricted presence indicate a role in lymphocyte function possibly via
recognition by some Sia-binding proteins. Additional studies are needed to find the 
GL7-bearing molecules and their supposed receptors. 
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Hungarian Summary – Összefoglalás 
A sejtek membránját fehérjék, lipidek, és szénhidrátok alkotják, melyek mind 
szükségesek a normális sejtm ködéshez. Monoklonális ellenanyagok segítségével 
vizsgáltuk a membrán koleszterin és sziálsav szerepét az immunsejtek m ködésében.
Kutatásaink során a munkacsoportunk által létrehozott új koleszterin-
specifikus ellenanyagokat (ACHA) alkalmaztuk. Ezen ellenanyagokról (AC1 és AC8) 
kimutattuk, hogy köt dnek a sejtmembránhoz. Antitestjeink a koleszterinben gazdag 
lipid raftokat és sejten belül is a lokálisan koleszterinben dús membrán struktúrákat 
(ER, Golgi-vezikulák) ismerik fel. Az AC8 ellenanyag közepes affinitással köt dik
koleszterin-dús liposzómákhoz. Az AC1 és AC8 antitestek a jöv ben a lipid tutajok új 
markerévé válhatnak. További eredményeink szerint az új IgG ACHA-k képesek 
gátolni az in vitro HIV-fert zést/termel dést. A gátlás hátterében az antitesteknek a 
célsejtek membránjához való köt dése áll. Ennek következtében a HIV-1 receptorok 
(f ként a CXCR4) egymáshoz, valamint lipid raftokhoz való helyzete megváltozik: a 
lipid raftok mérete növekedik, a CXCR4 raft-asszociációja fokozódik, membránban 
való mozgása lelassul. A vírus így nem képes a bonyolult, több lépéses horgonyzásra 
és ezáltal a célsejtbe való bejutásra. További kísérletek hivatottak feltárni 
ellenanyagaink moduláló szerepét más immunfolyamatokban. 
Egy sziálsav-tartalmú epitópot felismer  antitest (GL7) köt dési tulajdonságait 
is vizsgáltuk humán immunsejteken, melyr l korábban kimutatták, hogy aktivált egér 
T- és B-sejtekhez köt dik. Méréseink szerint a GL7 epitóp jelenléte emberben is 
limfocita-specifikus, azonban, egerekkel ellentétben, expressziója nyugvó, naív 
limfocitákon is kimutatható. Emberi mandulában a B-sejt follikulusok szélén 
elhelyezked  naiv B-sejtek mutatják a leger sebb GL7 pozitivitást. Más B-sejt 
populációk és T-sejtek kisebb mértékben expresszálják az epitópot. Továbbá 
kimutattuk, hogy a GL7 epitóp a limfocita membrán raftokban nagy gyakorisággal 
fordul el . A limfocita-korlátozott expresszió és az er s raft-asszociáltság arra utal, 
hogy a GL7 epitópnak szerepe lehet a T- és B-sejtek funkciójában, mely 
feltételezhet en valamely sziálsavat felismer  receptoron keresztül valósul meg. Az 
epitópot tartalmazó molekulá(k)nak és a felismre  receptor(ok)nak az azonosítása és 
jellemzése még további kísérleteket igényel. 
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